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ABSTRACT 
Jaagsiekte sheep retrovirus (JSRV) is the aetiological agent of ovine pulmonary 
adenocarcinoma (OPA), a contagious bronchioloalveolar carcinoma, which imposes 
a serious economic burden on the sheep farming industry. This study evaluated the 
immunological responses during experimentally induced JSRV infection and 
tumorigenesis in conventionally housed and specific pathogen free (SPF) neonatal 
lambs, and in adult field cases in the terminal stages of OPA. 
This study identified, for the first time, changes in cellular function in the 
peripheral blood ofJSRV-infected animals by measuring the in vitro 
lymphoproliferative response to various mitogens. The presence ofJSRV did not 
affect the level of response to phytohaemagglutinin (PHA) and pokeweed mitogen 
(PWM) stimulation, but a reduced response to concanavalin A (ConA) was 
demonstrated in the JSRV - infected animals. The reduced response to ConA was 
detected prior to the diagnosis of clinical symptoms and was also evident in the 
terminal stages of OPA. The presence ofJSRV also affected the mitogenicity of the 
mannose- specific, monocotyledonous Narcissus pseudonarcissus lectin (NPA). The 
level of proliferation was comparable between JSRV -infected and control lambs, but 
post -stimulation phenotyping revealed an altered phenotypic profile, with elevated 
numbers of T and B lymphocytes from JSRV -infected animals. Furthermore, the 
addition of exogenous marnose completely inhibited NPA mitogenicity in control 
but not in JSRV infected lambs. 
It has been established that NPA possesses insecticidal properties, which 
could potentially increase pest resistance in transgenic crops. During this study we 
revealed that NPA mitogenicity is age -dependent in sheep, with no 
lymphoproliferative response detected in adult animals. This research was extended 
to include human subjects, and we have shown that NPA is slightly mitogenic for 
adult lymphocytes but that mitogenicity is increased more than sevenfold for 
lymphocytes purified from umbilical cord blood. These findings indicate possible 
physiological implications as a result of introducing foreign lectins into human and 
animal food sources. 
v 
The peripheral blood mononuclear cells (PBMC) phenotypic profile was 
monitored during acute experimental JSRV infection, and also the immune status of 
natural OPA cases, in the terminal stage of the disease, was assessed. The PBMC 
were labeled using a panel of mouse monoclonal antibodies recognising sheep 
PBMC subsets, and results determined by flow cytometry. Neutrophils were counted 
also. The results confirmed the CD4 lymphocytopaenia and neutrophilia previously 
demonstrated in the blood of terminal OPA field cases. In contrast, no PBMC subset 
frequency alterations were detected, at any time in JSRV - infected lambs, which 
could have indicated an immunological response to JSRV infection. Moreover, the 
results showed that lymphocytopaenia and neutrophilia do not occur during 
experimentally induced infection leading to OPA. Hence, they are not an early event 
of tumorigenesis and may not be in direct response to JSRV infection but a 
consequence of secondary infections encountered during declining health. 
At necropsy, samples of lung and tumour were collected from JSRV -infected 
and control SPF lambs for immunohistochemical analysis. A novel aldehyde -free, 
zinc salts fixative (ZSF) originally produced for immunolabeling human samples 
was adapted and developed for ovine tissues. Antigen- retrieval steps were omitted 
with ZSF and immunolabeling of otherwise fixation- sensitive antigens was possible. 
This method also preserved the cellular morphology and delicate architecture of the 
lung tissue. No difference in the distribution of immune cells was identified in the 
non -affected area of the OPA lung when compared with the uninfected lung. 
Immunolabeling tumour samples revealed unexpectedly that very few tumour 
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1.1 Historical origins of ovine pulmonary adenocarcinoma 
Contagious bronchioloalveolar cancer now known as ovine pulmonary 
adenocarcinoma (OPA) is not a recently described disease. It's origins can be traced 
as far back as the nineteenth Century in South Africa, where it has been suggested 
that the disease was introduced by the importation of Spanish Merino sheep (Tustin 
1969, Wandera 1970). In the sheep farming regions of South Africa, harsh climatic 
and environmental conditions forced sheep farmers to live a semi -nomadic lifestyle, 
driving their flocks from one area to another, often over long distances, to provide 
adequate grazing for their animals. It was at the end of the sheep droves that 
shepherds began to detect clinical symptoms such as severe weight loss and laboured 
breathing. These symptoms were not restricted to a few isolated animals but were 
extensive enough to be regarded as a recognised disorder. The condition became 
known as driving sickness, Jaagsiekte, an Afrikaans term, "jaagt" meaning driving 
or droving and "siekte ", a corruption of the word ziekte meaning sickness. The term 
jaagsiekte was first used in a scientific context by Robertson (1904) and even today 
jaagsiekte is still a recognised alternative nomenclature for the disease also 
previously termed ovine pulmonary carcinoma (OPC) or sheep pulmonary 
adenomatosis (SPA) and recently renamed ovine pulmonary adenocarcinoma 
(OPA). 
1.2 Epidemiology 
Epidemiological studies of transmissible diseases in domesticated animals are 
an onerous undertaking as many parameters must be considered that affect the 
incidence. Sheep management policies vary considerably not only on a global scale 
but also at a regional level. For example the methods of farming lowland sheep 
2 
where considerable contact with the animals is maintained, are quite different from 
the relative isolation of hill sheep. Other factors include over -wintering conditions, 
breeding programmes, veterinary care and sheep management policies. 
The variations are aptly demonstrated when analysing the 1934 - 1952 cases 
of OPA in Iceland, where the mortality rate ranged from 50 -80% of sheep in some 
affected flocks. This outbreak was first identified in 1933, following the importation 
of rams from Germany, (Dungal et al 1938). Importation of sheep in the eighteenth 
and early nineteenth Centuries did not result in any OPA cases. Therefore the 
introduction of the Karakul breed in 1933 was regarded as the initial reservoir of 
infection (Tustin 1969, Palsson 1985). The mode of sheep management in Iceland 
has been strongly implicated in the spread of infection (Dungal 1938, Tustin 1969, 
Palssan 1985). On the mountainside, during the summer months, flocks from several 
farms intermingle freely. In autumn, flocks that may contain up to 4,000 sheep, are 
herded into large holding pens where they are separated for ownership by earmark; a 
process, which may take up to 3 days to complete. The individual flocks are then 
over -wintered in large sheep sheds for up to 5 months, depending on weather 
conditions. The unique nature of sheep farming and flock management in Iceland is 
ideally suited to the spread of infection (Verwoerd 1985). The subsequent eradication 
of OPA from Icelandic flocks was achieved only by severe culling. To date no 
recurrence of OPA has been reported in Icelandic flocks. 
1.2.1 Global distribution of OPA 
In Australia and New Zealand, only two cases of OPA have been reported 
despite the intensity of sheep farming, but OPA has been detected with varying 
prevalence in many major sheep farming regions worldwide. The primary source for 
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the epidemiological evaluation of OPA incidence was from the study of tissue 
samples obtained from abattoirs. The recorded incidence of OPA (based on such 
studies) was variable, for example, 0.08% in Spain (Dualde -Perez 1963), 0.1% in 
Peru (Cuba Caparo et al 1961), 0.2% in Northern Germany (Schultz et al 1965), 1.6- 
7.5% in Russia (Alley 1967), 10 -30% in Greece (Christodoulous and Tarlatzis 1952), 
and with up to 37% recorded in France (Moraillon and Yalcin 1967). The first 
recorded incidence of OPA in Malaysia was identified in purebred, imported sheep 
and crossbreeds in 1993 (Zamri -Saad et al 1995). Within a year an outbreak of OPA 
resulted, and subsequently more cases have been reported throughout the country 
(Krishnan and Paul 1994, Azman Shah et al 1996). 
OPA imposes a serious economic burden on the sheep farming industry due 
to the high mortality rates in infected flocks. During the Bulgarian epidemic, a 
mortality of 36% was recorded for some farms (Enchev 1961). In Greece between 
10% and 30% losses were documented (Christodoulous and Tarlatzis 1952), and up 
to 30% losses annually were calculated for some Kenyan (Shirlaw 1959) and South 
African farms (Tusin 1969). Regrettably the financial implications are not the only 
consequence of OPA. In 1987 Nieddu et al reported the presence of OPA in a flock 
of over 60 moufflon (Ovis munsimon) owned by the Wildlife Department of the 
Sardinian Government. With wild moufflon now designated as an endangered 
species, the purpose of rearing this flock was to return animals to the wild. 
Unfortunately measures to control the spread of infection were not employed early 
enough, resulting in spread to the indigenous wild population. 
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1.2.2 Epidemiology of OPA in Britain 
In the UK, a case of verminous pneumonia (Dykes and McFadyean 1888) 
retrospectively turned out to be the first description of OPA in Britain. This report, 
together with findings recorded by McFadyean (1920), were re- examined as a result 
of reports from South Africa (Robertson 1904, Cowdry and March 1927, de Kock 
1929) and it was concluded that verminous pneumonia was a misdiagnosis of OPA. 
The first major outbreak of OPA in Britain was reported in 1941 by 
Blakemore and Bosworth. It was located in Norfolk and implicated Scottish 
crossbreeds as the reservoir for infection. However, the first outbreak of OPA to 
actually occur in Scotland was not reported until 1946 by Harbour and Jamieson. The 
breeds implicated in this incidence were Scottish Blackface and half -breeds from 
Aberdeenshire and Berwickshire. A second outbreak in England, again in Norfolk, 
was reported by Stevens (1957). On this occasion the Scottish Greyface breed was 
involved. The significance of Scottish sheep in OPA outbreaks continued, from the 
observations by Mackay and Nisbet (1966) to the most recent British epidemological 
surveys, 1975 - 1981, recorded by Hunter and Munro (1983). 
Mortality, as a result of OPA, of less than 1% in British flocks was estimated 
by MacKay and Nisbet in 1966, but the mortality rate within affected flocks is now 
thought to be much higher. Studies of three flocks, over the period 1980 - 1981 
(Hunter and Munro 1983) and two flocks, studied over a five -year period, suggest a 
3% mortality (Sharp 1981). However, findings of the 1975 - 1979 and 1980 -1981 
Scottish surveys (Hunter and Munro 1983) report that 20% of all adult sheep, 
examined at post mortem, had OPA lesions; comparative studies undertaken by 
Williams and Ross (1983) estimate this figure at 21 %. These data may be grossly 
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underestimated as only a very small proportion of the sheep population undergo 
necropsy examination. Therefore the precise prevalence of OPA has not been 
determined. This emphasises the necessity for a reliable diagnostic test to identify 
OPA in the field, which would allow accurate, epidemiological surveillance. 
1.2.3 Breed and sex of animals affected by OPA 
Confirmed OPA cases have been detected in many breeds of sheep, 
throughout the world. However, there are conflicting opinions regarding the 
susceptibility to OPA in various breeds, with reports suggesting that the Icelandic 
Gottorp (Dungal et al 1938) and some British breeds such as Blackface, Greyface, 
Cheviot and Half -breed (Martin et al 1979, Hunter and Munro 1983) are highly 
susceptible, whilst other breeds are more resistant. There are many factors to 
consider in determining breed susceptibility, as the geographical location, climatic 
and environmental conditions are influential in determining the mode of husbandry 
and sheep management policies. A specific breed, indigenous or selected for its 
suitability to a particular mode of farming, is frequently the predominant breed 
within a region. Hence all the external factors pertaining to sheep farming within a 
region must be considered and comparisons made with other breeds farmed under the 
same conditions. It would be extremely difficult therefore to compare the 
susceptibility to OPA in breeds that are managed under very different conditions. 
Reports into gender susceptibility for OPA are conflicting, with some 
indicating an equal level of incidence in males and females (Damodaran 1960, Tusin 
1969) and others suggesting that males are more susceptible than females (De Kock 
1929, Kostenko 1968). As with breed susceptibility, external factors in the 
management of ewes and rams must be considered. It was observed by Mackay and 
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Nisbet in the 1966 survey, that rams and ewes are farmed in completely different 
ways. Rams are frequently intensely managed, housed together and receive more 
veterinary care than ewes. Furthermore, rams generally tend to be kept longer than 
ewes and therefore exposure to possible infection is increased, and also the time to 
develop OPA. 
1.3 The aetiology of OPA 
In a report from 1929, De Kock voiced his suspicions that OPA was a 
transmissible disease, but perhaps the first descriptions of a possible aetiological 
candidate preceded this when Robertson in 1904, described protozoan-like crescent - 
shaped bodies in OPA lesions. Mitchell (1915) however, discounted this theory, as 
his examination of OPA lesions did not detect any protozoa. Notwithstanding, the 
parasite theory was still upheld by McFadyean in 1920. Mycoplasmas as causative 
agents were examined (Mackay et al 1963) but rejected when it was found that they 
were not present in all OPA cases (Wandera 1971) and furthermore, that identical 
mycoplasmas to those identified in OPA were discovered in association with maedi 
visna, Pasteurella pneumonia and were also frequently isolated from the lungs of 
uninfected, healthy sheep (Mackay and Nisbet 1966, Wandera 1968, 1971, Jones 
1978). 
1.3.1 Evidence implicating a viral infection 
For many decades the aetiological agent of OPA remained elusive, but viral 
particles were detected in OPA tumours by Perk et al (1971), providing the first 
indication that a virus might be implicated. Morphologically the viral particles were 
characteristically retroviral, with the detection of type A particles in the epithelial 
cells. Furthermore, type C particles were described budding from the stromal cells in 
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the tumour nodule (the detection of type A and C viral particles was subsequently not 
substantiated). Studies of tumour extracts were extended to further characterise the 
biochemical and morphological features of the virus (Perk et al 1974, Martin et al 
1976). Viral particles with a density of 1.15- 1.20gm/m1 were identified, containing a 
reverse transcriptase, further substantiating the characteristics of a retrovirus. The 
reverse transcriptase activity in OPA tumour and lung fluid was further characterised 
(Verwoerd et al 1980, Herring et al 1983) and the virus was named Jaagsiekte sheep 
retrovirus (JSRV), the taxonomy reflecting the Afrikaans origins of the disorder 
(York et al 1991). 
1.3.2 Retrovirus taxonomy and classification 
The person who discovered the virus traditionally has the privilege to name it, 
with the host species and possibly the disease associated to infection often included 
in the name. The addition of a persons name in viral nomenclature is no longer 
acceptable, although several viruses, which were identified prior to this convention, 
do exist such as Rous sarcoma virus. The International Committee on the Taxonomy 
of Viruses is responsible for the classification of all viruses. The family Retroviridae 
is subdivided into seven subfamilies at present: mammalian C -type retroviruses, the 
prototype being murine leukaemia virus (MLV); avian C -type, with the prototype 
Rous sarcoma virus (RSV); the B -type retroviruses, prototype mouse mammary 
tumour virus (MMTV); D -type, with the prototype Mason Pfizer monkey virus (M- 
PMV); lentiviruses, with human immunodeficiency virus (HIV) as the prototype; the 
human T -cell leukaemia virus (HTLV)/bovine leukaemia virus (BLV) group, with 
the prototype HTLV -1 and the spumaviruses represented by the prototype human 
foamy virus (HFV). The classification of each genera is based on several criteria 
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including sequence similarities in their reverse transcriptase, viral core morphology 
and the location within the cell (cytoplasm or plasma membrane) of core assembly, 
and whether the virus possesses additional accessory genes. 
1.3.3 Retrovirus structure and life cycle 
The retrovirus structure is very simple, composed of a core containing the 
viral genomic material encapsulated within an envelope, which is enriched with viral 
glycoproteins. Contained within the viral core, the genome comprises two identical 
single strands of RNA and the enzymes necessary for retroviral replication, reverse 
transcriptase, integrase and protease. When integrated into the host genome the 
provirus comprises two long terminal repeat (LTR) sequences, which encode many 
regulatory signals and flank the open reading frames (ORF). The gag gene encodes 
the core proteins, the pol gene encodes for the enzymes reverse transcriptase, 
integrase and protease and the env gene encodes the envelope glycoproteins, which 
modify the envelope that has been constructed from the membrane of the previous 
host. Some retroviruses also possess oncogenes or proteins with specialized 
regulatory functions. 
Retroviral entry into the cell is mediated by recognition and interaction of the 
viral envelope proteins with specific cell surface receptors (Figure 1.1). The surface 
protein (SU) binds to the receptor, which brings the viral and cell membranes into 
close contact, resulting in a conformational change that allows the viral 
transmembrane protein (TM) to mediate membrane fusion. Some retroviruses enter 
the cell by receptor- mediated endocytosis (RME); the exploitation of a mechanism 
probably evolved by the cell for intracellular ingestion of beneficial extracellular 
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products. After entry into the cell reverse transcription of the retroviral RNA and 






Figure 1.1 Retrovirus life cycle. A mature virus particle enters the cell by receptor 
mediated endocytosis (RME) or fusion, uncoats to form a nucleoprotein complex, which 
mediates viral RNA reverse transcription and integration of the provirus (black) into the host 
chromosomal DNA (grey). Transcription of proviral DNA and translation of viral RNA. The 
proteins in the cytoplasm are combined with the RNA and associated to the viral envelope, 
resulting in assembly of a mature viral particle, which then buds out of the cell. 
The use of the cell RNA polymerase II in the transcription of the provirus, the 
mechanism used to cap, polyadenylate and splice the host RNAs, is exploited by the 
virus for processing RNA transcripts. The virus also utilizes the host polyribosomes 
for the translation of retroviral RNA. To complete viral replication recognition 
signals, which are not fully understood as yet, induce the viral RNA and core 
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proteins from the cytoplasm to associate with the envelope glycoproteins implanted 
in the plasma membranes. Finally, the viral encoded protease cleaves the 
polyproteins to generate the smaller polypeptides identified in mature retrovirus and 
the viral particles exit the cell by budding from the plasma membrane. 
1.3.4 Retroviral induced oncogenesis 
Although the majority of retroviral infections are non -pathogenic, several 
oncogenic retroviruses have been isolated from species of vertebrates including fish, 
chickens, rodents, cats, primates and humans. Epithelial carcinomas, sarcomas and 
various types of leukaemias have been identified (Weiss reviewed 1982, 1985). 
Oncogenic retroviruses are categorised into two groups, (i) retroviruses such as Rous 
sarcoma virus (RSV), which possess a viral oncogene responsible for inducing 
tumours and the ability to transform cells in culture (Bishop and Varmus 1982). The 
oncogene, integrated into the host genome is under control of the viral LTR, 
promoters and enhancers, which results in over expression of the protein and induces 
tranformation. (ii) retroviruses such as mouse mammary tumour virus (MMTV) lack 
oncogenes but can control the host genes by proviral insertion in a position adjacent 
or near to a cellular oncogene. The viral LTR overrides the host control and places 
the gene under the control of the virus. Therefore transformation of the host genome 
can occur either by transduction or insertional activation. 
1.4 Detection of viral antigens by the immune system 
To evoke an immune response the immune system must detect the presence 
of foreign antigens and then deploy strategies to combat the infection. These 
responses can be categorized into innate immunity, which is non -specific and utilizes 
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interferon, natural killer (NK) cells and phagocytes and adaptive immunity, which is 
highly specific for a particular pathogen and involves the recognition of antigen by 
specific T and B lymphocytes. 
1.4.1 Innate immune responses to viral infection 
Should virus survive past the outer defences such as IgA at mucosal surfaces, 
which inhibits virus adsorption and penetration, the first line of defence encountered 
is the innate immune system. As innate immunity is rapidly activated, within minutes 
or only a few hours after viral infection, it serves to protect the host by restricting 
early infection and the spread of virus. Against viral infection one of the first 
mechanisms in innate defence is the production of interferon (IFN). IFN is 
categorized into two types; type I, which includes IFN -a and ß and type II which 
includes IFN -y. Within hours of viral infection, interferon is induced which activates 
the surrounding cells, via their IFN -a /ß receptors, to synthesize more IFN (Vilcek 
and Sen 1996). The anti -viral mechanism used by IFN is determined by the type of 
virus, cell and interferon induced. Several interferon strategies to inhibit viral 
infection have been demonstrated. For example the disruption of viral replication by 
inhibition of protein synthesis is the mechanism used against adenovirus, influenza 
viruses and vaccinia virus (Hovanessian 1989), or the degradation of viral RNA, as 
demonstrated for picornaviruses (Sen and Ramsohoff 1992). It has also been shown 
that interferon can disrupt the penetration and uncoating of some retroviruses. In 
addition to direct anti -viral activity interferon is also implicated in the activation of 
NK cells, the up regulation of MHC, proteosomes and the TAP proteins and is 
associated with the terminal differentiation of T and B lymphocytes. Herpesviruses 
have been found particularly susceptible to the activity of NK cells (Shanley 1990). 
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The large granular NK cells are characterized by their ability to kill certain tumour 
cell lines in vitro. They are distinct from the T and B lymphocyte linage but can 
produce many of the anti -viral cytokines such as IFN -y, tumour necrosis factor a 
(TNF -a), tumour growth factor 31 (TGF -ß 1), granulocyte /macrophage -colony 
stimulating factor (GM -CSF) and interleukin -1 ß (IL-1[3) (Trinchieri 1989, Perussia 
1991). The mechanisms by which NK cells recognize virus infected cells is unknown 
but an inverse correlation between the level of MHC class I expression and killing by 
NK cells has been demonstrated (Liao et al 1991). It has been established that NK 
cells can be activated to participate in antibody -dependent cell cytotoxicity (ADCC), 
the recognition of IgG antibody- coated cell surfaces, resulting in the subsequent 
killing of the target cell (Kagi et al 1994). 
Macrophages and neutrophils can also kill virus -infected cells by ADCC 
through the opsonization of virus -antibody complexes or by direct intracellular 
killing via phagocytosis of the infected cell. The majority of IFN -a detected in the 
blood following infection is produced by the macrophages. In addition macrophages 
produce TNF -a, which can destroy virus -infected cells by apoptosis (Wong and 
Goeddel 1986), and arginase, which depletes the concentration of arginine at the 
local site (Bonilla et al 1984). Furthermore, following macrophage activation by 
IFN -y nitric oxide synthase production is induced that results in the generation of 
nitric oxide, which inhibits vaccinia virus and HSV replication (Karupiah et al 1993). 
1.4.2 Adaptive immune responses to viral infection 
Whilst transcriptionally inactive the retrovirus remains invisible to the 
immune system. Once a retrovirus is active within a cell the potential to elicit an 
immune response to viral antigens becomes evident. Retroviral infection is 
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predominantly cell -associated therefore it is the recognition and destruction of 
infected cells rather than free viral particles that is central in combating infection. 
Consequently, the cell -mediated response by cytotoxic T lymphocytes (CTL) 
predominates, although specific antibody responses can also be induced. The 
production of anti -viral antibodies confers an obvious advantage to the host, not only 
in directly controlling the spread of infection but also in contributing to the 
destruction of virus - infected cells. 
1.4.2.1 The role of antibodies in viral infection 
The first antibody identified responding to viral infection is IgM, which 
despite generally having low affinity does control the spread of virus in the blood. As 
the humoral response progresses and immunoglobulin class switching occurs, IgG 
with a high affinity for viral antigens predominates in the serum (Wabl and Steinberg 
1996), whilst the principal antibody identified at mucosal surfaces is IgA. The 
mechanism by which neutralization of virus occurs is dependant not only on the viral 
epitope and the class of antibody but also the nature of the infected cell (Dimmock 
1995). Neutralization can occur at the cell surface, for example by disrupting fusion 
of the viral envelope and the cellular membrane (Wharton et al 1995), or 
intracellularly by blocking uncoating of the virus (Vrijsen et al 1993). The 
involvement of antibodies in the destruction of virus -infected cells has also been 
demonstrated, for example in the ADCC process described in section 1.4.1. 
1.4.2.2 Presentation of viral antigens by MHC class I molecules 
To be recognised by the adaptive immune system, the viral antigen must be 
presented, in conjunction with major histocompatability complex (MHC). MHC 
restriction determines the type of T cell response elicited. All nucleated cells express 
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MHC class I that is recognised by cytotoxic T lymphocyte (CTLs), therefore the 
immune system has the opportunity to identify endogenous viral antigens presented 
on the surface of virtually all cells. Processing and presentation of virus via the 
endogenous antigen -presenting pathway is a multi -step process (Figure 1.2) starting 
with the degradation of viral proteins located in the cytoplasm into small peptides by 
the proteosome, a complex of proteolytic enzymes. The peptides are then transported 
to the endoplasmic reticulum (ER) by the transporter associated with antigen 
presentation (TAP) proteins. Two MHC- encoded subunits TAP 1 - 2 complex to form 
a heterodimer. In the ER the peptides bind to the MHC class I heavy chain. As the 
MHC binding cleft will accommodate peptides of eight - fifteen amino acids the 
peptide is further trimmed if required. With the assistance of molecular chaperones 
including calnexin, calreticulum and tapasin, the MHC light chain (ß- microglobulin) 
associates with the heavy chain to form the MHC class I trimolecular complex. This 
is now transported through the ER and the Golgi apparatus to the plasma membrane 
where it is recognised by the CTLs, which kill the infected cell. 
1.4.2.3 Presentation of viral antigens by MHC class II molecules 
Exogenous viral peptides are processed and presented complexed to MHC 
class II molecules that are expressed by antigen presenting cells (APC) and B 
lymphocytes. The MHC class II- antigen complex is recognized by helper T (TH) 
cells. MHC class II, composed of an a and ß chain is located in the ER, complexed 
to a polypeptide, the invariant chain (li), which is encoded by a gene out with the 
MHC. Unlike MHC class I, the class II aß -li complex does not encounter antigen in 
the ER and is not transported directly to the cell surface, but is transported through 
the Golgi apparatus to an acidic endosomal or lysosomal compartment where the li 
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Figure 1.2 Schematic diagram of antigen presentation by major histocompatability 
complex (MHC) class I. MHC class I recognises endogenous antigens. On entering the cell 
viral proteins are cleaved, transported by the TAP proteins and complexed to MHC in the 
endoplasmic reticulum (ER). MHC /antigen travels to the cell surface for recognition by 
cytotoxic T cells and /or macrophages. TAP, transporter associated with antigen presentation 
proteins ICAM, intracellular adhesion molecule; TcR, T cell receptor; IL, interleukin; TNF, 
tumour necrosis factor; IFN interferon; GM -CSF, granulocyte macrophage - colony 
stimulation factor. 
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Figure 1.3 Schematic diagram of antigen presentation by major histocompatability 
complex (MHC class II). Antigen presenting cells such as macrophages, dendritic cells and 
B lymphocytes express MHC class II, which recognises exogenous antigens. The MHC aß -li 
complex is formed in and transported through the endoplasmic reticulum (ER) to enter a 
transport vesicle. The li moiety dissociates and the aß chains are transported to the surface 
of the cell. A stable MHC class II molecule is formed when antigen binds. MHC class 
II /antigen is expressed on the cell surface for recognition by TH cells. ICAM intracellular 
adhesion molecule; LFA lymphocyte functional antigen; TcR T cell receptor; IL interleukin; TNF tumour 
necrosis factor; IFN interferon; GM -CSF granulocyte macrophage colony stimulation factor. 
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moiety dissociates from the complex. As the constraints of the MHC class II binding 
groove are similar to that of MHC class I (detailed above) exogenous antigen 
entering the cell by endocytosis can be cleaved by the proteolytic enzymes into 
smaller peptides during transportation to the acidic compartment where they 
encounter the MHC class II all complex. The dissociation of li facilitates antigen 
binding, generating a stable MHC class II /antigen molecule that is transported to the 
surface of the cell where it is recognized by TH cells. 
1.4.2.4 Determination of effector mechanisms 
In response to stimulation, naïve TH cells release a wide array of cytokines. 
The cytokines expressed by the TH cell determines whether the effector cells 
generated will differentiate into TH1 or TH2 cell types. As the cytokines released by 
TH1 and TH2 cells may represent two extremes of the wide pattern of cytokines 
secreted, categorization into only two types of responses may be an 
oversimplification. However the TH 1 response results in T cells that induce 
macrophage activation and promote cell mediated effector responses. In contrast, 
differentiation to T112 cells results in helper cells that induce B cell activation and 
enhance antibody production. The TH1 cell type releases IL -2 and IFN -y, with TH2 
cells producing IL -4, IL -6 and IL -10. Cytokines such as GM -CSF and TNF -a are 
released by both TH1 and TH2 cell types. Once the effector subset has become 
established the cytokines released can suppress the other cell subset, for example 
IFN -y produced by TH1 cells inhibits the proliferation of TH2 cells, and 
IL-1 0 from TH2 cells downregulates cytokine secretion by the TH1 subset. In a study 
by Clerici and Shearer (1993) it was reported that a TH 1 to TH2 switch was a crucial 
stage during HIV infection. They reported that a dominant TH1 type response was 
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detected in reaction to HIV antigens in seronegative, HIV- exposed subjects, whereas 
a dominant T142 type response was evident in the progression to immunodeficiency 
syndrome (AIDS), characterized by depletion of IL -2 and IFN -y and increased 
production of IL -4 and IL -10. It was hypothesized therefore that the TH1 response 
conveyed immunoprotection, preventing HIV and /or the progression to AIDS. 
Furthermore, that any stimuli inducing a TH2 response could act as cofactor in the 
development of AIDS. 
1.5 Characterisation of JSRV 
A serological cross -reaction between the JSRV p25 core protein and p27 core 
polypeptide of Mason Pfizer monkey virus (MPMV) and mouse mammary tumour 
virus (MMTV) demonstrated JSRV homology to type B and type D retroviruses 
(Sharp & Herring 1983). Further evidence characterising JSRV was demonstrated 
with the advancement of molecular techniques. Initially in 1991, York et al 
successfully isolated and partially cloned the JSRV genome by the synthesis of 
cDNA from genomic RNA purified from lung washes of infected sheep. 
Characterization of the clone (JS46.1) substantiated the previously identified 
homology with the type B and D retroviruses, but in addition, sequences homologous 
to a human endogenous retrovirus were detected. In contrast, clone JS46.1 did not 
hybridise to maedi -visna virus, the lentivirus often found in association with JSRV 
infection. 
Viral particles were purified from lung washes of OPA cases and the 
complete JSRV genome was cloned and sequenced by York et al in 1992a and b. It 
was revealed that the JSRV genome is 7,462 nucleotides long with a genetic 
organization characteristic of the type B and D oncoviruses: with gag, pro, pol and 
19 
env open reading frames (ORF), flanked by the long terminal repeats (LTR) found to 
be 397 bases, bound by the inverted repeat sequence CTGC at positions 7178 to 7181 
and GCAG at positions 122 to 125 (Figure 1.4). The gag ORF encodes the JSRV 
capsid protein (CA), with the Gag precursor identified as a 612 -amino acid 
polypeptide with a molecular weight of 68KDa. The 9.6KDa nucleocapsid protein 
(NC) of JSRV has two Cys -X2- Cys -X4- His -X4 -Cys sequences, separated by thirteen 
residues, which are thought to mediate binding of the NC to the genomic RNA. 
JSRV genome 7,462 nucleotides 
Figure 1.4. Schematic diagram of the complete JSRV genome. Sequencing the JSRV 
genome identified homology with type B and D retroviruses, characterised by gag, pro, pol 
and env regions flanked by long terminal repeats (LTR). Attached to the env region and 
overlapping pol an extra reading frame (ORF X) has been identified. 
The 326 residue pro ORF has a molecular weight of 35KDa. Pol is comprised of two 
moieties, a protease -like (PrL) domain and the active protease (PR). In the PR 
cellular aspartyl protease with a core amino acid sequence of Leu -Asp- Thr -Gly has 
been identified. The PrL and PR are thought to be expressed as a gag pro fusion 
polypeptide. Integrase, and reverse transcriptase (RT) with the active site composed 
of the sequence Tyr- Met -Asp- Asp are encoded by the pol ORF and are thought to be 
translated by the expression of a fused gag-pol-pro polypeptide. The env ORF, which 
overlaps the pol region, encodes the JSRV viral envelope protein precursor. The 
unglycosylated Env precursor has a molecular weight of 69KDa. The envelope 
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protein is comprised of two moieties, the surface protein (SU) with an estimated 
molecular weight of 47KDa and the transmembrane protein (TM), molecular weight 
33KDa. Three hydrophobic sections have been identified in the Env precursor, one 
(13 amino acids) corresponds to the signal peptide, the second (25 amino acids) was 
located downstream of the SU -TM cleavage site, and the third (24 amino acids) has 
been identified as the TM anchor, which intersects the membrane and is followed by 
the cytoplasmic tail. Also within the env region of JSRV and overlapping pol, an 
extra open reading frame (ORFX) was revealed (York et al 1991 & 1992). ORFX 
was found to be unusual in its location within the viral genome and very 
hydrophobic. It has been predicted that a polypeptide of 166 amino acids could be 
expressed (York et al 1992b), but to date, any product(s) encoded by ORFX remain 
unidentified although it has been established that the endogenous ORFX sequence is 
highly conserved (Bai et al 1996). In addition ORFX sequences from JSRV isolates 
from Britain, Italy, Spain and South Africa (Rosati et al 2000) were found to highly 
conserved also. This observation may suggest that ORFX could be an accessory 
gene, advantageous to the virus by bestowing some evolutionary advantage. 
1.5.1 Endogenous JSRV proviral sequences 
In mammalian systems studied, proviral DNA has been identified integrated 
into the host genome (Coffin 1982). These DNA sequences, possibly retained by 
ancestral hosts following viral infections and acquired by Mendelian inheritance 
through subsequent generations, become part of the genetic makeup of the species. 
The genome of sheep contains 15 to 20 copies endogenous proviral sequences that 
hybridise to JSRV probes (Hecht et al 1996, Bai et al 1996). It was essential 
therefore to develop a method of distinguishing the endogenous from the exogenous 
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virus. The compilation of restriction maps identified restriction sites unique to 
exogenous JSRV proviral DNA, and consequently resulted in exogenous specific 
molecular markers (Bai et al 1996). The Scal restriction site, located in the gag gene 
of the exogenous JSRV was the first recognised differentiation marker for JSRV 
(Palmarini et al 1996). Furthermore, it was revealed that, although the LTR region of 
the exogenous and endogenous DNA has approximately 94 -98% homology, 
significant diversity was found in the U3 region. The endogenous JSRV U3 has an 
average of 78% sequence identity to the exogenous foim, but at the 3' 173 bp region 
of exogenous proviral DNA only 56% sequence homology to the endogenous form 
was identified. This is as a result of deletions of a total of 47 bases and point 
mutations in the exogenous form, consequently resulting in a unique U3 sequence 
(Palmarini et al 1996a). In comparison with the highly conserved endogenous ORFX 
sequences collected from Australia, Italy, Britain and South Africa phylogenetic 
analysis of the ORFX sequences derived from lung secretions of OPA cases from 
Britain, Europe and South Africa revealed three geographically diverse groups. The 
viral isolate from the South African JSRV appeared to have greater homology to the 
endogenous sequences than that identified with the European isolates (Rosati et al 
2000). Palmarini et al (2000a) molecularly cloned three endogenous retroviruses of 
sheep and analysis of their proviral structure, phylogeny, and pattern of expression 
revealed that all three contained open reading frames for at least one of the structural 
genes. However, one clone was unable to produce viral particles and the construction 
of viral chimeras with exogenous JSRV21 detected a defect in the gag region of the 
endogenous sequence. Furthermore major differences from the exogenous JSRV 
were identified in two short regions in the gag (VR1 and VR2) of the endogenous 
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sequences. A third divergent region (VR3) was identified in the carboxy -terminal 
portion of the transmembrane protein. In every other respect, the endogenous 
sequences were found to be very similar to the exogenous (except for deletions and 
the high level of polymorphism in the U3 region of the LTR described previously). It 
was shown by Palmarini et al (2000a) that the exogenous form of JSRV has the 
strongest specificity for differentiated epithelial cells of the lung. Transient 
transfections and reporter assays determined that the LTR of the three endogenous 
sequences do not have the same tissue tropism as the exogenous JSRV. In contrast it 
was revealed that endogenous JSRV tropism is strongest in the uterus, with weaker 
expression in the gut and bronchiolar epithelium of the lung (Palmarini et al 2000b, 
2001) 
It was thought that perhaps the reactivation of the endogenous proviral DNA 
could result in the expression of exogenous JSRV in neoplastic cells. In that case 
exogenous JSRV would not be the aetiological agent of OPA but would be expressed 
as a result of neoplasia. However, JSRV capsid antigen has been detected in tumours, 
lung secretions, pulmonary lymph nodes and peripheral blood of OPA- affected 
animals and not in any other tissue of either affected or unaffected animals 
(Palmarini et al 1995, 1996a and 1997). This would suggest that although all sheep 
have endogenous JSRV, it is the exogenous form of the virus that is directly 
associated with OPA (Palmarini et al 1996a & 1997). 
1.5.2 JSRV, the confirmed aetiological agent of OPA 
Although substantial evidence implicating JSRV in the development of OPA 
had been demonstrated, (Martin et al 1976, Sharp and Herring 1983, Rosadio et al 
1988, Hecht et al 1996, Palmarini et al 1996), the question of whether the exogenous 
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23 
form of the virus alone was capable of inducing OPA remained unanswered until 
recently. In a study by Palmarini et al (1999) genomic DNA was isolated from a 
confirmed OPA case and exogenous JSRV proviral DNA was distinguished from 
endogenous sequences by JSRV -U3- specific hemi- nested PCR. A recombinant 
phage was produced with full length exogenous JSRV inserted and this was sub - 
cloned to create pJSRV21. The plasmid pCMV2JS21 was developed by replacing the 
U3 region of the upstream LTR with human cytomegalovirus (CMV) promoter. The 
plasmid was used to transiently transfect 293T cells and the culture supernatant was 
harvested, shown to contain JSRV and prepared as an inoculum to experimentally 
infect four neonatal lambs. Two lambs developed histologically confirmed OPA at 
four months post -inoculation. Evidence that the disease was induced by JSRV21 was 
demonstrated by exogenous -JSRV- specific PCR, and the presence of the restriction 
site Scal in the gag region, unique to the exogenous form of the virus. Therefore 
providing confirmation that exogenous JSRV is the aetiological agent of OPA. The 
development of the infectious molecular clone JSRV21 provided an in vitro system, 
which does not rely on the preparation of virus or infectious particles from natural 
sources. Using molecular techniques, it is now possible to examine the mechanisms 
of JSRV oncogenesis and study the pathology of OPA by manipulation of the JSRV 
genome. 
1.5.3 The homology of JSRV with other retroviruses 
As stated previously, the homology of JSRV to type B/D retroviruses was 
established when Sharp and Herring (1983) detected serological cross -reactivity 
between the JSRV p25 core protein and p27 core polypeptide of the B and D 
prototypes, mouse mammary tumour virus (MMTV) and Mason Pfizer monkey virus 
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(MPMV). It has been established that JSRV is morphologically similar to MMTV by 
the presence of the knoblike glycoprotein spikes on the surface of the envelope 
(Payne et al 1983). Phylogenetic analysis of the JSRV genome has also provided 
further evidence for homology with MMTV, MPMV, simian retrovirus type I (SRV) 
and human endogenous retrovirus (HERV -K). JSRV protein sequences were aligned 
to those identified from the type B/D retroviruses and the level of homology 
established by the degree of amino acid identity. For example alignment of the JSRV 
Gag polyprotein with those of MMTV and MPMV identified conserved sequences 
between the three viruses that correspond to the CA boundaries. Comparison of the 
terminal COOH of the NC is less clearly aligned but the location of the cleavage site 
Tyr /Gly -Ala identified in MPMV is similarly positioned in the JSRV Gag (York et al 
1992b). Overall for JSRV, MPMV and SMRV -type I more than 50% amino acid 
identity was detected in the Gag, Pol and Pro proteins, but no consistent alignment 
was detected for the Env proteins. In contrast the JSRV Env proteins were 
homologous with those from MMTV and HERV -K, but less than 38% amino acid 
identity was detected between their Gag proteins. A relationship in the structural 
organization of JSRV and type B Env proteins was evident, with many shared 
cysteines and glycosylation sites. Only weak similarities between the Env proteins 
of MPMV, SMRV and JSRV and the type B retroviruses were identified. MPMV 
and SMRV Env proteins were highly homologous to the type C reticuloendotheliosis 
virus (REV -A) (Sonigo et al 1986). 
Similar to JSRV, MMTV infection is also associated with an epithelial 
neoplasm, but despite the identified homology between the retroviruses, differences 
in the mode of transmission and localisation of viral transformation are evident. 
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MMTV is transmitted to the mouse pups via ingestion of the virus present in the milk 
from lactating mothers. The pups are infected during the first two -weeks of life, prior 
to acidification in the stomach (Acha -Orbea et al 1999). Therefore the virus has to be 
transported from the site of infection to the mammary epithelium, the site of 
transformation (Figure 1.5). 
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Figure 1.5 Schematic diagram of the life cycle of mouse mammary tumour virus 
(MMTV). Mouse pups are infected by milk containing MMTV particles. Virus can be detected 
in the Peyer's patches in the gut. B cells (and possibly dendritic cells (DC)) are infected an 
induced to express MMTV Sag, which activates T cells; creating a positive feedback loop 
that induces proliferation. A chronic immune response is mounted resulting in viral spread 
and transportation of MMTV to the mammary gland. 
This is achieved by viral uptake through the gut epithelium and the subsequent T cell 
independent infection of resting B cells in the Peyer's patches (Karpetian et al 1994). 
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The B cells are induced to replicate and express the MMTV superantigen (Sag) (Held 
et al 1993a). MMTV infected B cells then stimulate T cells, which express the Sag - 
specific Vp region. A positive feedback is elicited by T cells cytokine production, 
which induces the infected B cells to proliferate and consequently increase the 
MMTV viral load (Held 1993b). The virus is then transported to the mammary gland. 
Several studies have shown that an intact immune system is required for successful 
MMTV infection. Luther et al (1997) provided evidence to suggest the involvement 
of antigen presentation in MMTV infection by identifying dendritic cells in close 
contact with dividing Sag- reactive T cells. However despite the involvement of 
dendritic cells, mice deficient in B cells could not be infected, and although the lack 
of Sag - specific T -cells does not prevent MMTV infection, viral amplification cannot 
occur (Held et al 1993a). There is however no evidence to suggest that JSRV carries 
a super- antigen gene analogous to the MMTV -Sag. In contrast to the transportation 
requirement of MMTV to the site of transformation, the respiratory mode of JSRV 
transmission may facilitate direct access to the alveolar epithelial cells, although an 
initial infection of the lymphoid tissues in the upper respiratory tract cannot be 
overruled. A disseminated lymphoid infection has been established for JSRV 
(Holland et al 1999). Furthermore, Holland et al has provided evidence that 
dissemination occurs prior to tumorigenesis (this study is described in detail in 
section 1.6.2). 
Tumour of the ethmoid turbinates in the nasal cavity of sheep and goats, 
enzootic nasal adenocarcinoma (ENA) is caused by the retrovirus nasal 
adenocarcinoma virus (NAV). Similar to OPA, NAV originates from transformation 
of secretory epithelial cells and can be experimentally induced by inoculation of cell- 
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free tumour homogenates (De Las Heras et al 1991). Furthermore cross -reactivity 
with the major capsid protein of JSRV and MPMV suggests that NAV also has type 
D capsid protein (De Las Heras et al 1993). In a study by Cousens et al (1996) the 
gag region of NAV from nasal exudates, collected from three different farms, was 
partially sequenced and found to have 83 -92% homology with JSRV- related 
sequences. Furthermore it was revealed by Palmarini et al (2000a) that the gag VR1 
regions of JSRV and NAV contain a proline -rich region that is absent from the 
endogenous proviruses. In contrast, polymorphism between JSRV and NAV was 
detected in the transmembrane V3 region. Also NAV does not possess the Scal 
restriction site identified in the gag region of JSRV. However other restriction sites, 
specific to NAV have been identified. Therefore despite the high degree of homology 
between NAV and JSRV, diversity in the two viruses suggests that they are very 
distinct. Studies are currently underway to sequence the entire NAV genome and 
characterise the differences, not only between NAV and JSRV but also NAV isolated 
from goats, caprine nasal adenocarcinoma virus (CNAV) and from sheep, ovine 
nasal adenocarcinoma (ONAV). Recently it has been demonstrated that the ONAV 
does not possess the ORFX identified in the CNAV and in JSRV (Dr. C. Cousens, 
personal communication). Furthermore no evidence of a disseminated infection has 
been identified in the ovine variant (lacking ORFX) but dissemination to the 
lymphoid cells has been detected in the caprine varient (with ORFX) (Dr. A Ortin, 
personal communication). These preliminary observations may suggest a link 
between JSRV dissemination and the presence and expression of the ORFX gene. 
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1.5.4 The alveolar epithelial cells targeted by JSRV 
The monolayer lining the alveolar surface is composed of two distinct types 
of epithelial cells, the squamous Type 1 and the cuboidal Type II pneumocytes. A 
major role of these cells is to protect the lung from infection. The Type II 
pneumocytes and non -ciliated (Clara) cells are the only cells identified to date that 
are targeted by JSRV to undergo viral transformation ((Jassim 1988, Palmarini et al 
1995, DeMartini and York 1997). The type II pneumocytes, in addition to being an 
integral component of the alveolar epithelial layer, have several unique biological 
functions. Firstly they are responsible for the synthesis, storage and secretion of 
alveolar surfactant. The secretory function of the pneumocytes may be augmented by 
viral transformation, detected by the accumulation, and often copious quantity of 
fluid found in the lungs and respiratory tract of many affected animals. Secondly 
they maintain the integrity of the alveolar interstitium by regenerating and replacing 
Type I pneumocytes that have been damaged during lung injury. Thirdly studies have 
suggested that the alveolar epithelium may have immunomodulatory functions and 
play a role in determining immune responses in the lung. Studies of murine and rat 
models with acute interstitial lung disease have detected immunoreactivity with the 
expression of pro -inflammatory cytokines such as tumour necrosis factor -a (TNF -a), 
transforming growth factor-13 (TGF-13), interferon -y (IFN -y) and interleukin -4 (IL -4) 
expressed by the type II pneumocytes (Kapanci et al 1995, Wallace and Howie et al 
1999). In rats the type II pneumocytes have been found to produce monocyte 
chemoattractant protein -1 (MCP -1) in response to IL -1 stimulation (Paine et al 
1993), and can be induced to produce a neutrophil chemoattractant, thought 
analogous to IL -8 (Crippen et al 1995). In a study of human alveolar epithelial cells 
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by Eghtesad et al (2001), the constitutive production of MCP -1 by type II 
pnuemocytes was demonstrated and amplification of MCP -1 expression by 
stimulation with TNF -a was also established. Eghtesad et al (2001) also reported 
that the alveolar epithelial cells could induce the transendothelial migration of T cells 
and monocytes by participation in the local cytokine network within the lung. 
Furthermore the alveolar epithelial cells contribute to immunomodulation of 
inflammatory response by the expression of chemokines and biologically active 
mediators, which modulate the recruitment of alveolar macrophages and leukocytes 
into the microenvironment. It could be hypothesised therefore that the biological and 
immunological functions of the cells targeted for viral transformation, may 
themselves play an active role in determining the immune response during OPA 
tumorigenesis. 
1.5.5 The cell- surface receptor for JSRV 
Retroviral entry into a cell is initiated by the interaction of the viral envelope 
and a specific receptor present on the surface of the cell. The identification of the 
cell - surface receptor for JSRV was determined by using chimeric pseudotyped virus 
containing the gag and pol proteins from Moloney murine leukaemia virus, the env 
protein of JSRV and encoding human alkaline phosphatase (AP) as a detection 
marker for viral transduction (Rai et al 2001). Sheep and human cells (except HeLa 
cells) were transduced by this construct, but as rodent cells were not, this suggested 
that they do not possess a functional receptor for JSRV env. This facilitated 
phenotypic screening of human/hamster hybrid cell lines, which identified several 
closely linked markers localised to the p21.3 band of human chromosome 3. The 
JSRV receptor mapped to a region, which had previously been sequenced in a search 
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for cancer suppressor genes. This was identified as HYAL -2. a 
glycosylphosphatidylinositol (GPI)- anchored cell - surface protein (Rai et al 2001). 
GPI -proteins are found on the apical surface of epithelial cells and although HYAL -2 
is related to known hyaluronidases the function of HYAL -2 is unknown. For cells 
expressing HYAL -1, hyaluronidase activity has been demonstrated, but in contrast 
no hyaluronidase activity was evident in cells associated with HYAL -2. It was 
demonstrated that if HYAL -2 was removed the cells became resistant to JSRV 
infection. Furthermore, it was found that over expression of the rodent HYAL -2 
resulted in infection of rat cells and NIH 3T3 mouse cells, which do not normally 
have a functional receptor for JSRV. The generation of transgenic rodents with 
functional HYAL -2 receptors would advance the study of JSRV infection and 
oncogensis by providing a laboratory rodent model. 
1.6 Transmission of JSRV 
1.6.1 Early transmission experiments 
The first report that OPA was an infectious disease was described by De 
Kock in 1929, when he performed transmission experiments by cohabitation of 
affected and unaffected sheep. However, his findings were not conclusive as OPA 
lesions were detected in only one animal. Notwithstanding, the hypothesis that OPA 
was a contagious disease persisted and transmission experiments continued. The 
cohabitation experiment was successfully repeated, with OPA lesions detected in six 
out of eight incontact sheep (Dungal et al 1938). These findings provided the first 
compelling evidence for the transmission of OPA. To further substantiate the 
transmission theory a series of experiments were conducted, which included healthy 
sheep being inoculated with blood and fed faeces from affected animals. These 
experiments were unsuccessful. In contrast, when healthy and affected sheep were 
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housed in head to head contact, OPA was transmitted, therefore exhaled air was 
thought to be the source of infection. The exhaled air was collected into glycerine 
and administered to healthy sheep as an intratracheal or intrapulmonary inoculum. 
OPA lesions were identified at necropsy four to eight months post -inoculation 
(Dungal 1946). Thus during natural infection the mode of transmission is suspected 
to be inhalation of aerosols from infected flockmates. 
1.6.2 Experimental JSRV infection 
Transmission of OPA to healthy lambs has also been achieved by using 
material derived from OPA tumours. Lesions were identified in seven out of twenty - 
two sheep experimentally infected with cell -free suspensions by incontact, aerosol 
and inoculation (Markson and Terlecki 1964). In a similar study by Enchev (1966) 
using cell -free suspensions, five of sixteen sheep developed OPA lesions. 
Initially during experimental infection a long lag phase before the 
development of clinical disease was required. For example in the studies described 
above ( Markson and Terlecki 1964, Enchev 1966) clinical symptoms were not 
apparent until 19 and 23 months post -inoculation, respectively. In many studies 
clinical signs of OPA could only be detected after an incubation period of two to four 
years. Wandera in 1970 determined that the route of inoculation and the age of the 
animals were important factors in determining the incubation period. Experimental 
infection of lambs resulted in reducing the time to six months. The incubation time 
was further reduced by using an inoculum from partially purified, concentrated lung 
fluid. When inoculated intratracheally clinical disease was induced in neonatal lambs 
within three to four weeks (Sharp et al 1983). At the present time, under 
experimental conditions clinical and pathological OPA can be induced in neonatal 
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lambs by intratracheal inoculation with virus purified from tumour (Martin et al 
1976), lung fluid (Sharp et al 1983) or JSRV infectious molecular clones (Palmarini 
et al 1999, DeMartini et al 2001). 
1.6.3 Evidence for vertical transmission 
Recently evidence of possible vertical transmission of OPA has been 
demonstrated, with JSRV detected in foetuses from three histologically confirmed 
OPA cases (De las Heras et al 2000). Five foetuses, with a gestational age of 16 
weeks, were removed from one Spanish dam, and four foetuses, with a gestational 
age 15 -19 weeks, from two Scottish dams. No macroscopic or microscopic evidence 
of OPA was detected in the lungs, mediastinal lymph node or thymus of any of the 
foetuses, and immunohistochemistry did not detect JSRV capsid antigen (JSRV -CA). 
However, exogenous JSRV was detected by PCR in the lungs of four of the five 
Spanish foetuses and in the PBMC from two of the four Scottish foetuses (from the 
same dam). Further evidence to support JSRV infection in utero was demonstrated in 
the same study by the following. Histological examination of lung tissue collected 
from a three- day -old lamb revealed well -developed lesions characteristic of OPA 
tumour. Immunohistochemistry detected JSRV -CA in the lung, and JSRV was 
identified by PCR of DNA, excised from the lung tissue. The mother of this lamb 
was traced and although no macroscopic, microscopic or immunohistochemical 
evidence of OPA or JSRV -CA was found, JSRV was detected in the PBMC by PCR. 
The extent of tumour development in the three- day -old lamb suggested that it was 
infected in utero. It has been suggested that infection of the foetus arises from the 
dam via the placenta, although the mechanism of viral transportation across the 
placenta is not known (De las Heras et al 2000). Parker et al (1998) investigated the 
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the possibility of OPA -free lambs born from OPA- affected ewes by embryo 
transmission experiments. They found no evidence of infection in two to six day old 
embryos, suggesting that infection of the embryo does not occur until a later point in 
the gestation period. 
1.7 Pathogenesis of OPA 
The first pathological description of OPA was given in South Africa, by 
Mitchell in 1915. Today, OPA is classified as a contagious low -grade 
adenocarcinoma. Enlargement of the lungs, the development of neoplastic lesions 
and, in many cases, the production of lung fluid are the pathognomonic features of 
OPA (Sharp and Angus 1990). Two pathological forms of OPA have been identified, 
classical and atypical, and there appears to be a geographical distinction in the 
prevalence of the tumour type. 
1.7.1 Clinical symptoms 
The clinical signs of classical OPA are shallow breathing, an increase in 
respiration, exacerbated by any physical exertion, which causes the animal to pant 
and heave at the flanks. If OPA is advanced, moist raies can be detected, arising from 
the production and accumulation of fluid in the lungs, which can often be detected as 
a nasal exudate. Lung fluid is a liquid comprised of mucus, lipids, surfactant proteins 
and cells characterised mainly as macrophages (Palmarini 1995). It has also been 
reported that lung fluid is a major source of IgA (Smith et al 1975). The lung fluid 
can be collected from OPA cases by raising the hindquarters of the animal above the 
head allowing the fluid to pour from the nostrils (Figure 1.6). Lung fluid, collected 
from OPA cases (Figure 1.7) is a major source of JSRV, which can be partially 
purified as detailed in Chapter 2, section 2.1.3. 
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Figure 1.6. Wheelbarrow technique for the collection of lung fluid from OPA affected 
sheep. By raising the hindquarters of the animal the lung fluid draining from the nostrils can 
be collected. 
Figure 1.7. Collection of lung fluid from a sheep with OPA. 
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The volume of lung fluid produced varies from animal to animal but in some cases 
up to 500m1 per day has been collected. The production of lung fluid has long been 
recognised as a field test in the diagnosis of OPA (Stevens 1957). However, not all 
OPA affected sheep produce lung fluid, and fibrosed lesions are identified in the 
lungs of `fluid -free' sheep at necropsy (Sharp 1981). 
An increase in temperature is only detected in OPA cases in the terminal 
stages of disease, when a secondary infection is evident also. Appetite is not reduced 
in the OPA affected sheep, but the respiratory symptoms are accompanied by weight 
loss, with severe dyspnoea evident in advanced cases (Figure 1.8). Clinical signs of 
classical OPA inevitably result in progressive respiratory distress and the death of the 
animal. In contrast, the atypical form OPA usually remains subclinical, with OPA 
tumours only detected at necropsy performed during the diagnosis of unrelated 
illnesses (Gonzalez 1990), or identified during abattoir studies (De las Heras 1992). 
Figure 1.8 Adult sheep in the terminal stages of OPA. Severe weight loss is a symptom 
of OPA. 
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1.7.2 Classical OPA 
The classical form of OPA is commonly described in Scotland (Hunter and 
Munro 1983, Sharp and Angus 1990), South Africa (Tusin 1969) and Israel (Nobel 
1958). Furthermore in 2001, Sanna et al described classical OPA in archive tissues 
collected during the 1980s outbreak of OPA in Sardinian Moufflon (Ovis musimon), 
a wild sheep closely related to the domesticated sheep (Ovis aries) (Neiddu et al 
1987). 
1.7.2.1 Gross pathology of classical OPA 
In the initial development of classical OPA tumours observed 
macroscopically, the lesions are small, grey /white nodules of varying size, which are 
raised slightly from the surface of the lung. The nodules exist either as individual 
foci or have become confluent. In advanced cases the lungs are always greatly 
enlarged, in some instances to three or four times the normal size (Figure 1.9), and 
when examined within the thoracic cavity they may be attached to the cavity walls 
by connective tissue. 
Figure 1.9. OPA Lungs. The lungs from sheep affected by OPA are often greatly enlarged. 
The striated appearance on the surface of the lungs shown here is due to pressure on the rib 
cage during respiration. 
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The tumour mass is firm to touch, grey in colour and can be detected in any 
or all lobes of the lungs (Figure 1.10a). When the lung is cut the tumour has a 
pink/grey appearance and a white exudate can often be detected oozing from the cut 
surface (Figure 1.1 Ob). When present, lung fluid aerated by respiration is observed in 
the bronchi and bronchioles and pours from the trachea as a white frothy fluid, 
shown in Figure 1.10c (Dungal et al, 1938, Cuba -Caparo et al 1961, Wandera 1971, 
Gonzalez 1990, Sharp and Angus 1990). 
b c 
Figure 1.10. Gross pathology of classical OPA lungs. OPA lesions can be detected as 
small individual nodules or as shown in Figure 1.10a, a large confluent, grey /white tumour 
mass. Figure 1.10b shows the cut surface of the classical OPA lung. Lung fluid observed in 
the trachea as a white frothy liquid is shown Figure 1.10c. 
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1.7.2.2 Histopathology of classical OPA 
Histopathological examination of the classical OPA tumour shows a single 
layer of neoplastic cuboidal or columnar epithelial cells lining the airspaces of the 
alveoli or bronchioles. The tumour is surrounded and supported by stromal tissue, 
which becomes thicker and more fibrous as the tumour ages. Tumour nodules 
increase in size due to the spread of type II pneumocytes along the alveolar walls. 
Inflammatory infiltrates are often detected in the region of the tumour with numerous 
neutrophils and enlarged macrophages identified within the tumour and surrounding 
parenchyma (Nobel et al 1971, Perk 1982, Sharp and Angus 1985, 1990 and 
DeMartini 1997). As alveolar macrophages have been identified in early, 
uncomplicated lesions it is unlikely that their presence is due to secondary infection. 
Reports from various studies have also identified lymphocytes and plasma cells in 
the stroma of the tumour (Dualde -Perez 1966, Hod 1977, De las Heras 1995, Garcia - 
Goti 2000). 
1.7.3 Atypical OPA 
In Spain (Aragon and the Basque Country), although classical OPA is 
recognised, the atypical form of OPA has also been described. The pathology of 
atypical OPA was described by Dualde -Perez (1966), Gonzalez (1990) and De las 
Heras et al (1992), though in these reports the term `atypical OPA' was not used. 
Similarly in Peru, the OPA lesions described by Cuba -Caparo (1961) were of the 
atypical form of OPA. Both foil's of OPA have been identified, not only in the same 
flock of sheep, but also in the same lung (Gonzalez 1990). 
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1.7.3.1 Gross pathology of atypical OPA 
Atypical OPA lesions differ from the classical form macroscopically as the 
tumours are seen as individual, small, round, hard nodules located in the 
diaphragmatic lobe. When the lung tissue is cut the nodules are dry and white in 
colour (Figure 1.11). There is no evidence of fluid in the bronchi, bronchioles or 
trachea (De las Heras 1992). 
Tumour nodule 
Figure 1.11 Gross pathology of atypical OPA lung. The OPA lesions are observed as dry, 
white nodules with no evidence of lung fluid on the cut surface of the lung. 
1.7.3.2 Histopathology of atypical OPA 
Histopathological examination of the atypical OPA tumour reveals 
histological similarities to those of the classical form, but a more distinctive 
differentiation between the neoplastic region and the surrounding parenchyma is 
observed. Microscopic tumours can be identified as distinct foci; often surrounding 
the larger macroscopically observed nodules. Mononuclear cells have been identified 
in association with the bronchioles and non -neoplastic regions of the OPA lung. 
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Furthermore mononuclear cells characterised as lymphocytes and plasma cells have 
been detected infiltrating the stroma of the tumours to a much higher extent than in 
the classical form of OPA (Dualde -Perez 1966, Hod 1977, De las Heras 1995, 
Garcia -Goti 2000). In contrast the large infiltration of neutrophils detected in 
classical OPA is rarely found in association with atypical OPA. 
1.7.4 Two distinct forms of OPA or diverse pathology of the same disease 
As stated earlier, both forms of OPA have been identified in the same lung, 
and the exogenous - specific JSRV U3 LTR and the JSRV -capsid antigen have been 
detected in the lungs of sheep with classical or atypical forms of OPA. Furthermore 
atypical and classical OPA could not be distinguished by sequencing the JSRV LTR 
region (Garcia -Goti et al 2000). The absence of lung fluid, distinctive morphology 
and the quantitatively larger population of immune cells present may account for the 
asymptomatic nature of the atypical form of OPA. The greater infiltration of immune 
cells into the atypical tumour stroma may be indicative of an immune response, 
arresting tumour development or, as suggested in a report by De las Heras (1990), 
that the two forms of OPA may not be different diseases but the diverse pathology of 
the same disease. Also, Garcia -Goti et al (2000) when characterising the two 
pathological forms of OPA, suggested that the differences distinguishing the two 
forms `may represent the two extremes of a disease spectrum, rather than two 
separate forms of the disease.' 
1.7.5 OPA Metastasis 
OPA metastasis has also been previously reported, with spread to the regional 
draining lymph nodes being the main organs affected. In contrast metastasis to the 
extrathoracic regions is more infrequent (Rosadio et al 1988a, Bouljihad et al 1996 
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Palmarini et al 1995,1996b & 1997). There is general disagreement regarding the 
frequency of metastasis in OPA. The relative infrequency of this occurrence in sheep 
examined in many parts of the world may simply reflect the reduced lifespan of OPA 
affected animals. In contrast, a high rate of metastasis has been reported in Awasi 
(fat -tailed) sheep but this may represent a genetic predisposition for metastatic spread 
in this breed (Rosadio et al 1988). 
1.8 JSRV and ovine immunity 
1.8.1 The lack of humoral response 
The immunological response to JSRV infection is at present poorly 
understood. During JSRV infection and development of OPA a controversial issue 
immunologically has been the absence of a humoral response. In the 1983 study by 
Sharp and Herring, no JSRV -p25- specific antibodies were detected in the sera from 
seven adult OPA cases in the terminal stages of diseases, nor from two 
experimentally infected lambs. Subsequent studies have also failed to detect a JSRV- 
specific antibody response (De Martini et al 1988, Verwoerd 1990). In contrast to 
these experiments using natural material for the detection of an antibody response, 
seropositivity was reported to a recombinant Mason -Pfizer monkey virus (MPMV) 
p27 capsid antigen -glutathione S- transferase (GST) fusion protein (GST -p27). The 
fusion protein was constructed and used as an antigen in the development of an 
enzyme - linked immunosorbent assay (ELISA) (Kwang et al 1995). The cross - 
reactivity of the GST -p27 fusion protein to OPA was tested by Western blot, with 
positive reactions detected in the sera of seven (100 %) OPA positive sheep, and no 
reaction was detected in twenty -three OPA- negative controls. ELISA serodiagnosis 
of OPA detected 15.6% seropositivity in 160 visibly healthy sheep, 30% in 40 sheep 
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with chronic respiratory disease symptoms, (all from USA), and 2.7% of 73 healthy 
sheep and 45% of 96 previously confirmed OPA cases in Italy. An evaluation of the 
detection of JSRV- specific antibodies was re- examined in 1998 by Ortin et al to 
ascertain if antibody responses to recombinant JSRV -CA could be used as a 
diagnostic tool to identify OPA or enzootic nasal tumour (ENT) cases, by 
comparison with animals free of those infections. A recombinant JSRV -CA, with 
100% amino acid homology with ENTV, was expressed as a GST fusion protein and 
detected seropositivity in OPA and ENT cases (confirming the findings of Kwang et 
al), but a positive reaction was also detected in sera from histologically confirmed 
healthy animals, from flocks with no history of ENT or OPA. Further reservations as 
to the specificity of the reaction appeared when seropositivity was detected in the 
sera from seven out of eight sheep from the Falkland Islands and Australia; countries 
where OPA and ENT have not been reported. Evidence confirming that this reaction 
was not OPA or ENT specific was demonstrated by absorption with a lysate of E. 
coli containing GST but no JSRV (or ENTV related) proteins. This resulted in the 
elimination of positive reactions in all sera tested, whereas absorption with JSRV -CA 
resulted in a loss of reactivity in only a few animals. Therefore the likely explanation 
for the positive reactions was that seropositivity was a response to prokaryotic 
proteins or to the GST moiety of the construct. This study therefore supported the 
earlier findings that no JSRV -specific circulating humoral response was detected. 
1.8.2 JSRV disseminated lymphoid infection 
As described in section 1.3.6 the cells targeted for viral transformation are the 
type II pneumocytes and non -ciliated Clara cells in the lungs, but these are not the 
only cells infected by JSRV. Palmarini et al (1996b) identified a JSRV disseminated 
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infection of the lymphoid tissues of sheep affected by OPA. In 1999, Holland et al 
demonstrated the presence of proviral DNA or RNA in lymphoid cells, purified from 
the mediastinal lymph nodes of eight SPA cases. This was further characterised by 
identifying the lymphoid cells infected by JSRV, estimating the proviral load 
detected in each subset and establishing if the lymphoid infection could be detected 
prior to tumorigenesis (Holland et al 1999). Macrophages were recovered by 
adherence and the lymphocyte subsets were isolated by miniMACs selection using a 
panel of monoclonal antibodies specific for CD4, CD8 and B cells (sIg). The 
frequency of JSRV proviral DNA was determined by limiting dilution analysis 
(LDA) using the exogenous JSRV U3- specific hemi- nested PCR. It was revealed that 
JSRV proviral DNA was distributed in all the subsets examined. The estimated mean 
proviral load was found to be greatest in macrophages with one copy of JSRV 
provirus per 2,526 cells, followed by B cells (lcopy /3,768 cells), CD4 T cells 
(lcopy /6,825 cells) and CD8 T cells (lcopy /16,683 cells). Analysis of the peripheral 
blood mononuclear cells (PBMC) from eight animals estimated a JSRV proviral load 
of less than 1 copy /240,000 cells. As only a maximum of two of the eight replicates 
tested positive this could indicate that the proviral load in the blood is too low for 
consistent detection or may suggest that JSRV infection in the blood is transient. 
Immunohistochemistry, using the same monoclonal antibodies, was performed to 
identify any alteration in the phenotypic profile of the mediastinal lymph node and 
the blood as a result of JSRV infection. In the peripheral blood mononuclear cells 
(PBMC) from the eight OPA cases a CD4 T cell lymphocytopaenia was detected, in 
accordance with previous findings (Rosadio and Sharp 1992), in addition an overall 
increase in the total number of leukocytes was counted in the OPA cases, in 
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comparison with uninfected sheep (number of control animals was not stated). In the 
same study it was established from the detection of JSRV proviral load in the blood 
and mediastinal lymph nodes of thirteen experimentally JSRV infected neonatal 
lambs that the disseminated infection occurred as an early event, prior to the 
detection of clinical disease. Hemi- nested PCR detected JSRV provirus in the 
mediastinal lymph node of each of the thirteen lambs between seven and twenty - 
eight days post inoculation, although only one to five out of eight replicates were 
positive. OPA was histologically confirmed in one lamb at twenty -one days and one 
lamb at twenty -eight days post inoculation, confirming that JSRV dissemination to 
the lymphoid cells occurred as an early event, preceding tumour development. 
During this experiment the PBMC were tested also for the detection of JSRV 
provirus with only two of the thirteen samples testing positive (1/8 and 2/ 8 
replicates), providing evidence that the proviral load in the peripheral blood is very 
low during both natural and experimental JSRV infection. This study therefore 
provided evidence of dissemination to the lymphoid system and the peripheral blood 
in naturally infected OPA cases, in the terminal stages of disease. Furthermore, the 
major cell subsets infected were identified and it was established that JSRV infection 
of the lymphoid cells occurs as an early event during experimental JSRV infection. It 
remains to be established whether JSRV dissemination precedes or follows 
transformation of the epithelial cells in the lung. 
A comparative study of classical OPA, atypical OPA, in- contact sheep and 
sheep from non -affected flocks was performed to detect JSRV proviral DNA during 
the pre -clinical stages of naturally transmitted OPA (Gonzalez et al 2001). JSRV 
proviral DNA was detected by exogenous U3- specific hemi- nested PCR of 
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peripheral blood and samples of brain, kidney, mammary gland, mammary lymph 
node, spleen, mediastinal lymph node, non -tumour region of lung and tumour (where 
present). JSRV proviral DNA was detected in the peripheral blood leukocytes (PBL) 
of 100% of the classical, 83% of the atypical OPA cases, 40% of the in- contacts, and 
was not detected in any of the control sheep. The data was further analysed to 
determine the differences in the number of positive replicates between the four 
groups of sheep. The control group was not considered, as there was no JSRV 
proviral DNA detected. No difference was detected between the groups in the 
mammary gland, brain and kidney (examined collectively as a single group - extra - 
thoracic non -lymphoid (ENL) organs). The lung tumour samples were all positive in 
the classical and atypical OPA groups. From the way in which the data is expressed 
it is not possible to determine the group number of positive PBL replicates, as the 
PBL samples were included with non -neoplastic lung, spleen, mediastinal and 
mammary lymph node. The results showed that JSRV was detected in the blood of 
four out of ten in- contact sheep, in the absence of histologically evident OPA, but 
positive PCR was detected in only one out of eight replicates for three of the animals. 
Therefore, as with the Holland et al (1999) study, this is suggestive of the low viral 
load identified in the peripheral blood. 
1.8.3 Lymphocytopaenia and neutrophilia 
In a study by Rosadio and Sharp (1992) the phenotypic profiles of the 
peripheral blood leukocytes from six OPA adult ewes were characterised and 
compared with three uninfected control animals. Overall, a reduction in the absolute 
number of total lymphocytes was detected in the OPA cases in comparison with the 
controls. The major leukocyte frequency alteration was identified as a reduction in 
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circulating T cells, characterized by a CD4+ lymphocytopaenia. The absolute number 
of CD8 T cells and B cells were found to be elevated in the OPA cases but the 
percentage was reduced in comparison with the controls. This study also measured 
leukocyte frequency alterations in three lambs aged five - six weeks old, which had 
been experimentally infected with JSRV, and compared the phenotypic profile with 
that of two uninfected, age -matched control lambs. Leukocyte frequency alterations 
were also reported for the lambs. However, from the data presented a reduction of 
only 1.8% positively labelled CD2 T cells was detected in the infected lambs 
compared with the controls, although the differential in the absolute numbers of 
positive CD2 T cells was greater. However, the CD4 T cells were reduced by 3.5% 
in the JSRV -infected lambs compared with the control lambs. The percentage of 
CD8 T cells detected in the JSRV -infected lambs was increased, but the number of 
positively labelled CD8 T cells was not altered between the two groups. An increase 
was also detected in the percentage and numbers of B cells in the JSRV -infected 
lambs compared with the controls. 
The preliminary findings of Rosadio and Sharp (1992) included an evaluation 
of cells detected in bronchioalveolar lavage (BAL) from nine adult OPA cases, 
compared with six uninfected adults, and also three experimentally JSRV - infected 
lambs were compared with two age- matched controls. A 24 -fold increase in the 
influx of immune cells was identified in the BAL from the adult OPA cases, 
compared with the non -OPA adult sheep although the percentage of alveolar 
macrophages was comparable between the two groups. In contrast an increase in the 
total lymphocyte and polymorphonuclear cell populations were detected in the OPA 
cases. Characterization of the pulmonary leukocyte subsets revealed a decrease in 
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CD2 and CD4 T cells and increased CD8 T cells and B cells from the BAL from the 
OPA cases in comparison with the control sheep. A 34 -fold increase in the influx of 
immune cells was detected in the BAL from the experimentally infected lambs 
compared with the controls. The percentage of alveolar macrophages was reduced in 
the JSRV - infected lambs compared with the controls but the number of macrophages 
was greatly increased. No alteration between the two groups was detected in the 
number of total lymphocytes, and the number and percentage of polymorphonuclear 
cells were also increased in the JSRV -infected lambs. Characterization of the 
pulmonary leukocyte subsets revealed a decrease in CD2, CD4 and CD8 T cells and 
an increase of only 0.9% in B cells from the BAL from the JSRV -infected lambs in 
comparison with the BAL from the controls. Unfortunately, the statistical 
significance of the reported data for frequency alterations detected in the peripheral 
blood and BAL was not stated. The preliminary fmdings of a peripheral 
lymphocytopaenia was demonstrated from data generated at only one time point 
during the experimental JSRV infection and from only three JSRV -infected and two 
control lambs. Therefore an extended investigation into leukocyte frequency 
alterations during JSRV infection is required. 
1.9 Project aims 
It was the aim of this project to further the understanding of the relationship 
between JSRV and ovine immunity by identifying any immunological responses or 
alterations in the systemic immune system following JSRV infection. As a 
peripheral CD4 T cell lymphocytopaenia and neutrophilia previously have been 
identified in terminal OPA cases (Roasadio and Sharp 1992) it was hypothesised that 
any immune responses in JSRV infected animals may be detected systemically. This 
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hypothesis was tested by monitoring the phenotypic profile of the peripheral blood 
leukocytes and cell -mediated responses at all stages of disease from JSRV 
inoculation, through tumorigenesis and into the terminal stages of OPA. The 
immunological status in the terminal phase of the disease was determined by the 
phenotypic characteristics and cellular responses in the blood of naturally infected 
field cases, compared with those of non -OPA adult sheep. Clinical and pathological 
OPA was experimentally induced in neonatal lambs by intratracheal inoculation with 
virus purified from lung fluid (Sharp et al 1983). Thus monitoring phenotypic and 
functional changes in the peripheral blood during experimentally induced 
tumorigenesis was possible. Furthermore to determine whether the demonstrated 
lymphocytopaenia, neutropihia or as yet unidentified frequency alterations were 
early events during JSRV infection or occurred post -tumour development. To test the 
hypothesis that local immune responses may occur in the OPA lung, the 
identification of tumour infiltrating cells and alterations in their distribution patterns 
were investigated by comparative immunohistochemical analysis of immune cells in 
the lungs of confirmed OPA cases and control animals. 
To test these hypotheses it was proposed that 
The phenotypic frequencies in peripheral blood mononuclear cell (PBMC) 
subsets be monitored using a panel of monoclonal antibodies specific for CD2+ T 
cells, CD4+ T cells, CD8+ T cells, y8 T cells, B cells and MEC class II antigens, with 
the results determined by flow cytometry. Neutrophils would be counted also. 
To determine whether any observed leukocyte frequency alterations occur as 
early events during JSRV infection, during tumour development or are restricted to 
the terminal phase of the disease. 
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Alterations in cellular function, during JSRV infection would be determined 
by monitoring non -specific in vitro lymphoproliferation to mitogen stimulation, to 
identify changes in cell -mediated responses in the peripheral blood of JSRV - infected 
animals. 
In situ phenotyping of the OPA lung would provide preliminary 
identification of tumour infiltrating lymphocyte subsets. Furthermore comparative 
analysis between the non -neoplastic region of the OPA lung and lung tissue derived 
from uninfected control animals would identify any influx of immune cells into the 
tumour region and demonstrate any alteration in the distribution pattern of immune 
cells within the OPA lung. 
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Chapter 2 
General Materials and Methods 
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2.1 Animals 
2.1.1 Adult sheep in the terminal stages of OPA 
The acquisition of animals for research into ovine pulmonary 
adenocarcinoma (OPA) in adult field cases depends entirely on the goodwill of sheep 
farmers, who have agreed with the Moredun Research Institute to supply sheep 
suspected of having OPA. If symptoms of OPA, such as laboured breathing, weight 
loss and/or the production of lung fluid were identified by the farmer, the veterinary 
staff at the Institute were notified, and the animal was collected from the farm 
immediately. On arrival at the Moredun Research Institute a full veterinary 
examination was performed to determine the health of the sheep. The severity of 
symptoms in OPA cases ranged from slightly laboured breathing with limited weight 
loss to severe emaciation and breathing difficulties. The majority of sheep involved 
in this study had progressed into the terminal stages of OPA, with severe dyspnea, 
and in many cases, the production of lung fluid. 
All suspected OPA cases at the Moredun Research Institute were housed in 
pens separated from other sheep, and all contact with other animals was not 
permitted. Lung fluid if produced, and blood samples were collected (section 2.1.3.1 
and 2.1.4, respectively). During this project twelve cases of OPA were confirmed in 
adult sheep, aged between three and five years old, but on one occasion OPA was 
diagnosed in a female yearling. The majority of OPA cases were ewes, with several 
breeds of sheep implicated including Greyface, Texel and Blackface -X- Blackface 
Leicester. The male and female adult sheep used as control animals in these studies, 
were aged one to four years, and from various breeds including Dorset and Suffolk -X. 
All the controls were from stock at the Moredun Research Institute. 
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The animals were humanely killed by an overdose of pentobarbitone (Rhone 
Merieux, Tallaght, Dublin) and post mortem examinations performed to determine 
the disease status of each animal. The thoracic lymph nodes were removed, and the 
mediastinal and bronchial lymph nodes examined macroscopically for any evidence 
of enlargement. In the lungs, the presence of neoplastic lesions, identified as a large 
tumour mass and/or discrete nodules was recorded, together with any observed 
secondary infections. Samples of lung, tumour, mediastinal and bronchial lymph 
node collected at necropsy were fixed in formaldehyde and paraformaldehyde for 
histological analysis. Identification of tumour as isolated and/or confluent pulmonary 
neoplastic lesions histologically confirmed the presence of OPA. In some cases, 
hyperplasia of bronchial associated lymphoid tissue, mononuclear inflammation, and 
an influx of enlarged alveolar macrophages and neutrophils to the site of the tumour, 
were detected. Secondary infections have also been identified in association with 
OPA, predominately desquamative or suppurative pneumonia, and/or bacterial 
infections such as Pasteurella species. Histological analysis was performed at the 
Moredun Research Institute by Dr. Lorenzo Gonzalez (Veterinary Laboratory 
Agencies, Penicuik, Midlothian. Scotland). 
2.1.2 Experimental JSRV infection of neonatal lambs 
To monitor immune responses during the pre -clinical stages of disease, two 
experiments were performed. All lambs were born and housed at the Moredun 
Research Institute. 
i) Conventionally Housed Lambs: Ten Dorset lambs, born under natural 
conditions were used in this study. The lambs were fed by their mothers, 
consequently they received colostrum. From four weeks old their diet was 
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supplemented with high protein proprietary weaner pellets. They continued to be 
reared by their mothers until eight weeks of age. From fourteen weeks, the lambs 
were fed rearer pellets (lamb nuts), with the composition of lipids, protein and fibre 
modified to meet their dietary requirements. The lambs were fed using the lamb 
creep system (a feeding mechanism, which allows only lambs access to the feed 
whilst restricting the adults). A supply of hay was also available. The lambs 
remained on this diet until the termination of the experiment. At seven days old, six 
lambs (3 sets of twins) were intratracheally inoculated with JSRV, purified from lung 
fluid (section 2.1.3.2). The four remaining lambs (two sets of twins) were used as un- 
inoculated control animals. All animals were housed identically, with the JSRV- 
infected lambs and their mothers, the control lambs together with their mothers, kept 
in separate pens. 
ii) Specific pathogen free lambs (SPF): To extend the experiment performed with 
the conventionally housed lambs and minimise exposure to outside influences and 
secondary infections, the above experiment was repeated with ten Suffolk -X lambs. 
At four days old, six lambs (two sets of twins and two single lambs) were 
intratracheally inoculated with JSRV, purified from lung fluid (section 2.1.3.2). The 
four remaining lambs (two sets of twins) acted as un- inoculated control animals 
throughout the experiment. 
The SPF lambs were born by caesarean section and aseptically hand reared 
under modified conditions with sterilised air supply, bedding and food. Although 
not sterile, SPF containment supports a controlled environment, minimising 
exposure to infectious agents, to which lambs would otherwise be susceptible. From 
birth the lambs were given UHT cow milk. At two weeks old, this was 
54 
supplemented with LocushTM lamb feed until the introduction of supplemented feed 
at four weeks, using the lamb creep system outlined in section 2.1.2(i). The volume 
of UHT milk given was reduced until the lambs were fully weaned at six weeks. At 
twelve weeks the lambs were introduced to rearer pellets (lamb nuts), which they 
received thereafter, until the end of the experimental period. Sterilized hay was also 
available. 
2.1.3 JSRV inoculation of experimental lambs 
2.1.3.1 Lung fluid in OPA sheep 
Lung fluid, identified as a nasal exudate in OPA cases, was collected by `the 
wheelbarrow technique' where the hind- quarters of the sheep were raised whilst 
holding down the head, allowing the fluid to drain into a sterile collection vessel 
(Chapter 1, section 1.5.1). 
2.1.3.2 Preparation of JSRV inoculum 
The inoculum used to induce experimental infection in both the 
conventionally housed and SPF neonatal lambs was partially purified JSRV from 
lung fluid, collected from OPA cases. The JSRV inoculum was prepared by Patricia 
Dewar (Moredun Research Institute), according to the method originally described 
by Sharp et al (1983). The lung fluid was clarified by filtering through a sterile 
gauze- covered - funnel to remove large particles. The filtrate was then centrifuged for 
30 minutes at 1080g at 4 °C. The clarified lung fluid was layered on a 3m1/3m1, 
50/25% glycerol -TNE (1M sodium chloride, 0.1M Trisma -base, 10mM EDTA) 
buffered cushion, in a Beckman SW28 centrifuge tube, using a i6gauge hypodermic 
syringe. JSRV was concentrated through the cushion by centrifugation at 100,000g 
for 60 minutes at 4 °C. The supernatant was removed by aspiration and the tubes 
55 
inverted onto tissue paper to drain for 2 -5 minutes. Residual fluid was removed from 
the tube with a tissue. The pellet was re- suspended in PBS or supernatant to give a 
X15 final concentration with respect to the starting volume. The inoculum 
administered to the conventionally house lambs comprised JSRV re- suspended in 
PBS, the SPF lambs were inoculated with JSRV re- suspended in the supernatant. 
The inocula were stored at -70 °C until required and 5ml X15 JSRV /animal was 
administered by intratracheal inoculation. All the control animals remained un- 
inoculated. 
2.1.4 Blood sample collection 
For all animals, blood samples were collected by jugular venepuncture into 
sterile Vacutainer BrandTM evacuated blood collection tubes (Becton Dickinson, 
Rutherford, NJ, USA) containing preservative -free heparin [10 units per ml blood] 
(Sigma, Poole, Dorset), and 10011l aliquots were removed from each sample, prior to 
PBMC purification, and retained for the neutrophil counts (section 2.4). 
2.1.5 Diagnosis of disease 
In all experiments, when clinical signs of OPA were apparent, the lambs were 
humanely killed and post mortem examinations performed as described in section 
2.1. Identification of lesions as small discrete nodules at isolated foci and/or 
confluent pulmonary tumour macroscopically and histologically confirmed the 
presence of OPA. Histological investigations were performed at the Moredun 
Research Institute by Dr. Lorenzo Gonzalez (Veterinary Laboratory Agencies, 
Penicuik, Midlothian. Scotland). 
In some cases tissue samples were collected into a cryomatrix resin (Thermo 
Shandon, Pittsburgh PA, USA), snap frozen in liquid nitrogen and stored at -70 °C, 
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or fixed in paraformaldehyde, formaldehyde or zinc salts fixative (ZSF) and paraffin 
embedded. The tissue samples were then prepared for immunohistochemical 
analysis, full details of these procedures are in section 2.10, 2.11, 2.12, 2.13 and 
Chapter 5. 
2.2 Purification of peripheral blood mononuclear cells (PBMC) 
Neutrophilia in the peripheral blood of adult sheep in the terminal stages of 
OPA is a recognised phenomenon (Rosadio and Sharp 1992, Holland et al 1999). 
Inaccurate data would be generated during comparative studies by inadequate 
depletion of neutrophils from the blood. For example, to measure the proliferative 
responses of infected and control animals, identical concentrations of PBMC from 
both groups are required. A high numbers of neutrophils retained in the PBMC 
samples from infected animals would limit the number of lymphocytes available for 
stimulation. 
2.2.1 Purification of PBMC and depletion of neutrophils 
The large population of neutrophils present in the blood of adult OPA cases 
was not adequately removed by the standard laboratory PBMC purification method 
(Boyam 1968), where the whole blood is diluted or layered directly onto a density 
gradient. Therefore to purify the PBMC and to deplete the neutrophils three methods 
were tested. 
i) Removal of neutrophils by centrifugation of whole blood prior to PBMC 
purification: Samples of 10m1 whole blood were transferred to conical tubes 
and centrifuged at 300g for 15 minutes. The bully coat, together with a small 
volume of plasma was recovered and re- suspended in lml RPMI -1640 
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medium (Gibco BRL, Paisley, Renfrewshire) containing 514/ml glutamine, 
5 µg/ml penicillin/streptomycin, 0.5µg /ml gentamicin, 5µg /ml fungizone 
(Sigma, Poole, Dorset) and i Ounits /ml heparin. The sample was very gently 
mixed. *The cell suspension was then layered over 5m1 LymphoprepTM 
(Nycomed Pharma AS, Oslo, Norway) and centrifuged at 300g for 15 
minutes. The interface cells were recovered and re- suspended in 10m1 
RPMI -1640 containing 10% heat inactivated foetal calf serum (Gibco BRL, 
Paisley, Renfrewshire) and i Ounits /ml heparin. The samples were centrifuged 
at 240g for 10 minutes and the supernatant decanted. The cell pellet was then 
washed twice by centrifugation at 240g for 5 minutes and re- suspended in 
5m1 RPM-1640 medium (no added heparin). After a final wash the 
supernatant was decanted and the cells re- suspended in 5m1 RPMI -1640 with 
10% heat inactivated foetal calf serum added. Cytospins of the purified 
PBMC microscopically showed that few neutrophils were retained. 
Furthermore, this method did not adversely affect the number of PBMC 
recovered. The procedure was cost effective as no other reagents were 
required and only an extra 15 minutes centrifugation per sample was 
necessary. 
ii) Sedimentation. Using citrate as an anticoagulant, fresh venous blood was 
collected and centrifuged at 180g for 20 minutes. The cell pellet was re- 
suspended in four volumes of 6% (w /v) dextran T500: 0.9% (w /v) NaCl. An 
equal volume of phosphate buffered saline (PBS) was added and the cells left 
to sediment for 25 -40 minutes at room temperature. The leukocyte rich upper 
layer was collected. The PBMC were then purified as detailed from * in 
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method (i). As the cells were left to sediment for up to 40 minutes, this 
method was time consuming and additional reagents were required. The 
resulting PBMC were not purified to a high standard as microscopic 
observation of the PBMC cytospins revealed many neutrophils were still 
present (data not shown). 
iii) An adaptation of the method developed by Carlson and Kaneko (1972) to 
isolate leukocytes from bovine peripheral blood was tested. Briefly 10ml 
whole blood was centrifuged at 1000g for 15 minutes. The buffy coat and 
uppermost portion of the red cell column was recovered into 4m10.08% NaC1 
in 13.2mM PBS (pH 6.8). Erythrocytes in the suspension were lysed by the 
addition of 20m1 deionised water and gently mixed for 30 seconds. The 
isotonicity was then restored by the addition of 10m1 PBS (13.2mM pH 6.8) 
containing 2.7% NaCl. The cells were washed a further three times by 
centrifugation at 200g for 10 minutes and re- suspended in 5m1 PBS. 
Additional reagents were required for this method, and although the majority 
of neutrophils were removed (detected microscopically), this method also 
resulted in a reduced number of purified PBMC recovered (data not shown). 
All three methods to purify the PBMC were tested on three separate occasions, twice 
with blood from adult OPA cases and once with an uninfected control sheep. The 
results obtained from the infected animals were consistent with those detailed above, 
and no detrimental effects were observed in the PBMC from the control animal. 
Therefore method (i) was selected as the PBMC purification protocol. Consequently, 
to ensure that consistency was maintained with all blood samples, this method was 
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employed not only with adult OPA cases, but also with JSRV -infected lambs and all 
control animals. 
2.2.2 Cell counts 
A standard haematological counting fluid, 1.5% acetic acid, 0.01% Giemsa stain 
(BDH, Poole, Dorset) in distilled water was used to dilute the cells and lyse any 
remaining red blood cells. A suspension of 10µl PBMC was added to 90µ1 counting 
fluid and gently mixed. The cells were counted using a Neubaur haemocytometer and 
adjusted to a final concentration of 106 PBMC /ml. 
2.3 Phenotyping 
2.3.1 Phenotyping of purified PBMC 
2.3.1.1 Immunolabelling of PBMC 
PBMC phenotyping by indirect immunofluorescence was performed using 
standard laboratory procedures (Bachh et al 1995, Lloyd et al 1995). The purified 
PBMC were adjusted to a final concentration of 106 PBMC /ml. The PBMC at 5x105 
PBMC /ml were immunolabelled with a non -specific mouse immunoglobulin (IgG) 
as a control, (initially bovine serum albumin (BSA) was used to identify non -specific 
fluorescence), and mouse anti -sheep monoclonal antibodies specific for CD2+ T cells 
(135A), y6 T cells (86D) (Mackay et al 1988), CD4 +T cells (17D), CD8+ T cells 
(SBU -T8) (Maddox et al 1985), B cells (a -light chain VPM8) (Yirrell et al 1991) 
and MHC class II antigens (VPM54) (Gupta et al 1986), (all supplied by Prof. John 
Hopkins, University of Edinburgh). The immunolabelled samples were incubated for 
30 minutes at room temperature, in the dark. After incubation, lml PBS was added to 
each sample and the tubes centrifuged at 240g for 5 minutes. The supernatant was 
decanted and the secondary antibody, a rabbit anti -mouse Ig /fluorescein (FITC) 
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conjugate (DAKO, Ely, Cambridgeshire) was added at 100µl volume of 1:50 
dilution per sample. The samples were incubated for 30 minutes at room 
temperature, in the dark. After incubation, lml PBS was added and the samples 
centrifuged at 300g for 5 minutes. The supernatant was decanted and 1 ml PBS and 
10011110% formol saline added. The samples were stored at 4 °C for a maximum of 
56 hours before analysis. 
2.3.1.2 Flow cytometry 
The results were determined by flow cytometry using an EPICS XL -MCLTM 
profile (Coulter Electronics, Miami, Florida, USA), utilizing an argon ion laser set at 
a wavelength of 488nm. The PBMC were separated from the cell debris, 
characterised by forward scatter (FS) determining cell size, and side scatter (SS) 
determining cellular granularity. The immunolabelled lymphocytes were separated 
from the PBMC population with gates set around the lymphocyte region on 90° and 
forward angle scatter (Figure 2.1). Fluorescence data were collected on a minimum 
of 2000 lymphocytes, with a 1% background control. An example of the 
immunolabelled phenotypic profile, detected in adult sheep peripheral blood is 
shown in Figure 2.2. 
2.3.1.3 The optimisation of monoclonal antibody titres 
The affinity of individual monoclonal antibodies for cell surface receptors 
varies extensively. Therefore to analyse the leukocyte phenotypic profile of the 
blood, the optimum titre for each monoclonal antibody was determined from a 
titration series (Figure 2.3). The PBMC were immunolabelled as described in section 
2.3.1.1 with BSA as a control sample and 1µl, 2.51Al, 5µl, 10µ1 and 20µl monoclonal 
antibody /5 x 10' PBMC. At a concentration of 1 µU5 x 10' PBMC the percentage of 
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Figure 2.1 Computer generated dot plot of sheep peripheral blood showing scatter 
profile of the purified PBMC. The purified PBMC were immunolabelled with mouse ant - 
sheep monoclonal antibodies specific for CD2 T cells, B cells and MHC class Il antigens. 
The results were determined by flow cytometry. Vertical axis: side scatter (SS log) defining 
cellular granularity, horizontal axis: forward scatter (FS log) defining cell size. The results 
show the scatter profile of purified PBMC with defined lymphocyte region ( ), identified by 
positively immunolabelled CD2 T cells and B cells. Cells expressing MHC class lI antigens 
were identified by gating the entire PBMC population ( ), incorporating the lymphocyte 
region and other cells not recognised by the panel of monoclonal antibodies used, but 
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Figure 2.2 Histograms of lymphocyte subsets and MHC class Il expression in the 
purified PBMC of sheep. The PBMC were immunolabelled with monoclonal antibodies 
specific for CD2, CD4, CD8, yS T cells, B cells and MHC class Il antigens, and the 
percentage of positively immunolabelled cells detected by flow cytometry, Y axis: cell 
frequency. X axis: log green fluorescence. Peaks at origin were due fluorescence of 
background debris (Figure 2.2a). Figures 2.2 b -f: Lymphocyte subsets were selected by 
gating, based on light scatter characteristics determining the lymphocyte region. Figure 2.2g: 
Percentage of cells expressing MHC class Il antigens was selected by gating entire PBMC 
population, excluding debris. 
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positive cells was comparable with the background control. At 2.505x105 PBMC 
an increase in the percentage of each subset was evident but increased further with 
the addition of 5111/5x105 PBMC. No significant difference in the percentage of 
positive cells was detected when labelled with 5p1, 104 and 20µÚ5x105 PBMC. 

















Figure 2.3 Optimum monoclonal 
antibody concentration. The PBMC 
subsets were immunolabelled with a 
titration series of mouse anti -sheep 
monoclonal antibodies, and the results 
were determined by flow cytometry. 
Vertical axis: percentage of positive 
labelled cells in sheep peripheral blood. 
1st horizontal axis: panel of monoclonal 
antibodies. 2nd horizontal axis: 
monoclonal antibody concentration 
(11/5x105 PBMC). The results for the 
lymphocyte subsets are shown as 
percentage positive immunolabelled 
cells/lymphocyte region. Cells 
immunolabelled for MHC class Il 
antigens are shown as percentage 
positive immunolabelled cells/PBMC. 
2.3.2 Phenotyping using whole blood samples 
2.3.2.1 Identification of the lymphocyte region in whole blood samples 
The purification of peripheral blood mononuclear cells (PBMC) from a large 
number of samples is a labour intensive and time -consuming procedure, with the 
condition of the PBMC deteriorating if they are retained on the bench for long 
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periods of time. To expedite laboratory procedures, phenotyping using whole blood 
was considered. It was essential to ensure that this procedure could be performed 
consistently; not only with blood from uninfected animals, but that the presence of 
JSRV did not in any way compromise the assay. Therefore the phenotypic profiles of 
mononuclear cells present in whole blood samples were compared with those in the 
corresponding purified PBMC. 
Aliquots of 100µ1 whole blood were immunolabelled by incubation with 
monoclonal antibodies following the protocol for PBMC phenotyping described in 
section 2.3.1.1. After incubation with the secondary antibody, and prior to the 
addition of PBS and formol saline, the red blood cells were lysed by adding 2ml 
ErthyrolyseTM red blood cell lysis buffer (Serotec, Kidlington, Oxford) diluted 1:10 
in distilled water. The samples were incubated in the dark for 10 minutes at room 
temperature. After incubation 2m1 PBS was added and the samples centrifuged at 
300g for 5 minutes. The supernatant was decanted and the cells re- suspended in lml 
PBS, centrifuged at 300g for 5 minutes, the supernatant decanted, and lml PBS and 
10% formol saline added. PBMC were purified from the remainder of the 
corresponding whole blood sample (section 2.2.1) and immunolabelled as detailed in 
section 2.3.1.1. The lymphocyte subset frequencies identified in whole blood 
samples and corresponding PBMC were determined and compared by flow 
cytometry as detailed in section 2.3.1.2. 
The large amount of cell debris, and the presence of the polymorphonuclear 
cells retained in the whole blood impeded identification of the lymphocyte 
population (Figure 2.4a). Therefore, the lymphocyte region was first identified and 
gated in the corresponding purified PBMC sample as detailed in section 2.3.2 using 
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the CD2+ monoclonal antibody (Figure 2.4b). The lymphocyte region parameters 
were confirmed using a B cell monoclonal antibody. After gating, and retaining the 
parameters the whole blood samples could be analysed. 
a b 
Figure 2.4 Scatter profile of mononuclear cells from whole blood and purified PBMC. 
Computer generated dot plot of sheep peripheral blood. Vertical axis: side scatter (SS log) 
defining cellular granularity, horizontal axis: forward scatter (FS log) defining cell size. The 
results show the scatter profile of whole blood sample (Figure 2.4a), with large amounts of 
cell debris and polymorphonuclear cells obscuring the lymphocyte regions. Figure 2.4b. 
shows the scatter profile of purified PBMC with defined lymphocyte region (a), identified by 
CD2+ and B cell monoclonal antibody labelling. Cells expressing MHC class Il antigens were 
identified by gating the entire PBMC population (b), incorporating the lymphocyte region and 
other cells not recognised by the panel of monoclonal antibodies used, but excluding the cell 
debris. 
2.3.2.2 Whole blood and PBMC phenotypic comparison 
The percentage of lymphocyte subsets identified within whole blood samples 
was compared with the percentage present in the corresponding purified PBMC from 
the same adult sheep. Purified PBMC and mononuclear cells present in whole blood 
samples were phenotyped using monoclonal antibodies recognising CD2, CD4, CD8 
and 78 T cells and B cells, and the results determined by flow cytometry (sections 
2.3.1 and 2.3.2, respectively). The percentage of positive immunolabelled 
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lymphocytes were decreased in the whole blood samples in comparison with the 
percentage detected in the purified PBMC. The phenotypic profile from three adult 
OPA cases, (Figure 2.5a) revealed significantly (p = 0.02) reduced percentages of 
CD2 T cells (PBMC 31.3 ± 4.6, whole blood 11.1 ± 2.7), y8 T cells (PBMC 12.8 ± 
0.4, whole blood 4.9 ± 0.9 (p = 0.001)) and B cells (PBMC 31.3 ± 4.4, whole blood 
19.2 ± 1.8 (p = 0.02)). The phenotypic profile from the whole blood and the purified 
PBMC of three uninfected adult sheep is shown in Figure 2.5b. Comparison between 
PBMC and whole blood detected significantly (p = 0.003) reduced percentages of 
CD2 T cells (PBMC 49.5 ± 0.4, whole blood 15.6 ± 5.1) and 78 T cells (PBMC 11.6 
±2.1, whole blood 4.3 ± 1.5 (p = 0.04)). No significant difference in the percentage 
of positively immunolabelled CD4 or CD8 T cells was identified between the whole 
blood and purified PBMC, from either group of animals. 
The decrease in CD2 and 78 T cells identified in the whole blood may 
suggest that the epitopes present on the cell surface were masked by the large 
accumulation of debris present in the sample. The decreased B cell population 
observed in the whole blood from the OPA sheep, whilst not evident in the control 
animals, was not suggestive of a JSRV -related response as no difference was 
detected in the corresponding purified PBMC sample. The percentages of 
immunolabelled lymphocyte subsets, detected in the purified PBMC of the control 
sheep, were comparable to those previously identified in other studies characterising 
the ovine PBMC phenotypic profile (Smith et al 1994, Bachh et al 1995). However 
overall, the inconsistencies identified with the whole blood and purified PBMC 
suggest that whole blood phenotyping was not the optimal method for comparative 
studies during JSRV infection and the development of OPA. To ensure constant 
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reliability during all experiments and monitoring programmes throughout this 
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Figure 2.5 Phenotyping mononuclear cells from whole blood and purified PBMC. 
Comparison of the lymphocyte phenotypic profile of purified PBMC and whole blood from 3 
adult OPA cases (Figure 2.5a) and 3 uninfected adult sheep (Figure 2.5b). Results are 
shown as percentage positive immunolabelled cells in peripheral blood, ± SEM. 
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2.4 Determination of neutrophil numbers 
The neutrophils present in the blood samples were determined from 100111 
aliquots of whole blood retained prior to the purification of the PBMC. The red 
blood cells were lysed by adding 2m1 ErthyrolyseTM red blood cell lysis buffer 
diluted 1:10 in distilled water to the whole blood. The samples were incubated for 10 
minutes at room temperature. The cells were washed by adding 2m1 PBS per sample 
and centrifuged at 300g for 5 minutes, the supernatant was decanted, and the cells re- 
suspended in lml PBS, centrifuged at 300g for 5 minutes, the supernatant decanted, 
and lml PBS and 10% formol saline added. 
Initially, the proportion of neutrophils present in each blood sample was 
determined microscopically based on cellular morphology. To ascertain the presence 
of neutrophils in the samples 2001A1 aliquots were removed and cytospins prepared 
(Cytocentrifuge, Shandon Southern Products Ltd., Runcorn, Cheshire) following the 
manufacturer's instructions. The cells were fixed in methanol for 10 minutes, air - 
dried and stained for 15 minutes with 1:10 Giemsa stain (BDH, Poole, Dorset), 
gently washed under running tap water and air- dried. 
In subsequent studies the percentage of neutrophils present in the whole 
blood was ascertained by flow cytometry (EPICS XL- MCLTM) profile, based on cell 
size and granularity, determined by forward and side scatter profile, utilizing an 
argon ion laser set at a wavelength of 488nm. The neutrophils present in the purified 
PBMC sample (Figure 2.6a) were gated on 90° and forward angle scatter and the set 
parameters were used to identify the neutrophils present in the whole blood sample 
(Figure 2.6b). Data were collected on a minimum of 5000 events. 
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Figure 2.6 Neutrophils detected in sheep peripheral blood by flow cytometry. Computer 
generated dot plots of sheep peripheral blood. Vertical axis: side scatter (SS log) defining cellular 
granularity, horizontal axis: forward scatter (FS log) defining cell size. Figure 2.6a: Scatter profile 
of purified PBMC showing *gated neutrophils. These parameters were set and retained to gate 
the neutrophil population present in the whole blood sample. Figure 2.6b: The scatter profile of 
the corresponding whole blood sample with the *gated neutrophil population identified. 
2.5 Lymphoproliferation 
2.5.1 Lymphoproliferation of purified PBMC 
The level of lymphoproliferative response stimulation species 
specific, and the concentration of individual mitogens required to stimulate optimum 
responses differs considerably. Therefore the optimum titre for each mitogen used in 
lymphoproliferation studies was identified from a concentration curve. 
The in vitro lymphoproliferative responses to mitogens were measured as 
previously described (Burrells and Wells 1977, Wells et al 1979, Kilpatrick 1998). 
The PBMC were purified from the venous blood of sheep as described in section 
2.2.1 and adjusted to a final concentration of 106 PBMC /ml (section 2.2.2). Various 
concentrations of phytohaemagglutinin (PHA), concanavalin A (ConA) and 
pokeweed mitogen (PWM) (all from Sigma, Poole, Dorset) were added to 106 
PBMC /ml RPMI -1640 medium. Control samples (excluding a lectin) were prepared 
also. All samples, at 2x105 PBMC /well were dispensed, in triplicate, into sterile 96- 
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well, round bottomed plates (Bibby Sterilin, Stone, Staffordshire). The plates were 
incubated in 5% CO2 at 37 °C for a total of 96 hours, with the addition of 0.7p,Ci/well 
[methyl- 3H]thymidine (specific activity 2.0Ci/mmol, Amersham, Little Chalfont, 
Buckinghamshire) for the final 16 hours. The cells were then harvested onto 
fibreglass sheets (Automash 2000, Dynatech), air -dried and transferred to vials. 
Commercial liquid scintillant (Packard Bioscience, Groningen, The Netherlands) at 
1 ml per vial was added and 3H- thymidine uptake measured as counts per minute 
(cpm) (Packard Tri -Carb Liquid Scintillation Analyser). The optimum 
concentrations, identified by the maximum response, were found to be 121.1g /ml for 
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Figure 2.7 Optimum mitogen 
concentrations. Titration series to determine 
the concentrations of mitogens required to 
induce maximum lymphoproliferation of sheep 
PBMC. Results are shown as counts per 
minute (cpm). Results determined by 3H- 
thymidine uptake, after 96 hours in culture. The 
unstimulated PBMC (472 cpm) has been 
subtracted. Figure 2.7a: PHA stimulation, 
optimum *1214/ml. Figure 2.7b: ConA 
stimulation, optimum *1514/ml. Figure 2.7c 
PWM stimulation, optimum *2ug /ml. 
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2.5.2 Lymphoproliferation of PBMC depleted of adherent cells 
A 20m1 volume of venous blood was collected (section 2.1.4), and the PBMC 
were purified as described in section 2.2.1(i)). The cells were counted (section 2.2.2) 
and adjusted to a final concentration of 10' cells /ml RPMI -1640 medium, containing 
antibiotics and 10% foetal calf serum. Three aliquots of the PBMC were prepared. 
Entire -PBMC Lymphoproliferation was performed with 106 PBMC /ml and the 
optimum titre of the required mitogen (including a control sample, without any 
mitogen), as detailed in section 2.5.1. An aliquot of 5x105 cells was retained for 
detection of MHC class II antigens by flow cytometry. 
PBMC depleted of adherent cells The adherent cells were removed from the PBMC 
prior to lymphoproliferation by incubating a 5m1 volume of 10' PBMC /ml in a 50m1 
tissue culture flask in 5% CO2 at 37 °C for 1 hour. The non -adherent cells were 
decanted, and a 104,1 aliquot removed and retained for cytospin analysis. The cells 
were counted (section 2.2.2) and 5x105 cells retained for detection ofMHC class II 
antigens by flow cytrometry. The optimum titre of the required mitogen was added 
to a concentration of 106 cells /ml and lymphoproliferation (including a control 
sample, without any mitogen) was then performed as detailed in section 2.5.1. 
The adherent cells were scraped from the flask using a sterile cell scraper (Merck 
Eurolab Ltd, Lutterworth, Leic.) and re- suspended in lml RPMI -1640 medium, 
containing antibiotics and 10% foetal calf serum. A1001.11 aliquot of cells was 
removed and retained for cytospin analysis. 
Reconstituted -PBMC The adherent cells were centrifuged at 300g for 5 minutes and 
the supernatant decanted. The pellet of adherent cells was restored to the remaining 
depleted PBMC, the cells were counted (section 2.2.2) and adjusted to a final 
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concentration of 106 PBMC /ml RPMI -1640 medium, containing antibiotics and 10% 
foetal calf serum. A100111 aliquot was removed and retained for cytospin analysis, 
and 5x105 PBMC were retained for detection of MHC class II antigens by flow 
cytometry. Lymphoproliferation assays (including a control sample, without any 
mitogen) were then performed as detailed in section 2.5.1 
2.5.3 Confirmation of removal of adherent cells from the PBMC 
From the retained aliquots, cytospins of the PBMC depleted of adherent cells, 
the isolated adherent cells and the reconstituted -PBMC were prepared as detailed in 
section 2.4. Microscopic examination of the cellular morphology confirmed that the 
adherent cells had been removed from the PBMC, as only lymphocytes were 
identified in the depleted PBMC sample. In the adherent cell sample no lymphocytes 
were evident, with only monocytes identified. The reconstituted -PBMC sample was 
found to contain a mixed population of lymphocytes and monocytes (results not 
shown). To confirm that the expression of MHC class II was reduced in the 
adherent -cell -depleted -PBMC, compared with the entire and the reconstituted- 
PBMC, the cells were immunolabelled with a monoclonal antibody specific for 
MHC class II antigens (and IgG control), following the protocol detailed in section 
2.3.1.1. The results, determined by flow cytometry (section 2.3.1.2) are shown in 
Figure 2.8, confirmed that the percentage of immunolabelled cells expressing MHC 
class II antigens was reduced in the PBMC depleted of adherent cells (9.0 %) in 
comparison with the percentages detected in the entire PBMC (39.8 %) and 
reconstituted PBMC (35.4 %). 
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Figure 2.8 Flow cytometry histograms of MHC class Il detected in the entire -PBMC, 
PBMC depleted of adherent cells and reconstituted -PBMC. The percentage of cells 
expressing MHC class II antigens in the entire -PBMC, PBMC depleted of adherent cells and 
reconstituted -PBMC (adherent cells replaced) were compared. The cells were 
immunolabelled with a mouse ant -sheep monoclonal antibody specific for MHC class II 
antigens and the results determined by flow cytometry. The results are shown as percentage 
positive MHC class II immunolabelled cells detected in each sample. Figure 2.8a: The IgG 
control sample (entire -PBMC) with a 3.2% background autofluorescence. Figure 2.8b: The 
entire -PBMC. Figure 2.8c: The percentage of MHC class Il expression in the PBMC 
depleted of adherent cells. Figure 2.8d: The reconstituted -PBMC (after the adherent cells 
had been returned to the PBMC). 
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2.6 Storage conditions of samples for in vitro studies 
2.6.1 The effects of storage on venous blood samples 
For comparative analysis, consistency of the PBMC purified from each blood 
sample must be maintained. To ascertain the optimum conditions for holding whole 
blood, without degradation of the cell surface antigens, the effects of time and 
temperature on whole blood, prior to the purification of PBMC for phenotyping 
analysis and lymphoproliferation assays were examined. The phenotypic profile of 
stored immunolabelled PBMC was evaluated also. 
2.6.1.1 Effect of whole blood storage on the phenotypic profile of the PBMC 
The PBMC, purified from freshly collected blood samples and after the 
heparinised blood had been stored for 24 and 48 hours at room temperature and 4 °C, 
were phenotyped using monoclonal antibodies specific for CD2, CD4, CD8, y8 T 
cells and B cells (section 2.3.1.1) and the results were determined by flow cytometry 
(section 2.3.1.2). 
As shown in Figure 2.9, storage of heparinised whole blood at room 
temperature, for up to 48 hours did not adversely affect the phenotypic profile of the 
subsequently purified PBMC subsets, as the results were comparable to those 
obtained with fresh blood and are in accordance with the finding of Lloyd et al 
(1995). In contrast blood stored at 4 °C for 24 and 48 hours resulted in reduced 
lymphocyte sub -population detected, with all subsets affected. Therefore it was not 
possible to store the blood samples at 4 °C, even for a period of 24 hours, as this 
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Figure 2.9 PBMC phenotyping after the storage of whole blood samples. The 
phenotypic profile of the PBMC purified from freshly collected blood was compared with 
blood after storage for 24 and 48 hours at room temperature (R.T.) and 4 °C. The PBMC 
were immunolabelled with mouse anti -sheep monoclonal antibodies recognising CD2, CD4, 
CD8, y8 T cells and B cells, and the results were determined by flow cytometry. Vertical axis: 
percentage positive lymphocyte subsets in peripheral blood. 1st horizontal axis: panel of 
monoclonal antibodies 2nd horizontal axis: storage conditions. The results are shown as 
percentage positive cells /blood. 
2.6.1.2 The effect of whole blood storage on PBMC lymphoproliferation 
The proliferative response to PHA stimulation (section 2.5.1) was measured 
for PBMC purified from freshly collected blood samples, and after the heparinised 
blood had been stored for 24 and 48 hours at room temperature and 4 °C. The 
lymphoproliferative response of the PBMC from fresh blood generated 24306 counts 
per minute (cpm). After storage of the whole blood for 24 hours at room 
temperature, the response was reduced by 20 %. However, after storage for 48 hours 
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the response detected was only 45% of the response detected with the fresh blood 
samples. Whole blood stored at 4 °C for 24 and 48 hours resulted in a complete loss 
of lymphoproliferative response to PHA stimulation (Figure 2.10). These fmdings 
conclude therefore that ovine blood could be stored for up to 24 hours at room 
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Figure 2.10 Lymphoproliferation after storage of whole blood samples, prior to PBMC 
purification. The lymphoproliferative response to PHA stimulation was measured in the 
PBMC purified from freshly collected whole blood and compared with the response 
generated after storage for 24 and 48 hours at room temperature (R.T.) and 4 °C. Results are 
shown as counts per minute (cpm), determined by 3H- thymidine uptake with unstimulated 
PBMC (fresh blood 310, after storage for 24 hours: R.T. 320, 48 hours R.T. 178, 24 hours 
4 °C 56, 48 hours 4 °C 42 cpm) subtracted. 
2.6.1.3 The effects of storage on immunolabelled, formalin -fixed PBMC. 
PBMC were immunolabelled as detailed in section 2.3.1.1 with a panel of 
mouse anti -sheep monoclonal antibodies recognising CD2, CD4, CD8, y8 T cells and 
B cells. The immunolabelled cells were then fixed in 10% formol saline and stored at 
4 °C. The phenotypic profile was determined by flow cytometry (section 2.3.1.2) at 
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24, 48, 56,72 and 96 hours post -labelling, with samples maintained at 4 °C between 
tests. 
No detrimental effects on the percentage of positively immunolabelled cell 
subsets were identified up to 48 hours. A decrease in several subsets, particularly 
CD8 and y6 T cells was identified from 56 hours (results not shown). These findings 
are in accordance with the observations of Lloyd et al (1995). As a result of these 
findings, flow cytometry of samples in all subsequent experiments was performed 
within 56 hours of immunolabelling. 
2.6.1.4 Optimal conditions for venous blood samples 
As the blood samples required to be stored at room temperature, and 
considering variations in ambient temperature, this protocol may not be relevant 
particularly during seasonal extremes. Moreover, to maintain consistency during 
monitoring programmes, one method was selected and upheld throughout. It was 
concluded therefore, that throughout this project all comparative studies would 
utilise PBMC purified from freshly collected blood samples. For other individual 
experiments, the PBMC would be purified within 24 hours of blood sample 
collection. 
2.7 Detection of IFN -y in plasma 
The plasma retained from venous blood samples collected during 
experimental JSRV infection of conventionally housed and SPF lambs (section 2.1.2) 
was stored at -20 °C in 50011l aliquots. The level of IFN -y in the plasma of the JSRV- 
infected and control lambs was estimated using the sandwich enzyme immunoassay, 
Bovine Gamma Interferon Test (BOVIGAMTM), a bovine IFN -y detection test which 
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also recognises ovine IFN -y (CLS, Melbourne Australia). The tests were performed 
following the manufacturer's instructions, using the reagents provided. All samples 
were prepared in duplicate by dispensing 501A1 of each test plasma, the positive 
bovine IFN -y and the negative bovine IFN -y controls into the 96 well plates. The 
samples were diluted with 5011.1 plasma diluent buffer and each sample was mixed by 
pipetting up and down 5 times. The plate(s) were covered and incubated at room 
temperature for 60 ± 5 minutes. The contents of the wells were shaken out and filled 
with wash buffer, emptied and re -filled (6 times in total). After the final wash the 
plates were placed face down on tissue paper and allowed to drain. The conjugate 
solution was diluted as directed, and 100111 was added to each well. The plate(s) were 
covered and incubated at room temperature for 60 ± 5 minutes and then washed as 
detailed above. The enzyme substrate solution was prepared by diluting the 
chomogen in enzyme substrate buffer, and 1000well was added. The plates were 
covered with aluminium foil and incubated at room temperature for 30 minutes. After 
incubation, the enzyme stopping solution was added at 501.11/well. The results were 
determined by optical density at 630nm, within 5 minutes of stopping the reaction. 
(Dynatech MR5000 microplate reader). The test was validated by determining the 
mean absorbance for the positive and negative control samples, within the acceptable 
range of means: the negative bovine IFN -y control ( <0.130), each replicate must not 
vary >0.040. The positive bovine IFN -y control ( >0.700), the replicates must not 
deviate by more than 30% from the mean absorbance. The mean absorbance was 
calculated for each of the samples and compared to the negative control. Plasma 
samples with a mean absorbance value in excess of 0.050 of the negative control 
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mean were compared to the positive control mean absorbance value. All plasma 
samples within the range of the negative control were considered negative for IFN -'y. 
2.8 Carboxyfluorescein diacetate succinimidyl ester (CFSE) 
proliferation assay 
Carboxyfluorescein diacetate succinimidyl ester (CFSE) is a fluorescent dye, 
which possesses identical spectral characteristics to the fluorochome, fluorescein. 
The addition of the reagent pluronic increases the permeability of the cell membrane, 
allowing the CFSE to be internalised and incorporated into the lymphocytes. The 
CFSE is stably retained within the cytoplasm of lymphoctyes that have been 
stimulated to undergo mitotic division. Serially, half the fluorescence is inherited by 
each subsequent generation of cells. The carboxyl groups present in the CFSE 
compound are cleaved by cytoplasmic esterases, allowing the fluorescent intensity 
(directly proportional to the CFSE concentration) to be determined for each 
generation of proliferating cells by flow cytometry. The data generated can be 
extended further to identify the lymphocyte subsets responding to mitogen 
stimulation. The PBMC are counter -labelled with a panel of monoclonal antibodies 
recognising lymphocyte subsets, and the concurrent use of rabbit anti -mouse 
immunoglobulin /phycoerythrin (Ig /PE) (Sigma, Poole, Dorset) for the secondary 
antibody facilitates analysis by flow cytometry (Lyons 1999 and references 
contained therein). 
2.8.1 PBMC preparation 
PBMC recovered after LymphoprepTM separation (section 2.2.1(i)) were re- 
suspended in 10m1 ice -cold Hanks balanced salts solution (HBSS) (Life 
Technologies Ltd., UK) with lOunits /ml heparin added. They were centrifuged at 
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300g for 15 minutes and the supernatant decanted. The PBMC were re- suspended in 
10m1 ice -cold HBSS and centrifuged again at 300g for 15 minutes. The cells were 
then re- suspended in lml HBSS, counted as detailed in section 2.2.2, and adjusted to 
a final concentration of 2 x 107 PBMC /ml. The cells were divided into two 15m1 
conical tubes (labelled CFSE + and CFSE -), and the total volume of PBMC in each 
tube recorded. 
2.8.2 Preparation of CFSE 
In a waterbath, 1 vial of commercially purchased CFSE and 1 vial of 
pluronic (both from Molecular Probes, Oregon, USA) were brought to 37 °C. Each 
vial was microcentrifuged for 1 minute and 20µl pluronic added to the CFSE. The 
sample was mixed thoroughly. A 1011l volume of CFSE /pluronic mix was added to 
20m1 HBSS, (final concentration 511M CFSE). Followed by vortexing and filter 
sterilisation (0.22µM micropore filter). 
2.8.3 CFSE labelling 
An equal volume of CFSE/HBSS was added to CFSE+ samples and an equal 
volume of HBSS only was added to CFSE" samples. Both samples were incubated at 
37 °C in 5% CO2 for 15 minutes. The reaction was stopped by adding an equal 
volume of ice -cold FCS to both samples. The samples were centrifuged at 180g for 
20 minutes at 4 °C and the supernatants decanted. The cells were re- suspended in 8ml 
RPMI -1640 containing 10% FCS and centrifuged at 180g for 10 minutes at 4 °C. 
This was repeated 2 times (3 washes in total). The cells were brought to a final 
concentration of 106 PBMC /ml RPMI -1640 medium containing antibiotics and 10% 
foetal calf serum. 
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2.8.4 Lymphoproliferation 
The required number of 96 well, round bottomed plates were labelled CFSE+ 
and CFSE ", with the mitogen used and the identity of the monoclonal antibody that 
would be used to counter -label the cells (duplicate wells for each monoclonal 
antibody). Mitogens (at the optimum concentrations) were added to the PBMC and 
the samples at 2 x105 cells /well were dispensed. The plates were incubated at 37 °C 
in 5% CO2 for 96 hours. After incubation the duplicate wells were pooled into 
labelled test tubes and lml PBS was added. The samples were centrifuged at 300g 
for 5 minutes. The supernatant was decanted. 
2.8.5 Monoclonal antibody counter- staining for lymphocytes subset selection 
Monoclonal antibodies specific for CD2, CD4, CD8,y8 T cells and B cells (at 
optimum titres Chapter 3, section 3.2) were added to appropriately labelled tubes. 
The samples were incubated for 30 minutes at 4 °C. After incubation lml PBS was 
added to each tube and centrifuged at 300g for 5 minutes. The supernatant was 
decanted and 1001.11(1:20 dilution) rabbit anti -mouse Ig /PE was added. The samples 
were incubated for 30 minutes at 4 °C. To each tube lml PBS was added and 
centrifuged at 300g for 5 minutes. The supernatant was decanted and 50001 PBS and 
l0041 10% formol saline added. The samples were stored at 4 °C for a maximum of 
48 hours. 
2.8.6 Phenotyping by flow cytometry 
The results were determined and analysed by flow cytometry, using a four 
colour, twin laser fluorescence activated cell sorter, FACSCaliburTM(Becton 
Dickinson, New Jersey, USA) with an argon laser set at 488nm. Cell debris was 
excluded using a forward and side scatter gate. The cells were acquired and the data 
were generated using CellquestTM (Becton Dickinson, New Jersey, USA) software, 
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with a minimum of 2000 events per sample counted. Computer generated scatter 
profiles and histograms of proliferating PBMC subset generations (fluorescence -1 
(FL -1, CFSE concentration)) were obtained to identify the percentage of positive 
cells (fluorescence -2 (FL -2, PE)) immunolabelled with the monoclonal antibodies. 
2.9 Data analysis 
2.9.1 Phenotyping (section 2.3). 
Percentage positive immunolabelled cells in sheep blood Results expressed as the 
percentage of immunolabelled cells in peripheral blood were computer generated 
directly during analysis by flow cytometry. Comparative analysis of the animal 
groups was determined by calculating the mean percentage of cells labelled positive 
with each monoclonal antibody tested, ± standard error of the mean (SEM). A two - 
tailed student's t -test determined the level of significance between each group. 
Proportion of immunolabelled cells per ml blood Where phenotyping data were 
expressed as the actual number of immunolabelled cells per ml blood, the number of 
cells detected by flow cytometry, that were positively immunolabelled with each of 
the monoclonal antibodies tested was calculated as follows:- 
numbers of positively labelled cells = proportion of labelled cells in the sample 
total number of events 
proportion of labelled cells in the sample x PBMC /ml blood (cell count, section 2.2) 
= number of immunolabelled cells /ml blood. 
Group results: the mean number of immunolabelled cells per ml blood for each 
group was determined, ± SEM. A two- tailed student's t -test determined the level of 
significance between each group. 
83 
2.9.2 Lymphoproliferation (section 2.5) 
The results of the lymphoproliferation assays were expressed as counts per 
minute (cpm), determined by 3H- thymidine uptake. For sheep lymphoproliferation 
assays three replicates of each sample were prepared, and five replicates for the 
experiments with human blood. In each experiment the mean cpm of the sample 
replicates, and the control mean cpm were calculated. The results were shown as the 
mean cpm with the control mean cpm subtracted. Group results: the mean cpm of 
each group was determined, ± SEM. A two -tailed student's t -test determined the 
level of significance between each group. 
2.10 Tissue fixation and preservation 
Tissue samples (5 -6mm thick) collected at necropsy from adult OPA cases 
and experimentally JSRV -infected lambs (section 2.1) were preserved in a range of 
fixatives for subsequent immunohistochemistry. 
2.10.1 Zinc salts fixative (ZSF) 
Zinc salts fixative (ZSF) was initially prepared by adding 0.05% calcium 
acetate to 0.1M Tris base. The pH was adjusted to 7.4 - 7.6, followed by the addition 
of 0.5% zinc acetate and 0.5% zinc chloride. The tissues were fixed for 4 -8 hours 
and then trimmed to 2 - 3mm thickness, placed in cassettes and post -fixed in fresh 
ZSF for a further 24 --72 hours. The tissues were then placed in cassettes and 
immersed in 70% ethanol for 30 minutes. 
2.10.2 Alcohol/zinc acetate (AZA) 
An equal volume of 70% ethanol was added to ZSF, and the tissues fixed as 
detailed above. 
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2.10.3 Aldehyde fixatives 
Formaldehyde: Commercial 40% formaldehyde (Becton Dickinson, 
Rutherford, NJ, USA) was added to phosphate buffered saline (PBS) to final 
dilutions of 4 %, 2% and 1%. 
Paraformaldehyde: In a fume cupboard, 24g of paraformaldehyde was 
dissolved in 550m1 of heated PBS, followed by filtration through a Whatman No 1 
filter paper. The final volume was adjusted to 600m1 with PBS (final dilution of 4 %). 
Paraformaldyehyde was stored at 4 °C for a maximum of three days. 
2.10.4 Cryopreservation 
The tissue samples (5 -6 mm) were placed in aluminium foil containers 
containing OTCTM (Thermo Shandon, Pittsburgh PA, USA); more OTC was added 
to cover the tissues, which were then snap frozen in liquid nitrogen. The tissues were 
stored at -70 °C until required. 
2.11 Preparation of fixed tissues for immunohistochemistry 
2.11.1 Paraffin wax embedding 
Following fixation in ZSF or aldehydes, the tissues were embedded in 
paraffin wax by an automated process (Hypercentre X processor, Thermo Shandon, 
Pittsburgh PA, USA). Firstly the tissues were dehydrated by passing through graded 
alcohols (80% ethanol, 45 min; 95% ethanol, 75 min; 99% ethanol, 3 x 75 min; 
isopropanol, 2 x 90 min; isopropanol/xylene [1:1 v:v], 90 min; xylene 2 x 90min). 
The tissues were then embedded in medium temperature [56 - 58 °C] paraffin wax, (2 
x 105 min). 
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2.11.2 Dewaxing ZSF and aldehyde -fixed tissues 
Tissue sections 51.tm thick were cut on a microtome, and placed on to 
Superfrost P1usTM treated glass sides (Menzel- Glaser, Germany) and dried at 37 °C. 
The tissues were dewaxed and rehydrated by placing the slides in xylene, (2 x 5 
min), 100% ethanol, 95% ethanol, 75% ethanol (5 min each). This procedure was 
performed immediately prior to immunolabelling or antigen retrieval. 
2.11.3 Antigen retrieval of aldehyde -fixed tissues 
(i) Microwave oven: Antigen retrieval by boiling the tissues in a microwave 
oven was attempted using a method adapted from previously reported 
protocols (Shí et al 1981, Gown et al 1993, Sibony et al 1995, Pileri et al 
1997). The tissues were dewaxed and rinsed in 0.85% NaC1 for 5 min. The 
slides were placed in a plastic, microwavable rack and immersed in sodium 
citrate buffer (12m10.1 M citric acid and 48m10.1 M tri- sodium citrate in 
600m1 distilled water, pH 6.0) in a glass container. The slides were heated, on 
full power, in a 650 - 700W microwave oven for 7 minutes (checking fluid 
level after 4 minutes). After heating the slides were allowed to cool in the 
buffer for 20 minutes and then rinsed in PBS, 2 x 5 min. Several attempts at 
antigen retrieval by the microwave method were performed with the 
following alterations to the protocol. After rehydration, the NaC1 step was 
omitted and the slides immersed in PBS. The microwave time was increased 
to 10 and 15 mins, adding more buffer every 5 minutes. Citrate buffer was 
replaced with disodium salt dihydrate buffer (10mM EDTA, PH 8.0) (Leong 
et al 1998) as the retrieval solution. Combinations of the above changes to 
the protocol were tested. 
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(ii) Pressure -cooking: Antigen retrieval by heating the tissues in a pressure 
cooker was attempted using a method adapted from previously reported 
protocols (Norton et al 1994, Miller et al 1995). The tissues were dewaxed as 
detailed above, and placed in Tris- buffered saline (TBS). Two litres of citrate 
buffer (as previously described) were brought to boiling point in a pressure 
cooker (Prestige Group, UK), without sealing the lid. The slides were placed 
in metal racks (evenly spaced) and lowered into the buffer. The pressure 
cooker lid was sealed and weighted. When full pressure was reached, heating 
was timed for 5 minutes. The pressure cooker was depressurised in cold 
running water. The slides were removed and placed under running tap water 
and then transferred to TBS. 
2.12 Cryostat sections 
The cutting chamber in the cryostat (Cryostat 2800 Frigocut -E) was adjusted 
to -15 °C, the recommended temperature for lung and lymph nodes. All instruments, 
brushes, needles, forceps, etc., were placed and retained in the cutting chamber. The 
tissues were removed from -70 °C storage and brought to -15 °C. The specimen stage 
(holding device for the tissue block) was kept at room temperature. A small amount 
of cryocompound was applied to the specimen stage to attach the tissue block. The 
specimen stage and attached tissue were then placed in the cutting chamber to ensure 
good adhesion between the specimen and the specimen stage. Tissue sections of 8 - 
10µm were cut by adjusting the position of the blade to the required thickness, and 
aligning the tissue and anti -roll guide. Depressing the foot pedal moved the tissue 
vertically; the cut section was then placed on the Superfrost PlusTM treated glass 
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slide. The sections were air dried and fixed in acetone for 15 min, allowed to air dry 
again and stored at -4°c until required. Cryopreserved sections were rehydrated by 
passing the slides through graded alcohols as described for aldehyde fixed tissues. 
This procedure was performed immediately prior to immunolabelling. 
2.13 Immunohistochemistry 
2.13.1 Immunolabelling tissue sections 
The tissues were labelled with mouse anti -sheep monoclonal antibodies and 
the positively immunolabelled cells were detected microscopically by the EnVision 
PlusTM detection system (DAKO, Ely, Cambridge, UK). The entire 
immunohistolabelling procedure was performed using a vertical staining system, 
SequenzaTM slide rack and COVERPLATE system (Shandon, Runcorn, UK). After 
rehydration, dewaxing (and antigen retrieval, where appropriate), the fixed or 
cryopreserved tissue sections were immersed in TBS buffer for 5 mins. The area of 
slide around each section was dried using a tissue. The slides were placed in a 
COVERPLATETM immunostaining chamber and inserted into the SequenzaTM slide 
rack. The reservoir was immediately filled with TBS and allowed to drain through. 
To each reservoir l000 peroxidase block (0.03% hydrogen peroxide in methanol) 
were added and incubated at room temperature for 5 minutes. The slides were then 
washed twice by filling the reservoirs with TBS and allowing to fully drain. To block 
non -specific antigens 1000 of 25% normal goat serum in TBS were added and 
incubated at room temperature for 30 minutes. The slides were then washed twice 
with TBS and 1000 of mouse anti -sheep monoclonal antibodies were added at the 
optimum (or required) dilutions. The racks were covered and incubated at 4 °C 
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overnight. The slides were washed twice in TBS and 104t1 of secondary antibody 
(peroxidase- labelled polymer conjugated to goat anti -mouse immunoglobulins, 
supplied in the EnVision P1usTM detection kit were added to each reservoir and 
incubated at room temperature for 30 mins. The slides were washed twice with TBS 
buffer. The substrate chromogen, 3,3'- diaminobezidine (DAB), supplied in the 
detection kit, was added at l00µ1 per slide and incubated at room temperature for 7.5 
mins. The slides were washed twice in distilled water and then removed from the 
COVERPLATES and immersed in haematoxylin at room temperature for 1 min, 
rinsed in distilled water and immersed in Scotts tap water solution (STWS) at room 
temperature for 1 min and rinsed again in distilled water. The tissues were 
dehydrated by passing through graded alcohols (75% ethanol; 95% ethanol; 100% 
ethanol; xylene x 2, all for 5 mins at room temperature). Coverslips were applied to 
the slides using DPX mountant. 
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Introduction 
The immunological responses during JSRV infection are poorly understood. 
No JSRV- specific circulating antibodies have been detected in adult clinical cases of 
OPA (Sharp and Herring 1983, Ortin et al 1998) or during experimentally induced 
JSRV -infection (van der Molen personal communication). Furthermore, no systemic 
cell- mediated responses have been identified, thus far. There are no field tests 
currently available to diagnose JSRV infection prior to the onset of clinical disease: 
consequently monitoring the immune responses of adult JSRV -infected sheep during 
tumorigenesis has been impeded. However, clinical and pathological OPA can be 
experimentally induced in neonatal lambs by intratracheal inoculation with virus 
purified from tumour (Martin et al 1976), lung fluid (Sharp et al 1983) or a JSRV 
infectious molecular clone (Palmarini et al 1999, DeMartini et al 2001), giving the 
opportunity to follow any immunomodulations temporally. 
In this investigation, it was proposed to evaluate the systemic immune 
responses at all stages of disease, from experimentally induced JSRV infection and 
tumorigenesis in lambs to the terminal stages of OPA in adult sheep. For all animals, 
experimental lambs and adult sheep alike, the peripheral blood leukocytes were 
characterised to identify phenotypic frequency alterations, which may indicate an 
immunological response during JSRV infection. In vitro lymphoproliferation to 
mitogen stimulation was performed to identify any alteration in cellular function 
during JSRV infection. Evidence of any changes in the concentration of IFN -y in the 
blood of experimental lambs was determined also. The experimental procedures are 




































































































































































































Adult JSRV -infected sheep, in the terminal stages of OPA A CD4 +lymphocytopaenia 
and neutrophilia have been demonstrated previously in the peripheral blood in such 
sheep (Rosadio and Sharp 1992, Holland et al 1999). It also has been established that 
a JSRV -disseminated infection occurs with viral RNA and proviral DNA found in 
cells of the immune system (Holland et al 1999). In the study reported here (section 
3.1) the immunological status in the terminal phase of OPA was measured by 
characterising the phenotypic profile and responses to mitogen stimulation in a single 
blood sample collected from clinical cases prior to humane killing, and compared to 
blood collected from adult control animals without OPA. 
Experimental JSRV infection of neonatal lambs To monitor systemic immune 
responses during the pre -clinical stages of disease two experiments were performed 
with: (i) conventionally housed lambs and (ii) specific pathogen free (SPF) lambs. 
Experimental infection was induced in the neonatal lambs by intratracheal 
inoculation with JSRV purified from lung fluid. The remaining age -matched lambs 
in each experiment acted as controls throughout. Serial blood samples were collected 
until the onset of clinical disease. When symptoms of OPA were apparent, the 
animals were killed and necropsy performed. Macroscopic and histological 
examination of tumour and lung tissue confirmed the disease status of each animal 
(section 3.2). 
Phenotyping analysis To determine the peripheral blood leukocyte (PBL) phenotypic 
characteristics of adult JSRV infected sheep, in the terminal stages of OPA (section 
3.1.1) and to monitor any phenotypic frequency alterations in the PBL of 
experimentally infected lambs (section 3.2.3) the cells were phenotyped using a 
panel of monoclonal antibodies recognising CD2, CD4, CD8, y8 T cells, B cells and 
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MHC class II antigens and the results determined by flow cytometry. Neutrophils 
were counted also. 
Lymphoproliferation: To identify any changes in cell -mediated responses in the 
adult OPA cases and during experimental JSRV infection, in vitro 
lymphoproliferation following stimulation by various mitogens was measured. The 
response to phytohaemagglutinin (PHA) and concanavalin A (ConA) stimulation 
was measured in adult sheep with OPA and compared with the response detected in 
adult controls (section 3.1.2). The lymphoproliferative responses to PHA, ConA and 
pokeweed mitogen (PWM) stimulation were monitored in the blood samples 
collected from the lambs experimentally infected with JSRV and control lambs 
(section 3.2.4). 
Identification of PBMC subsets responding to PWM and ConA stimulation The aim 
of this study was to determine which lymphocyte subsets were induced to undergo 
mitotic division by stimulation with PWM and ConA (section 3.3). The lymphocyte 
subsets proliferating in response to PWM and ConA stimulation were identified by 
flow cytometry using internalised carboxyfluorescein diacetate succinimidyl ester 
(CFSE) and monoclonal antibody selection. 
Requirement for antigen presentation in mitogenicity: The objective of this study 
was to determine if the mitogenicity of PHA, ConA and PWM was dependent on 
antigen presentation (section 3.4). The lymphoproliferative response to the mitogens 
was measured and compared in the entire -PBMC population, in PBMC depleted of 
adherent cells and in reconstituted -PBMC (adherent cells replaced), all derived from 
the same blood samples. 
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IFN -y levels detected in the blood of experimentally JSRV - infected lambs: It was 
hypothesised that changes in the concentration of IFN -y detected in the blood of 
JSRV - infected lambs could indicate activation of an immunological response or that 
cytokine alterations were induced as a result of the infection. The level of IFN -y in 
the blood samples collected during the experimental JSRV infection of 
conventionally housed and SPF lambs was measured and compared with the level in 
the uninfected animals (section 3.5). 
3.1 Adult sheep in the terminal stages of OPA 
The systemic immune system of adult sheep in the terminal stages of OPA 
was evaluated by comparing the phenotypic profile and cellular responses in the 
peripheral blood, with blood samples collected from uninfected control animals from 
the Moredun Research Institute. Details of all the sheep involved in this study are 
described in Chapter 2, section 2.1.1. 
3.1.1 The phenotypic profile of peripheral blood leukocytes in adult sheep, in 
the terminal stages of OPA 
3.1.1.1 Methodology 
The phenotypic profile of the peripheral blood leukocytes was characterized 
from venous blood samples collected (Chapter 2, section 2.1.4) from twelve adult 
OPA case in the terminal stages of disease and ten adult control sheep, age -matched 
where this information was available. Aliquots of 10011l whole blood were retained 
for the neutrophil counts as detailed in Chapter 2, section 2.4. The PBMC were 
purified (Chapter 2, section 2.2.1) and adjusted to a final concentration of 106 
PBMC /ml. The PBMC were phenotyped using a panel of mouse anti -sheep 
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monoclonal antibodies specific for CD2, CD4, CD8, 76 T cells, B cells and MHC 
class II antigens and the results were determined by flow cytometry (Chapter 2, 
section 2.3). The data were analysed and group results compiled as detailed in 
Chapter 2, section 2.9. 
3.1.1.2 Altered immune cell populations are demonstrated in adult sheep with 
terminal OPA 
The results for each of the cell subsets are shown in Figure 3.2. The 
percentage of positively immunolabelled CD2 T cells (42% ± 3) in the lymphocyte 
region of the PBMC from the OPA group was significantly decreased (p = 0.02) in 
comparison with the percentage (52% ± 3) detected in the control group. The 
reduced T cell population was further characterised by a statistically significant 
(p= 0.004) reduction in the percentage of positively immunolabelled CD4 T cells in 
the blood of the OPA sheep (16% ± 2) compared with the control animals (24% ± 2). 
The percentage of neutrophils present in the blood of the OPA sheep (52% ± 6) was 
significantly higher (p =0.05) compared with percentage detected in the control 
animals (33% ± 6). No statistically significant difference in the percentage of 
immunolabelled cells was identified for CD8 T cells, y6 T cells, B cells or MHC 
class II antigens, between the two animal groups. 
3.1.2 Lymphoproliferation in response to mitogen stimulation in adult sheep in 
the terminal stages of OPA 
3.1.2.1 Methodology 
The PBMC were purified (Chapter 2, section 2.2) from blood samples 
collected from ten adult sheep in the terminal stages of OPA and ten adult control 
animals. Lymphoproliferation following stimulation with PHA and ConA was 
measured as detailed in Chapter 2, section 2.5 and the level of response to each 
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CD2 CD4 CD8 yS T cells B cells MHC class Il neutrophils 
in Control adults n = 10 
Cell subsets 
0 OPA cases n = 12 
Figure 3.2 The phenotypic profile of the peripheral blood leukocytes from adult sheep 
with OPA and control sheep. The PBMC were purified from blood samples collected from 
12 adult sheep in the terminal stages of OPA and 10 control adult sheep. The PBMC were 
phenotyped with a panel of mouse anti -sheep monoclonal antibodies specific for CD2, CD4, 
CD8, yS T cells, B cells and MHC class II antigens. The results were determined by flow 
cytometry. Results for CD2, CD4, CD8, yS T cells and B cells are shown as the percentage 
positively immunolabelled cells /lymphocyte region of the PBMC ± SEM. Cells in the PBMC 
expressing MHC class I I antigens are shown as the percentage positively immunolabelled 
cells/PBMC, ± SEM. The percentage of neutrophils present in the blood was also recorded, ± 
SEM. 
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mitogen between the two animal groups was compared. The data were analysed and 
group results compiled as described in Chapter 2, section 2.9. 
3.1.2.2 The cellular response to ConA stimulation is altered in OPA adult sheep 
No significant difference in the level of response to PHA stimulation was 
detected between the two groups of animals. However, a significantly (p = 0.03) 
reduced response to ConA stimulation was detected in the PBMC purified from the 
blood of the OPA cases (10955 cpm ± 2532) compared with the response detected in 





Controls JSRV infected 
Figure 3.3 Lymphoproliferation to PHA and ConA stimulation in adult sheep with OPA 
and control sheep. The PBMC purified from the blood of 10 adult OPA cases and 10 control 
adult sheep were stimulated with PHA and Conk The results are shown as counts per minute 
(cpm) ± SEM, determined by 3H- thymidine uptake with the unstimulated PBMC: control sheep 
326 cpm and OPA cases 304 cpm subtracted. No significant difference in the response to PHA 
stimulation was detected between the two animal groups. The response to ConA stimulation 
was statistically significantly reduced (p =0.03) with the adult sheep with OPA in comparison with 
the control animals. 
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3.2 Experimental JSRV- infection of neonatal lambs 
Experimental JSRV infection was induced in six conventionally housed and 
six SPF neonatal lambs by intratracheal inoculation with JSRV purified from lung 
fluid (Chapter 2, section 2.1.3). The remaining four lambs in each experiment acted 
as controls throughout. The two groups of lambs were housed separately. Venous 
blood samples were collected from the lambs (Chapter 2, section 2.1A) at weekly 
intervals until they were ten weeks old and then every two weeks until the onset of 
clinical disease. When symptoms of OPA were apparent, the animals were killed and 
necropsy performed. Macroscopic and histological examination of tumour and lung 
tissue confirmed the disease status of each animal (Chapter 2, section 2.1.5). Details 
of the JSRV experimental infections are summarized in Figure 3.4. 
3.2.1 Conventionally housed lambs 
Ten lambs were housed with their mothers under conventional conditions as 
described in Chapter 2, section 2.1.2 (i). Unfortunately, before weaning when the 
lambs were five weeks old, two of the dams (mothers of control lambs) developed 
mastitis, which potentially could have affected their lambs' immunological 
responses. A coccidia infection was detected in several lambs at approximately two 
months of age and, although remaining sub -clinical, an immunological response to 
this concurrent infection could not be disregarded. 
Five out of the six conventionally housed lambs experimentally infected with 
JSRV (Chapter 2, section 2.1.3) developed histopathologically confirmed OPA. 
Clinical symptoms were diagnosed and OPA confirmed in three lambs at twelve 
weeks, one lamb at sixteen weeks, and one lamb at twenty weeks old: One JSRV- 
inoculated lamb with respiratory symptoms, was killed at eighteen weeks of age but 
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OPA was not confirmed. Two of the control lambs were killed at sixteen weeks and 
the remaining two controls were killed at twenty weeks of age. Details of the 
experimental infection and age of lambs, diagnosed with clinical signs of OPA are 
summarised in Figure 3.4. 
3.2.2 Specific pathogen free (SPF) lambs 
To minimise interference from possible intercurrent infections and confirm 
the results obtained with the conventionally housed animals, the experiment was 
repeated with ten lambs born and housed in SPF conditions as described in Chapter 
2, section 2.1.2 (ii). Three out of the six SPF housed lambs, experimentally infected 
with JSRV (Chapter 2, section 2.1.3), developed histopathologically confirmed 
OPA. One JSRV -infected lamb died at eleven days old (cause unknown). OPA was 
confirmed in one lamb at nine weeks, one lamb at eighteen weeks and one lamb at 
twenty weeks of age. One lamb was killed at fourteen weeks but OPA was not 
diagnosed. OPA was not confirmed for the remaining JSRV -inoculated lamb, killed 
at twenty weeks of age. Two control lambs were killed at sixteen weeks and the 
remaining two control lambs were killed at twenty weeks. Details of the 
experimental infection and ages of lambs, diagnosed with clinical signs of OPA are 
summarised in Figure 3.4. 
3.2.2.1 Blood clots were detected in the samples from SPF lambs. 
Regrettably during this experiment an unexplained problem occurred with the 
blood samples collected from the SPF lambs. At two weeks of age clots were 
detected in several of the blood samples, which meant that the functional assays of 
the PBMC were not carried out on a regular basis. Initially not all lambs were 
affected, but by five weeks of age clots were evident in all the blood samples 
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collected from the JSRV -infected and control lambs. Several investigations were 
performed to identify the cause of this problem. 
3.2.2.2 Investigations performed to identify the cause of the clots in the blood of 
SPF lambs 
The blood samples were histologically analysed, and fibrin clots were 
revealed, containing peripheral blood leukocytes. Biochemical analysis did not 
indicate any abnormality in the composition of the blood. The preservative -free 
heparin used in sample collection was tested with blood from adult sheep and 
conventionally housed age -matched lambs. No clotting was evident in any blood 
sample examined. Notwithstanding, a new supply of heparin was used but the 
problem persisted. The technique employed in bleeding the animals was examined 
but no cause could be identified. The diet of the SPF lambs (Chapter 2, section 2.1.2 
(ii)) was reviewed (the SPF lambs were not fed sheep milk, but were given UHT 
cow milk, with the composition of lactose and lipids differing from ewe milk) and 
although no specific cause for this phenomenon was confirmed, the problem ceased 
when the lambs were completely weaned at six weeks old and fed only Lamb Nuts, 
possibly indicating a dietary cause. 
3.2.3 The phenotypic profile of peripheral blood leukocytes, monitored during 
experimental JSRV- infection 
3.2.3.1 Methodology 
To monitor any phenotypic frequency alterations in the peripheral blood 
leukocytes (PBL) of experimentally infected lambs, from inoculation to the onset of 
clinical disease, venous blood samples were collected as described in Chapter 2, 





































































































































































































































Aliquots of 1001A1 whole blood were retained for neutrophil counts as detailed in 
Chapter 2, section 2.4. The PBMC were purified as detailed in Chapter 2, section 
2.2.1 and adjusted to a final concentration of 106 PBMC /ml (Chapter 2, section 
2.2.2). The PBMC subset frequencies were monitored in both the conventionally 
housed and SPF lambs by phenotyping with a panel of mouse anti -sheep monoclonal 
antibodies specific for CD2, CD4, y8 T cells and B cells (Chapter 2, section 2.3.1.1) 
and the results determined by flow cytometry (Chapter 2, section 2.3.1.2). The data 
were analysed and group results compiled as described in Chapter 2, section 2.9. The 
PBMC purified from the blood of the conventionally housed lambs also were 
immunolabelled with monoclonal antibodies specific for CD8 T cells and MHC class 
II antigens also. Unfortunately as a result of the problems encountered in the blood 
of the SPF lambs (section 3.2.2) immunolabelling for CD8 and MEIC class II 
antigens was not performed at all the time points with these animals. 
Sample Numbers 
Time points 1 2 3 4 5 6 7 8 9 10 12 14 16 18 20 
Conventionally 
housed controls 




6 6 6 6 6 6 6 6 6 6 6 3 3 2 1 
SPF controls 4 4 4 4 4 4 4 4 4 4 4 4 4 2 2 
SPF JSRV infected 6 5 5 5 5 5 5 5 5 4 4 3 3 2 2 
Table 3.1 Number of animals at each time point during experimental JSRV infection. 
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3.2.3.2 No phenotypic alterations in peripheral blood subsets were detected in 
JSRV- infected lambs 
No statistically significant phenotypic alterations were detected in any of the 
immunolabelled cell populations from the JSRV -infected lambs in comparison with 
their respective controls, at any time point during the experiments. The phenotypic 
profiles of CD2, CD4, yS T cells and B cells, from conventionally housed and SPF 
lambs are shown in Figures 3.5a -d, respectively. 
Lymphocytopaenia and neutrophilia were not demonstrated in JSRV- infected lambs 
No statistically significant differences in the number of positively 
immunolabelled CD4 T cells /ml blood were detected in the experimentally JSRV- 
infected compared with the controls lambs, at any time point during the experiments 
(Figure 3.5b). In addition no alteration in the percentage of neutrophils in the blood 
was detected in the JSRV -infected lambs, in comparison with the control lambs 
(Figure 3.5e). Consequently during experimental JSRV infection there was no 
evidence of the CD4 lymphocytopaenia or neutrophilia previously demonstrated in 
the peripheral blood of adult OPA cases (Rosadio and Sharp 1992, Holland et al 
1999) and shown in section 3.1.1.3 of this study. 
The phenotypic profiles of CD8 T cells and MHC class II antigens detected 
in the conventionally housed lambs are shown in Figure 3.6 a and b. No significant 
differences in the phenotypic profiles were observed between the control and 
infected lambs, at any time point during JSRV infection. These trends were 
confirmed, at the time points available, with immunolabelled PBMC from the SPF 
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Figure 3.5 Leukocyte subset frequencies in the peripheral blood during experimental 
JSRV infection. The PBMC were purified from the blood of lambs during experimental 
JSRV infection: (! -) conventionally housed control lambs: 1 -16 weeks n =4, 18 -20 weeks 
n =2. ( ) conventionally housed JSRV- infected lambs: 1 -12 weeks n =6, 14 -16 weeks n =3, 
18 weeks n =2, 20 weeks n =1. ( ) specific pathogen free control lambs: 1 -16 weeks n =4,18- 
20 weeks n =2. (A) specific pathogen free JSRV- infected lambs: 1 week n =6, 2 -9 weeks 
n= 5,10 -12 weeks n= 4,14 -16 weeks n= 3,18 -20 weeks n =2. The PBMC were phenotyped with 
monoclonal antibodies specific for CD2, CD4, y6 T cells and B cells, with the results 
determined by flow cytometry. The results are shown in Figure 3.5 a -d, respectively as the 
number of positively immunolabelled cells /ml blood. Neutrophils were also counted (Figure 
3.5e), with results shown as percentage neutrophils /blood. Each time point represents the 
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Figure 3.6 CD8 T cells and MHC class II antigen frequencies in the peripheral blood 
during experimental JSRV infection of conventionally housed lambs. The PBMC were 
purified from the blood of ('') conventionally housed control lambs: 1 -16 weeks n =4, 18 -20 
weeks n =2. (ï >) conventionally housed JSRV- infected lambs:1 -12 weeks n =6, 14 -16 weeks 
n =3, 18 weeks n =2, 20 weeks n =1. The PBMC were phenotyped with mouse anti -sheep 
monoclonal antibodies specific for CD8 T cells and MHC class lI antigens, with the results 
determined by flow cytometry. The results are shown in Figure 3.6 a and b, respectively, as 
the number of positively immunolabelled cells /ml blood. Each time point represents the 
group mean ± SEM. 
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3.2.4 Lymphoproliferation in response to mitogen stimulation during 
experimental JSRV- infection. 
3.2.4.1 Methodology 
During experimental JSRV infection, the PBMC were purified (Chapter 2, 
section 2.2.1) from the blood of the conventionally housed and SPF lambs. 
Lymphoproliferative responses to PHA, ConA and pokeweed mitogen (PWM) 
stimulation were measured (Chapter 2, section 2.5) For each JSRV -infected group 
the level of response to mitogen stimulation was compared with the response 
detected in the corresponding control lambs. The data were analysed and group 
results compiled as described in Chapter 2, section 2.9. 
3.2.4.2 The cellular response to ConA stimulation is altered in experimentally 
JSRV- infected lambs 
The lymphoproliferative response to mitogens in the conventionally housed 
lambs (six JSRV -infected and four control lambs) was measured at four, eight and 
twelve weeks. At sixteen weeks the response of three JSRV - infected and four 
controls lambs, and at twenty weeks the response of the remaining JSRV -infected 
and two control lambs was measured. The results are shown in Figure 3.7. No 
difference in the lymphoproliferative response to PHA (Figure 3.7a) or PWM 
(Figure 3.7b) stimulation was detected between the JSRV -infected and the control 
lambs. In contrast, the infected lambs were less responsive to ConA stimulation than 
the control animals (Figure 3.7c). This observation was first detected prior to the 
onset of clinical disease when the lambs were eight weeks of age. The mean 
lymphoproliferative response detected in the six JSRV - infected lambs was only 34% 
of the mean response detected in the four control animals. The reduced response to 
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Figure 3.7. Lymphoproliferative response to PHA, PWM and ConA stimulation during 
experimental JSRV- induced OPA in conventionally housed lambs. PBMC purified from the 
blood of conventionally housed lambs were stimulated with PHA, PWM and ConA. The results 
are shown at 4, 8, 12, 16 and 20 weeks. The results are shown as counts per minute (cpm), ± 
SEM determined by 3H- thymidine uptake with the unstimulated PBMC cpm subtracted (4 weeks 
171 : 192, 8 weeks 182 : 192, 16 weeks 228 : 243 and 20 weeks 340 : 175 cpm) control lambs 
and JSRV- infected lambs respectively. The lymphoproliferative response to PHA stimulation is 
shown in Figure 3.7a, to PWM in Figure 3.7b and to ConA in Figure 3.7c. No significant 
difference to PHA or PWM was detected between the JSRV -infected and control lambs, at any 
time point. In contrast statistically significantly ( *p =0.002 - 0.008) reduced responses to ConA 
stimulation were detected in the JSRV -infected lambs, compared with the controls. At 20 weeks 
only one JSRV- infected and two control lambs remained giving cpm of 2207 and mean cpm 
19231, respectively. 
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of the JSRV infected lambs was only 20% of the response identified in the control 
animals, at sixteen weeks the response of the JSRV - infected lambs was 23 %, in 
comparison with the control lambs. At the end of the experiment at twenty weeks 
the response detected in the remaining JSRV - infected lamb was 10% of the mean 
response detected in the two control animals. 
The lymphoproliferative responses detected in the SPF lambs confirmed 
these findings. The results (when available) are shown in Figure 3.8. When the 
lambs were 4 weeks old the mean lymphoproliferative response detected in the five 
JSRV - infected lambs was 75% of the mean response detected in the four control 
animals. The reduced response to ConA stimulation was evident at all other time 
points, at six weeks the response of the JSRV infected lambs was only 38% of the 
response identified in the control animals, at sixteen weeks the response of the 
JSRV -infected lambs was 36 %, in comparison with the control lambs. At eighteen 
and twenty weeks old two JSRV -inoculated and two control lambs remained. The 
mean response to ConA stimulation with the control lambs was 2212 ± 57 and 1813 
± 336, respectively, compared with 1210 and 2059 cpm in the JSRV -inoculated 
lamb with no histopathologically confirmed OPA, 856 and 659 cpm for the 
confirmed OPA case. 
3.3 Identification of PBMC subsets responding to PWM and ConA 
stimulation 
As an altered response to ConA stimulation was detected in the JSRV- 
infected animals the identity of the lymphocyte subsets responding to stimulation 
with this mitogen were determined. For comparison, the responder cells to PWM 
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Figure 3.8. Lymphoproliferative response to PHA, PWM and ConA stimulation during 
experimental JSRV- induced OPA in SPF lambs. PBMC purified from the blood of SPF 
lambs were stimulated with PHA, PWM and ConA. The results are shown as counts per 
minute (cpm), ± SEM determined by3H-thymidine uptake with the unstimulated PBMC cpm 
subtracted (4 weeks 167 : 295, 6 weeks 165 : 190, 16 weeks 224 : 229, 18 weeks 212 :260 
and 20 weeks 375 : 296 cpm) control lambs and JSRV -infected lambs respectively.. The 
response to PHA at 4, 6, 16 and 18 weeks is shown in Figure 3.8a. PWM at 16, 18 and 20 
weeks in Figure 3.8b and to ConA at 4, 6 16 18 and 20 weeks in Figure 3.8c. No significant 
difference to PHA or PWM was detected between the JSRV- infected and control lambs, at 
any time point. In contrast statistically significantly ( *p =0.01 - 0.07) reduced responses to 
ConA stimulation were detected in the JSRV -infected lambs, compared with the controls. 
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3.3.1 Methodology 
A 20m1 blood sample was collected from a two -month -old lamb (Chapter 2, 
section 2.1.4) and the lymphocyte subsets responding to PWM and ConA stimulation 
were identified by carboxyfluorescein diacetate succinimidyl ester (CFSE) - 
monoclonal antibody selection as detailed in Chapter 2, section 2.8, using a panel of 
mouse anti -sheep monoclonal antibodies specific for CD2, CD4, CD8,18 T cells and 
B cells. 
3.3.2 T and B lymphocytes respond to PWM and ConA stimulation 
PWM stimulation The CFSE results are shown in Figure 3.9 a -e, 1: scatter profile, 2: 
responder cell histograms, 3: table of percentage cells detected in each generation. 
The results revealed that only 2.3% of CD2+ T cells remained in the parent 
population, and proliferation in response to PWM stimulation resulted in 27% of the 
CD2 +T cells detected in generation five, 26.5% in generation six and 18.9% in 
generation seven. In generation eight the percentage of CD2+ T cells detected was 
only 2.6 %. 
The CD2 T cell response was further characterised by CD4 and CD8 antibody 
labelling. The proliferative profile of CD4 +and CD8+ T cells corresponded with the 
response detected by CD2 monoclonal antibody selection in that both subsets 
responded to PWM stimulation until generation five when 28.6% CD4+ and 26.7% 
CD8+ T cells were detected. 
The parent generation of y8 T cells contained 6.9 %, and 45.1% were detected 
in generation two. The results indicated that PWM was not strongly mitogenic for yS 
T cells. 
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3 Parent 2 3 4 5 6 7 8 9 10 
CD2 2.3 5.2 4.8 9.8 27.6 26.5 18.9 2.6 1.5 0.4 
CD4 3.8 6.5 6.2 12.8 28.6 26.0 14.3 1.2 0.2 0.1 
CD8 8.2 7.7 7.8 11.9 26.7 23.9 11.6 1.3 0.4 0.2 
yS T 
cell 
6.9 45.1 12.4 10.5 10.0 8.8 5.7 0.0 0.3 0.0 
B 
cells 
6.7 10.6 5.5 5.2 18.3 7.4 30.8 11.8 2.0 1.3 
Figure 3.9 Carboxyfluoresecein diacetate succinimidyl ester (CFSE) /monoclonal 
antibody detection of lymphocyte subsets responding to PWM stimulation. The PBMC 
were purified from the blood of a 2- month -old lamb. Prior to stimulation with PWM CFSE was 
incorporated into the cells. The cells were collected post- stimulation and phenotyped with a 
panel of monoclonal antibodies specific for CD2, CD4, CD8, y8 T cells and B cells. The 
results are shown for each lymphocyte subset (a -e) as 1: scatter profile with responder cells, 
2: histogram of generations proliferating in response to PWM and 3: table of percentage cells 
detected in each generation. 
Generation key Software modelling was used to 
generate populations of dividing 
cells by the use of computer fitting 
to determine the series of curves 
which accommodate the 
experimental data. The 
proportion of cells in each 
generation (cell division) was 
determined by the relative area 
i* under each normal curve. 
Single line = normal curve 
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The results provided evidence that B cells will proliferate in response to PWM 
stimulation with 10.6% detected in generation two. Only approximately 5.0% B cells 
were found in generations three and four, with 18.3% B cells detected in generation 
five and 30.8% B cells detected in generation seven. The percentage of B cells in 
subsequent generations decreased from 11.8% in generation eight to 2% and 1.3% in 
generations nine and ten. 
ConA stimulation The CFSE results are shown in Figure 3.10 a -e.The lymphocyte 
profiles in response to ConA stimulation were found to be very similar to those 
revealed in response to PWM. The majority of CD2 T cells responded through four 
generations from 2.3% detected in the parent population, with 22.7% cells detected 
in generation five. 
CD4 and CD8 antibody labelling revealed that CD4+ and CD8+ T cells 
responded to ConA stimulation. As with the response detected by CD2 monoclonal 
antibody selection, both subsets responded until generation five when 24.0% CD4+ 
and 30.2% CD8+ T cells were detected. 
The yg T cell profile in response to ConA stimulation was also analogous to 
that identified with PWM. The parent generation ofy6 T cells, in response to ConA 
stimulation, contained 12.8 %, with 33.5% detected in generation two. The 
percentage of .1,8 T cells decreased from 18.7% in generations three to 3.1% detected 
in generation seven. Only 1.3% yg T cells were detected in generation eight and 
<1.0% in generations nine and ten. 
B cells responded to ConA stimulation with 12.2% detected in the parent 
generation. The percentage of B cells detected in generations two was 14.4 %, and 
9.3% and 10.0% in generations three and four, respectively. The percentage of B 
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3 parent 2 3 4 5 6 7 8 9 10 
CD2 2.3 9.6 9.4 9.8 22.7 19.4 20.0 4.3 1.5 0.6 
CD4 2.9 10.3 11.0 12.3 24.0 19.5 15.9 2.5 1.0 0.2 
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Figure 3.10 Carboxyfluoresecein diacetate succinimidyl ester (CFSE) /monoclonal 
antibody detection of lymphocyte subsets responding to ConA stimulation. The PBMC 
were purified from the blood of a 2- month -old Iamb. Prior to stimulation with ConA CFSE was 
incorporated into the cells. The cells were collected, post- stimulation and phenotyped with a 
panel of monoclonal antibodies specific for CD2, CD4, CD8, y5 T cells and B cells. The 
results are shown for each lymphocyte subset (a -e) as 1: scatter profile with responder cells, 
2: histogram of generations proliferating in response to ConA and 3: table of percentage 
cells detected in each generation. 
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Software modelling was used to 
generate populations of dividing 
cells by the use of computer fitting 
to determine the series of curves 
which accommodate the 
experimental data. The 
proportion of cells in each 
generation (cell division) was 
determined by the relative area 
under each normal curve. 
4.4 
2 parent 
cells found in generation five was 16.6 %, with 20.8% detected in generation seven. 
The percentage of B cells remaining in subsequent generations decreased from 4.9% 
in generation eight to <1.0% in generations nine and ten. 
To summarise the results: evidence of lymphoproliferation in response to 
PWM and ConA was demonstrated for both T and B lymphocytes. Further 
characterisation of the T cell population demonstrated that CD4+ and CD8+ T cell 
subsets responded to each mitogen. By comparison only a limited response was 
detected for y6 T cells, as the majority of cells did not divide beyond the second 
generation. B cells also responded to PWM and ConA stimulation through to 
generation five where 18.3% (PWM) and 16.6% (ConA) were detected, but in 
response to each mitogen the majority of B cells progressed to generation seven with 
30.8% (PWM) and 20.8% (ConA). This observation indicated that B cells do respond 
to PWM and ConA stimulation, and may suggest also that two B cells subsets exist 
in the blood of sheep, one subpopulation perhaps responding to stimulation by the 
mitogens directly, and a T cell directed response by a second subpopulation of B 
cells. 
3.4 The requirement for antigen presenting cells in the 
lymphoproliferative response to mitogens 
3.4.1 Methodology 
The cells in the PBMC, which adhere following culture for one hour at 37 °C, 
represent the major populations of antigen presenting cells. The PBMC from four 
lambs were purified (Chapter 2, section 2.2.1) and the lymphoproliferative responses 
to PHA, ConA and PWM stimulation in the entire -PBMC, the PBMC depleted of 
adherent cells and reconstituted -PBMC were compared (Chapter 2, section 2.5.2). 
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Expression of MHC class II antigens in each of the PBMC samples was determined 
as detailed in Chapter 2, section 2.5.3. The data were analysed and group results 
compiled (Chapter 2, section 2.9). 
3.4.2 The lymphoproliferative response to PHA, ConA and PWM stimulation is 
not dependent on antigen presentation 
For each mitogen tested the entire PBMC generated a higher response than 
the PBMC depleted of antigen presenting cells, although this difference was not 
found to be statistically significant (PHA p =0.4, PWM p =0.4 and ConA p =0.2). The 
response to each mitogen increased when the antigen presenting cells were returned 
to the PBMC. The results are shown in Figure 3.11. PHA stimulation of the entire - 
PBMC generated 4937 cpm + 1242. The lymphoproliferatve response was reduced 
by 36% in the adherent -cell- depleted -PBMC. When the adherent cells were returned 
to the PBMC (reconstituted -PBMC) lymphoproliferation to PHA stimulation 
increased to 84% of the response detected in the entire -PBMC. In comparison to the 
response generated by the entire -PBMC (1845 cpm ± 474) to PWM stimulation, the 
response, after adherent cell depletion, was reduced by 36 %. When the adherent 
cells were returned to the PBMC ( reconstituted -PBMC) lymphoproliferation 
increased to 98% of the response detected in the entire -PBMC. The 
lymphoproliferative response to ConA stimulation detected with the PBMC depleted 
of adherent cells was reduced by 50% in comparison with the response detected in 
the entire -PBMC (3225 cpm ± 685). Lymphoproliferation increased by 21% when 
the adherent cells were returned to the PBMC. 
The phenotypic profile of cells expressing MHC class II antigens in each of 
the PBMC samples revealed that the mean percentage of MHC class II expression 
was significantly reduced (p= 0.0004) in the PBMC depleted of adherent cells 
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(10.6% ± 1) in comparison with the entire PBMC (32.7% ± 3) and with the 
reconstituted PBMC (26.9% ± 3) (p= 0.002). The results revealed however that not 
all antigen presenting cells were removed by adherence, and that replacement of the 
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Figure 3.11 Requirement for antigen presenting, adherent cells in the mitogenicity of 
PHA, ConA and PWM for sheep lymphocytes. The lymphoproliferative responses to 
stimulation of the entire -PBMC, adherent -cell -depleted -PBMC and reconstituted -PBMC 
(replacement of adherent cells) were measured in blood samples collected from 4 lambs. 
Results are shown as counts per minute (cpm) ± SEM, determined by 3H- thymidine uptake 
uptake with the unstimulated PBMC (135 cpm) subtracted. No statistically significant 
difference was identified between the groups to stimulation with any of the mitogens tested. 
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3.5 Concentration of IFN -y in the plasma during experimental 
JSRV infection. 
3.5.1 Methodology 
Plasma was retained from the blood samples collected at various time points 
during experimental JSRV infection of conventionally housed and SPF lambs. The 
concentration of IFN -y detected in the blood was measured using the sandwich 
enzyme immunoassay, Bovine Gamma Interferon Test (BOVIGAMTM) as described 
in Chapter 2, section 2.7. Conventionally housed lambs: four control lambs were 
tested from weeks one to sixteen, and two lambs at weeks eighteen and twenty. Six 
JSRV -infected lambs were tested from weeks one to twelve, two lambs at 18 weeks 
and one lamb at twenty weeks. Blood samples from two control lambs and two 
JSRV -infected SPF lambs were tested at all time points. 
3.5.2 Experimental JSRV infection does not alter the concentration of IFN -y 
detected in the blood 
No significant alteration in the level of IFN -y was detected in the blood of 
JSRV - infected lambs, compared with their corresponding controls, from inoculation 
to the onset of clinical disease. 
Increased levels of IFN -y were observed in the blood of both the infected and 
control conventionally housed lambs between two and eight weeks of age (Figure 
3.12a). This increase coincided with an intercurrent coccidia infection in several of 
the animals (section 3.4.2). No detectable levels of IFN -y were identified in the SPF 
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Figure 3.12 IFN-'y detected in the blood during experimental JSRV infection. 
Concentration of IFN -y measured in the plasma retained from venous blood samples 
collected during experimental JSRV infection of conventionally housed and SPF lambs. IFN- 
y was detected by sandwich enzyme immunoassay and results determined by optical density 
at 630nm. The results are represented by the group mean ± the standard deviation of the 
mean. Figure 3.12a: Conventionally housed control lambs: 1 -16 weeks n =4, 18 -20 weeks 
n =2. Conventionally housed JSRV- infected lambs: 1 -12 weeks n =6, 14 -16 weeks n =3, 18 
weeks n =2, 20 weeks n =1. Figure 3.12b: SPF lambs, 2 JSRV infected and 2 uninfected 
control lambs at each time point. 
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3.6 Indirect sandwich ELISA for the detection of JSRV- capsid 
specific antibodies 
In adult OPA cases, no circulating JSRV- specific antibodies have been 
recorded (Sharp and Herring 1983, Ortin et al 1998). It was proposed that the plasma 
retained from the blood samples collected during the experimental JSRV infections 
should be tested by indirect sandwich ELISA to measure any JSRV- specific 
antibodies. 
3.6.1 Methodology 
Plasma collected from all the lambs were tested for the presence of JSRV 
capsid antigen (JSRV -CA) antibodies by ELISA. A recombinant JSRV -CA coating 
antigen was prepared by cloning part of the JSRV gag gene (nucleotide sequence 
published by York et al 1992) into plasmid pBAD/His A (Invitrogen, Groningen, 
The Netherlands), and expressed in E. coli LMG 194 cells. Supernatant collected 
from E. coli culture without the CA insert was used as a negative control. Sheep 
anti -CA serum, as a positive control, was generated according to Palmarini et al 
(1995) with some minor adaptations. The specific absorption values were calculated 
by subtracting the control values from the test values. The cut -off point to define 
seropositivity was set as the mean OD of a negative control serum (pre - 
immunisation serum) plus 3 times the standard deviation of the mean (4 replicates). 
3.6.2 No detectable JSRV specific antibody response was evident during 
experimental JSRV infection 
No antibodies specific for the capsid of JSRV were found in during 
experimental JSRV infection and OPA development (see paper bound to this thesis). 
This work was performed in collaboration with Dr. Renate van der Molen (The 
University of Edinburgh). 
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3.7 Discussion 
The phenotypic profile of the peripheral blood leukocytes and cell mediated 
responses of the systemic immune system were evaluated at all stages of disease 
from experimentally induced JSRV infection and tumorigenesis in neonatal lambs to 
the terminal stages of OPA in adult sheep. For all animals, the peripheral blood 
leukocytes were characterised to identify phenotypic frequency alterations and 
lymphoproliferation to mitogen stimulation was performed to identify any alteration 
in cellular function during JSRV infection. The concentration of IFN -y in the blood 
of experimental lambs was measured also. The results of each study are summarised 
in Figure 3.13. 
This investigation of the systemic immune responses, following experimental 
JSRV infection, has identified for the first time an alteration in cellular function. A 
significantly reduced response to ConA stimulation was evident in the PBMC from 
the blood of conventionally housed and SPF, JSRV- infected lambs (section 3.2.5.2). 
Furthermore, the suppressed response to ConA stimulation was detected as an early 
event, as it was first apparent from eight weeks of age, prior to the diagnosis of 
clinical disease. Moreover, the change in cellular function was evident in natural 
JSRV infection also, demonstrated by the reduced response to ConA stimulation in 
adult sheep, in the terminal stages of OPA (section 3.1.2.2). No difference between 
the JSRV - infected and control animals was detected when the PBMC were 
stimulated with PHA and PWM. It is widely known that there is no common 
carbohydrate specificity between the three lectins; PHA binding to glycoproteins 
containing N- acetylgalactosamine, PWM binding to 
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Figure 3.13 Summary of results: Systemic immunity during JSRV infection 
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N- acetylglucosamine and ConA having an affinity for a- D- mannosyl and a -D- 
glucosyl residues. 
The cells responding to PWM and ConA stimulation were identified by 
CSFE /monoclonal antibody immunolabelling and the types of cells responding to 
ConA stimulation did not differ from the cells responding to PWM (section 3.3). 
Both CD4 and CD8 T cells were induced to undergo mitotic division, and only a 
limited response was detected for -y6 T cells. CFSE identification of responder cells 
indicated that PWM and ConA stimulation induced B cell proliferation that is 
possibly T cell dependant. This may suggest that the activation of T cells and their 
ability to induce B cell lymphoproliferation could be impaired by the presence of the 
virus. 
The reason for the reduced response to ConA stimulation is as yet unknown 
but several factors, identified in other retroviral infections, indicate a possible 
mechanism for this observation during JSRV infection. The envelope proteins of 
human immunodeficiency virus (HIV) (Pahwa et al 1986), human T cell leukaemia 
virus (HTLV) (Wainberg et al 1985), baboon leukaemia virus (BaLV) (Denner et al 
1990) and Mason -Pfizer monkey virus (MPMV) (Blaise et al 2001) are all capable 
of suppressing lymphoproliferative responses to mitogen stimulation. It has been 
established that retroviral suppression can be selective for one mitogen without the 
response to other mitogens being affected. For example, HIV -1 inhibits PHA 
induced lymphoproliferation but does not affect the response to ConA stimulation 
(Mann et al 1987). The transmembrane protein pl5E from FeLV (Mathes et al 1978, 
1979) or MuLV (Ruegg et al 1989, Schmidt et al 1987) induces immunosuppression 
by preventing aggregation of ConA receptors, suggesting that expression of this 
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protein interferes with the redistribution of the cytoskeleton (Dunlap et al 1979). 
Therefore, in JSRV infection and OPA development, specific changes in 
glycoprotein -bound- carbohydrate residues resulting from the presence of JSRV may 
be involved. 
To test the hypothesis that the mitogenicity of ConA may depend on antigen 
presentation, the PBMC were depleted of adherent cells. However, it was 
demonstrated in this study that the depletion of adherent cells did not significantly 
affect the lymphoproliferative response to ConA, or indeed to PHA or PWM 
stimulation. However, it must be noted that the removal of adherent cells did result 
in a decrease in the lymphoproliferative response (particularly to ConA), and the 
requirement for antigen presentation was only tested in uninfected lambs. As the 
removal of adherent cells did not result in total depletion (identified by MHC class II 
immunolabelling), the few remaining cells might be sufficient for antigen 
presentation. Furthermore, adherence does not remove the (non- adherent) B cells, 
which were retained within the PBMC. Therefore this preliminary result is not 
conclusive (section 3.4.2). 
During the disseminated JSRV infection, the highest level of proviral load (1 
infected cell per 1,524 cells) was identified in the monocyte /macrophage population 
(Holland et al 1999). Retrovirally -induced cytokine alterations resulting in down - 
regulation of lymphocyte and monocyte functions have been demonstrated. Reduced 
levels of IL -2, IFN -a and IFN --y in the presence of FeLV resulted in suppressed 
lymphoproliferative response to ConA stimulation (Hebebrand et al 1977, Copelan 
et al 1987). Decreased IFN -7, paralleled by increased levels of IL -10, impeding the 
ability of monocytes to promote IFN -y production by T cells (Haraguichi et al 1995), 
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and retrovirus - induced cytokine switching from IL -12 to IL -4 in dendritic cells has 
also been identified; IL -12 being essential for dendritic cell maturation into antigen 
presenting cells capable of stimulating T cell proliferation (Kellecher et al 1999). In 
this investigation no alterations in IFN -y levels, specific to infected animals, were 
detected throughout the experiments (section 3.5.2). Consequently during 
experimental JSRV infection there was no evidence to suggest that retrovirally 
induced cytokine switching had occurred involving IFN -y. Furthermore no JSRV 
specific antibodies were detected at any time point during the experimental infection. 
The phenotypic profile of the peripheral blood leukocytes were monitored 
during experimental JSRV infection. As a consequence of the data generated, the 
development of the ovine systemic immune system in young lambs was 
demonstrated. The phenotypic frequencies of T cells, B cells and neutrophils in the 
blood of the conventionally housed lambs were measured pre -JSRV inoculation, at 
weekly intervals (except week 3) until ten weeks old and subsequently at two -week 
intervals until the end of the experiment at twenty weeks. Phenotypic monitoring was 
repeated with the SPF control lambs pre -inoculation and at two -week intervals until 
twenty weeks. Blood samples were collected from four conventionally housed 
control lambs and four SPF control lambs until sixteen weeks, and from two lambs in 
each group at eighteen and twenty weeks. 
Development of the systemic immune system of the conventionally housed 
lambs is shown in Figure 3.14a. For the first two weeks after birth a higher 
percentage of neutrophils (week 1: 27% ± 8, week 2: 23% ± 6) was detected in the 
blood, in comparison with the percentage of positively immunolabelled lymphocytes 
detected (T cells: week 1: 4% ± 1, week 2: 15% ± 1, B cells week 1: 1% ± 1, week 
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2: 7% ± 1). When the lambs were four weeks of age, the percentage of 
immunolabelled T (19% ± 3) and B lymphocytes (12% ± 2) in the blood were higher 
than the percentage of neutrophils (8% ± 2). The percentage of immunolabelled T 
and B cells continued to increase, with no significant alteration in the percentage of 
neutrophils detected in the blood, until the lambs were twenty weeks old. It was 
observed that the percentage of immunolabelled B cells in the blood (25% ± 2) was 
higher than the percentage of T cells (20% ± 5) at five weeks old, corresponding to 
the time when mastitis was diagnosed in two of the dams (section 3.4.1); again in 
comparison to the percentage of immunolabelled T cells, equivalent or higher 
percentages of immunolabelled B cells were detected in the blood when the lambs 
were seven and eight weeks old, possibly in response to the coccidia infection 
diagnosed in several of the lambs. 
Development of systemic immunity in the SPF lambs is shown in Figure 
3.14b. Pre -JSRV inoculation a higher percentage of neutrophils (17% ± 6) were 
detected in the blood, in comparison with the percentage of positively 
immunolabelled lymphocytes (T cells: 11% ± 4, B cells 3% ± 1). When the lambs 
were one week old, the percentage of positively immunolabelled T cells (17% ± 5) 
was higher than the percentage of neutrophils (12% ± 1), with 6% ± 2 B cells 
detected and at two weeks the percentage of immunolabelled T cells (24% ± 5) and 
B cells (10% ± 2) in the blood had increased, in comparison with the percentage of 
neutrophils (13% ± 6). From four weeks of age, until the lambs were twenty weeks 
old the percentage of immunolabelled T and B cells detected in the blood continued 
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Figure 3.14 Ontogeny of ovine systemic immunity. The PBMC purified from the blood of 
the control lambs were phenotyped with a monoclonal antibody specific for CD2T cells and 
B cells. The results were determined by flow cytometry and are shown as the percentage of 
positively immunolabelled cells /blood. The neutrophils were counted also. Each time point 
represents the group mean ± SEM. Figure 3.7a: The conventionally housed lambs, 1 -16 
weeks n =4, 18 -20 weeks n =2. Figure 3.7b: SPF lambs, 1 -16 weeks n= 4,18 -20 weeks n =2. 
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A T cell : B cell mean ratio of 2 : 1 within the range 1.6 to 2.8, was demonstrated 
for lambs aged four to twenty weeks. 
The observed trend could indicate that innate immunity (determined by the 
percentage neutrophil population in the blood) predominated in both conventionally 
housed and SPF neonatal lambs until the acquired immune system (determined by 
the increasing percentage of positively immunolabelled T and B lymphocytes) 
became fully established from four weeks of age. It is not suggested, however, that 
the lymphocytes were absent from the blood at an early age, but may indicate that 
immature lymphocytes do not express the cell surface receptors for the monoclonal 
antibodies used. 
This present study revealed no alteration in phenotype frequencies in the 
peripheral blood throughout experimental JSRV infection (section 3.2.3.2). The 
CD4+ lymphocytopaenia detected in the blood of adult sheep during the terminal 
stages of OPA, by Roasadio and Sharp (1992), Holland et al (1999) and in this study 
was not identified during experimental JSRV infection. Similarly the neutrophilia, 
demonstrated here and by Rosadio and Sharp (1992) in the blood of adult OPA cases 
was not observed during experimentally - induced tumorigenesis (section 3.1.1.3). 
Until tests are developed to diagnose JSRV infection prior to the onset of clinical 
symptoms, it is not possible to detect when, during natural infection, the 
lymphocytopaenia and neutrophilia first occur. However, the results obtained in this 
study provide evidence that the lymphocytopaenia and neutrophilia are not early 
events in JSRV infection and suggest that they might not be a direct response to 
JSRV infection but a consequence of increased susceptibility to secondary 
infections, encountered as the health of the animal declines. 
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Chapter 4 
The mitogenicity of the monocotyledenous 
Narcissus pseudonarcissus lectin 
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Introduction 
Since the mitogenic properties of plant lectins were first identified by Nowell 
in 1960, their ability to induce non - specific lymphoproliferation has been used as a 
standard laboratory tool to evaluate immunocompetence (Lis and Sharon 1977 and 
1986). By inducing mitotic division in resting lymphocytes, activated, cytokine- 
producing cells are generated, allowing in vitro evaluation of immune status, 
alteration in cellular function and cell -mediated responses during infection (Barker 
1969, Kilpatrick 1998). Lectin -induced mitogenicity has been demonstrated in T 
cells, both CD4 and CD8 subsets, and B cells, with divergence to various maturation 
stages, including fully differentiated plasma cells (Kilpatrick 1998 and 1999). 
Most of the commercially available lectins are derived from dicotyledenous 
plants such as phytohemagglutinin (PHA) from the red kidney bean Phaseolus 
vulgarus, concanavalin A (ConA) from the jack bean Canavalia ensiformis and 
pokeweed mitogen (PWM) from the poke plant Phytolacca americana. The 
biological activity of such lectins are well documented (Kilpatrick 1991 and 1995). 
The mitogenicity of lectins derived from monocotyledonous sources, in 
particular members of the grass family such as wheat germ agglutinin (WGA), also 
have been extensively examined (Kilpatrick and McCurrach 1987). Lectins from 
several non -grass monocotyledonous plants have been isolated recently and their 
properties evaluated (Kilpatrick et al 1999). Several species of plants from the super - 
family Amaryllidaceae possess lectins that are specific for the carbohydrate ma nose 
(Van Damme et al 1988). One such lectin is Narcissus pseudonarcissus agglutinin 
(NPA) derived from daffodil bulbs; NPA exists as a non -glycosylated dimeric or 
trimeric structure composed of 12.5kDa subunits with three binding pockets per 
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monomer, specific for al -3 linked mannose and al -6 mannose residues (Van 
Damme et al 1988). A study by Sauerborn et al (1999) has identified NPA in a 
tetrameric form, suggesting that this lectin could possess potentially up to 12 binding 
pockets per cluster. 
It has been proposed that the specificity of NPA for mannose could be 
exploited to combat retroviral infections, where the viruses or viral components 
contain glycoproteins with terminal al -3 linked or al -6 linked D- mannose. It has 
been reported that the infectivity of human immunodeficiency virus (HIV) types 1 
and 2 (Muller et al 1988 and Balzarini et al 1991), and simian immunodeficiency 
virus (SIV) (Weiler et al 1990) have been attenuated in the presence of mannose- 
binding- lectins, by direct competitive inhibition. Hence the development of several 
potentially antiretroviral strategies based on the mannose specificity of NPA have 
been proposed, for example the development of NPA- based -medication, and also a 
vaccine against RNA viruses, encompassing anti -lectin antibodies, consequentially 
targeting the virus indirectly. This strategy is possibly applicable to OPA, as no 
JSRV -specific antibodies have been detected in the blood of infected animals (Sharp 
and Herring 1983, Ortin et al 1998). Furthermore, the use of NPA, in conjunction 
with radioisotopes, fluorochromes or enzymic labelling, as diagnostic tools in the 
detection and in situ identification of retroviruses is also under consideration 
(Scottish Crop Research Institute, European Patent 0497825, 1996). 
With the potential use of NPA a possibility in JSRV research, the principal 
aim of the present study was to assess the mitogenicity of NPA for sheep 
lymphocytes, and ascertain if the lymphoproliferative response to NPA stimulation 
was altered in JSRV -infected compared with uninfected sheep. 
134 
Optimum NPA concentration As the lymphoproliferative response to this lectin was 
unknown in sheep, the optimum concentration of NPA required to induce maximum 
proliferation was determined by stimulating the PBMC purified from blood samples 
of adult sheep, and lambs aged one month. The optimum concentration of NPA was 
determined from the resulting standard curves (section 4.1.1). 
Determination of age -dependency in the mitogenicity of NPA for sheej, lymphocytes 
As a consequence of the unexpected findings disclosed during the NPA optimisation 
assays, it was suspected that NPA could be mitogenic for the PBMC from young 
lambs and not adult sheep. An investigation to determine age -related 
lymphoproliferation to NPA stimulation was conducted with lambs aged four days to 
four months of age, and also adult sheep aged one to three years (section 4.1.2). 
Identification of PBMC subsets responding to NPA stimulation The aim of this study 
was to determine which lymphocyte subset(s) responded to NPA stimulation. Dual 
colour flow cytometry, utilising internalised carboxyfluoresecein diacetate 
succinimidyl ester (CFSE) and monoclonal antibody selection (Chapter 2, section 
2.8) was performed to phenotypically characterise the generations of cells 
proliferating in response to NPA stimulation (section 4.2). 
The dependence of NPA mitogenicity on antigen presenting cells To ascertain if the 
mitogenicity of NPA required antigen presenting cells, the lymphoproliferative 
response to NPA stimulation was measured and compared in the entire -PBMC 
population, adherent cell -depleted -PBMC and reconstituted -PBMC (adherent cells 
replaced), all derived from the same blood sample (section 4.3). 
The mitogenicity of NPA during JSRV infection To identify any alteration in 
lymphoproliferation in the presence of JSRV, the response to NPA stimulation was 
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measured and compared in the PBMC from experimentally JSRV -infected and 
control lambs (section 4.4.1). 
Comparison of the lymphocyte phenotypic profile, pre- and -post -NPA stimulation 
This comparative study was performed to identify any phenotypic frequency 
alterations, post -NPA stimulation, in JSRV infected and control lambs. Before and 
after NPA stimulation, the PBMC of JSRV- infected and control lambs were 
phenotyped by labelling with monoclonal antibodies recognising T and B 
lymphocytes, and the results determined by flow cytometry. The lymphocyte 
profiles identified for the individual lambs, pre- and -post -stimulation, were compared. 
Furthermore, the profiles from the JSRV -infected group were compared with those 
detected in the control group (section 4.4.2). 
Mannose Inhibition of NPA mitogenicity It has been established that NPA is 
specific for al -3 linked and al -6 linked mannose. Consequently, providing 
mitogenicity occurs through the mannose pathway, it was hypothesised that the 
addition of exogenous mannose to the lectin, prior to incubation with the PBMC, 
should suppress the lymphoproliferative response by competitive inhibition. 
Therefore, to determine if NPA mitogenicity for the PBMC of lambs was via the 
mannose pathway, the response to NPA following pre -incubation with mannose was 
measured (section 4.5). 
Optimum mannose concentration The optimum concentration of mannose required 
to achieve the maximum level of inhibition to NPA stimulation was measured and 
compared with the mitogenicity of NPA alone. (section 4.5.1.2). 
136 
Mannose inhibition during JSRV infection To determine if the inhibitory effect of 
mannose on NPA mitogenicity was affected by the presence ofJSRV, comparative 
analysis ofJSRV- infected and control lambs was performed (section 4.5.2). 
Determination of age- dependency on the inhibitory effect of mannose It was 
envisaged that the level of mannose inhibition on NPA mitogenicity may be related 
not only to the presence ofJSRV but also to the age of the lambs. Therefore the 
lymphoproliferative responses to NPA and NPA/mannose stimulation were 
measured, at various ages, in JSRV -infected and control lambs. (section 4.5.2). 
NPA mitogenicity for human lymphocytes The investigation into the mitogenicity 
of NPA for sheep PBMC unexpectedly revealed that NPA was mitogenic in lambs 
and not adult sheep (section 5.1.2). The significance of this finding may have far 
reaching consequences for humans and domesticated animals, as interest in 
monocotyledonous lectins has evolved since the discovery that several members of 
the super - family Amaryllidacceae, such as NPA and Galanthus nivalis (GNA) 
derived from snowdrop bulbs have an antimetabolic effect on insects (Down et al 
1996). It was hypothesised that the insecticidal properties could be harnessed to 
transgenically modify arable crop plants. Consequently several prototype crops have 
already been developed (Machuka et al 1999). It was envisaged that NPA, identified 
as virtually non -mitogenic for adult humans (Kilpatrick et al 1990, Fenton et al 
1999) may be mitogenic for the lymphocytes of children, therefore a comparative 
investigation to measure the human lymphoproliferative response to NPA stimulation 
was undertaken (section 4.6). 
Optimum NPA concentration The optimum concentration of NPA required to induce 
maximum proliferation in human lymphocytes was determined by stimulating the 
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mononuclear cells purified from umbilical cord blood, and the PBMC from adult 
venous blood.. The optimum concentration of NPA was determined from the 
resulting standard curves (section 4.6.1.2). 
Determination of age - dependency in the mitogenicity of NPA for human 
lymphocytes A comparative study measuring the lymphoproliferative response to 
NPA stimulation, with mononuclear cells from umbilical cord blood and adult 
PBMC, was performed (section 4.6.1.3). 
4.1 Sheep lymphoproliferative response to NPA stimulation 
4.1.1 Optimisation of NPA concentration 
The PBMC were purified from blood samples collected from two, one- 
month -old lambs as detailed in Chapter 2, section 2.2.1 and adjusted to a final 
concentration of 106 PBMC /ml. The proliferative response to stimulation with 
various concentrations of NPA (Vector Laboratories, Peterborough, England) was 
determined, following the lymphoproliferation protocol in Chapter 2, section 2.5. 
The data were analysed as detailed in Chapter 2, section 2.9. The optimum 
concentration of NPA determined from the titration series shown in Figure 4.1a was 
found to be 1001.1g /ml, generating 4228 counts per minute (cpm) for lamb A and 
6756 cpm for lamb B. To determine if this concentration of NPA was optimum for 
adult sheep also, lymphoproliferation was performed as detailed above with the 
PBMC purified from the blood of two adult animals (Chapter 2, section 2.2). The 
titration series produced is shown in Figure 4.1b. No lymphoproliferative response 
was detected with any of the concentrations of NPA previously tested with the 
PBMC from the lambs, the maximum response (after subtraction of the un- 
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stimulated control PBMC) was <100cpm. Therefore the concentration series was 
extended up to 800µg /ml. The results revealed unexpectedly that NPA was non - 
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Figure 4.1 Optimisation of NPA concentration. Titration series to determine the optimum 
concentration of NPA required to induce maximum lymphoproliferation in sheep PBMC. The results are 
shown as counts per minute (cpm), determined by 3H- thymidine uptake. Figure 4.1a: The PBMC from 
two 1- month -old lambs were stimulated with various concentrations of NPA. The cpm from 
unstimulated PBMC (lamb A 181: lamb B 212 cpm) were subtracted. The maximum lymphoproliferative 
response to NPA stimulation was detected *100ug /ml. Figure 4.1b: The PBMC from two adult sheep 
were stimulated with various concentrations of NPA. The cpm from unstimulated PBMC (sheep A 221: 
sheep B 243 cpm) were subtracted. No lymphoproliferative response to NPA stimulation was detected 
in adult sheep, at any concentration tested. 
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4.1.2 NPA stimulation of the PBMC from lambs and adult sheep 
4.1.2.1 Methodology 
To extend the findings that NPA is non -mitogenic for the PBMC from adult 
sheep, an investigation into age -related mitogenicity was performed. In total, the 
PBMC were purified from 74 blood samples. The animals were categorised into 
three groups: Group A, lambs aged four days to one month (n = 37), Group B, lambs 
aged two - four months (n = 26), and Group C, adult sheep aged one - three years (n 
= 11). The lymphoproliferative response to PHA and NPA stimulation was 
determined for the three age groups. The data were analysed and group results 
compiled (Chapter 2, section 2.9). 
4.1.2.2 NPA mitogenicity is age- related in sheep 
In response to PHA stimulation no significant difference was detected in the 
mean counts per minute (cpm) between the three age groups (group A 9039 ± 4226, 
group B 8906 ± 5076 and group C 8198 ± 1524). In contrast, stimulation with NPA 
generated a mean cpm of 5154 ± 445 and 2203 ± 616 for the lambs Groups A and B, 
respectively, in comparison to a mean cpm of 330 ± 128 for the adult Group C. The 
results obtained for the lambs, in comparison with the adult sheep were found to be 




















Figure 4.2 Age -related lymphoproliferative response to NPA and PHA stimulation. The 
PBMC of 74 animals (categorised in 3 age groups, A B and C) were stimulated with NPA 
and PHA. The results are shown as counts per minute (cpm) ± SEM, determined by 3H- 
thymidine uptake with the unstimulated PBMC cpm (group A 152; group B 284; group C 184 
cpm) subtracted. Comparison in the levels of lymphoproliferation between the 2 groups of 
lambs (A and B) and the adult group C were not significantly different in response to PHA 
stimulation, but were found statistically significant in response to NPA, group A (p = 0.0005) 
and group B (p = 0.004). 
4.2 Identification of the PBMC subsets responding to NPA 
stimulation 
4.2.1 Identification of lymphocyte subsets expressing cell surface receptors for 
NPA 
To determine which lymphocyte subsets present in sheep peripheral blood 
possess a receptor for NPA, the PBMC were incubated with NPA conjugated to the 
fluorochrome, fluorescein (NPA/FITC) (Vector Laboratories, Peterborough, 
England) and counter -labelled with mouse anti -sheep monoclonal antibodies specific 
for CD2, CD4, CD8, y8 T cells and B cells, followed by incubation with a rabbit 
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anti -mouse immunoglobulin/phycoerythrin conjugate (Ig/PE) (Sigma, Poole, Dorset). 
The PBMC subsets binding the lectin were identified by dual colour flow cytometry. 
4.2.1.1 Methodology 
The PBMC were purified (Chapter 2, section 2.2) from the blood of a two month 
old lamb. Aliquots of 5 x 105 PBMC were incubated with NPA/FITC for 30 minutes at 
room temperature, in the dark. After incubation lml PBS was added to each aliquot and 
centrifuged for 5 minutes at 300g. The supernatant was decanted and the PBMC were 
immunolabelled (Chapter 2, section 2.3) with the panel of primary monoclonal 
antibodies detailed above and a mouse IgG control. The secondary antibody Ig/PE was 
added to each sample (100µg /m1), replacing the Ig/FITC detailed in Materials and 
Methods. The results were determined by dual colour flow cytometry, using an EPICS 
XL -MCLTM profile (Coulter Electronics, Miami, Florida, USA), utilising argon ion 
lasers set at wavelengths of 488nm (FL -1: FITC absorbs blue light and emits green 
fluorescence) and 600nm (FL -2: PE absorbs yellow -green light and emits red 
fluorescence). The percentage of double -labelled cells for each of the PBMC subsets was 
identified by dual fluorescence (FL1/FL2) quadrant separation, with colour 
compensation adjusted to eliminate dual colour autofluorescence. The background 
control was set at 1.0% and data were collected on a minimum of 5000 lymphocytes. 
4.2.1.2 T and B lymphocytes possess the receptor for NPA 
All the lymphocyte subsets analysed were found to express cell surface 
receptors for NPA, identified as the percentages of double -labelled cells in the blood. 
The results for each subset are shown in Figure 4.3, with the exception of the CD2 
immunolabelled sample, which was accidentally deleted from the computer, but the 
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Figure 4.3. Lymphocyte subsets expressing cell surface receptors for NPA. The 
PBMC purified from the blood of a 2- month -old lamb were labelled with NPA/FITC, and 
counter -labelled with a panel of monoclonal antibodies /PE (including a mouse IgG control). 
The percentage lymphocytes /blood (B -E), expressing the receptor for NPA was determined 
by dual colour flow cytometry. The results are shown as the percentage of double -labelled 
cells in the peripheral blood, identified in quadrant 2 of each dot plot. 
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percentage of positively double -labelled cells in the blood detected by the CD2 
monoclonal antibody was recorded at 32 %. The percentage of positively labelled 
cells in the blood, detected by the remainder of the monoclonal antibody panel was: 
CD4 (19 %), CD8 (8 %), y8 T cells (16 %) and B cells (15 %). 
4.2.2 Identification of the PBMC subsets responding to NPA stimulation 
4.2.2.1 Methodology 
A 20m1 blood sample was collected from a two -month -old lamb and the 
lymphocyte subsets responding to NPA stimulation were identified by 
carboxyfluoresecein diacetate succinimidyl ester (CFSE) /monoclonal antibody 
selection as detailed in Chapter 2, section 2.8, using a panel of monoclonal 
antibodies specific for CD2, CD4, CD8, y8 T cells and B cells. 
4.2.2.2 T and B lymphocytes respond to NPA stimulation 
The CFSE results (Figure 4.4 a -e, 1: scatter profile, 2: responder cell 
histograms, 3: table of percentage cells detected in each generation) revealed that 
40.1% of CD2+ T cells remained in the parent population, with 40.4% cells detected 
in generation two having responded to NPA stimulation, and 9% continued to 
generation three. The CD2 T cell response was further characterised by CD4 and 
CD8 antibody selection. In response to NPA stimulation, 30.4% CD4 +T cells were 
detected in generation two, 14.1% in generation three. The percentage of CD4+ T 
cells continued to decrease from 4.8% in generation four to <1% from generation 
seven onwards. The results showed that CD8+ T cells did not respond to NPA 
stimulation with 92.1% retained in the parent generation, and only 5.6% CD8 +T cells 
detected in generation two. The percentages of CD8+ T cells in generation three, and 




















parent 2 3 4 5 6 7 8 9 10 
CD2 40.1 40.4 9.0 3.6 1.8 2.8 0.2 0.9 0.9 0.0 
CD4 46.4 30.4 14.1 4.8 1.4 1.9 0.7 0.0 0.0 0.0 
CD8 92.1 5.6 0.8 0.3 0.0 0.0 0.6 0.4 0.0 0.0 
y8 T 
cells 
68.4 28.8 0.4 0.4 0.1 0.2 0.2 0.9 0.2 0.0 
B 
cells 
6.4 67.7 6.2 10.6 2.8 1.9 1.1 1.4 0.8 0.7 
Figure 4.4 Carboxyfluoresecein diacetate succinimidyl ester (CFSE) /monoclonal 
antibody detection of lymphocyte subsets responding to NPA stimulation. The PBMC 
were purified from the blood of a 2- month -old lamb. Prior to stimulation with NPA, CFSE was 
incorporated into the cells. The cells were collected, post -NPA stimulation and phenotyped 
with a panel of monoclonal antibodies specific for CD2, CD4, CD8, y6 T cells and B cells. 
The results are shown for each lymphocyte subset (A - E) as 1: scatter profile with responder 
cells detected in * top right quadrant, 2: histogram of generations proliferating in response to 
NPA and 3: table of percentage cells detected in each generation. 
Software modelling was used to 
generate populations of dividing 
cells by the use of computer fitting 
to determine the series of curves 
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68.4 %, with 28.8% detected in generation two and from generation three onwards 
<1% 76 T cells were detected. The results provided evidence that B cells proliferated 
in response to NPA stimulation with 67.7% detected in generation two. Although 
only 6.2% B cells were found in generation three this percentage increased to 10.6% 
in generation four. The percentage of B cells in subsequent generations decreased 
from 2.8% in generation five to <2% in generations six -eight, and <1% in 
generations nine -ten. 
To summarise the results: evidence of lymphoproliferation was demonstrated 
for both T and B lymphocytes. Further characterisation of the T cell population 
identified that the CD4+ subset were the most predominant responder cells to NPA, 
and by comparison 76 T cells showed a limited response. No evidence of CD8+ T cell 
responses were detected. It would appear from the results that B cells responded also, 
with the majority of B cells progressing to generation two. The percentage of B cells 
increased from 6.2% in generation three to 10.6% in generation four, signifying a 
proliferative response. This observation may indicate a lymphoproliferative response 
by a subpopulation of B cells that is T cell directed. 
4.3 Lymphoproliferation to NPA stimulation is adversely affected 
by the depletion of adherent cells from the PBMC 
The PBMC from four lambs were purified (Chapter 2, section 2.2) and the 
lymphoproliferative responses to NPA stimulation in the entire -PBMC, adherent - 
cell- depleted -PBMC and the reconstituted PBMC were compared (Chapter 2, section 
2.5.2). The data were analysed and group results compiled (Chapter 2, section 2.9). 
A statistically significantly reduced response to NPA stimulation was demonstrated 
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in the adherent -cell -depleted -PBMC (258 cpm ± 54) compared with the levels of 
response identified for the entire -PBMC (2111 ± 373 (p = 0.003)) and reconstituted- 
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Figure 4.5The influence of antigen presenting, adherent cells in the mitogenicity of 
NPA for sheep lymphocytes. The lymphoproliferative responses to NPA stimulation of the 
entire -PBMC, adherent -cell -depleted -PBMC and reconstituted -PBMC (replacement of 
adherent cells) were measured in blood samples collected from 4 lambs. Results are shown 
as counts per minute (cpm) ± SEM, determined by 3H- thymidine uptake with the 
unstimulated PBMC (135 cpm) subtracted. The results show that the lymphoproliferative 
response to NPA stimulation of the adherent -cell -depleted -PBMC is significantly reduced 
compared with the entire PBMC (p= 0.003), and the reconstituted PBMC (p= 0.004). 
4.4 NPA mitogenicity during JSRV infection 
4.4.1 Lymphoproliferation to NPA stimulation in JSRV- infected and uninfected 
lambs 
The lymphoproliferative responses (Chapter 2, section 2.5) to NPA 
stimulation were measured in the purified PBMC (Chapter 2, section 2.2) from six 
experimentally JSRV -infected lambs aged 2, 8, 12 and 16 weeks, and compared with 
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the responses detected in four, age- matched control lambs. No significant difference 
in the level of response to NPA stimulation was identified at any time between the 
two groups: 2 weeks (JSRV -infected 1665 cpm ± 688, controls 2211 cpm ± 909), 8 
weeks (JSRV -infected 4493 cpm ± 2264, controls 5404 cpm ± 2883), 12 weeks 
(JSRV -infected 1440 cpm ± 1038, controls 2057 cpm ± 1467) and 16 weeks (JSRV- 
infected 2028 cpm ± 767, controls 1278 cpm ± 641) (Figure 4.6). Therefore, it is 
evident from this study that the lymphoproliferative response to NPA mitogenicity is 
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Figure 4.6 Lymphoproliferation to NPA stimulation in JSRV- infected and control 
lambs. The lymphoproliferative responses of PBMC from 6 JSRV- infected and 4 control 
lambs was measured and compared at 2, 8, 12 and 16 weeks post- infection. The results are 
shown as counts per minute(CPM) ± SEM, determined by 3H- thymidine uptake. The 
unstimulated PBMC (2 weeks 130 : 275, 8 weeks 167 : 171, 12 weeks 128 : 160 and 16 
weeks 135 : 193 cpm, control and JSRV- infected lambs respectively) were subtracted. No 
significant difference in the level of response was detected between the infected and control 
groups, at any time point tested. 
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4.4.2 Lymphocyte profile of JSRV infected and control lambs pre and post - 
NPA- stimulation 
4.4.2.1 Methodology 
The PBMC from three experimentally JSRV -infected and three control lambs 
were purified (Chapter 2, section 2.1) and adjusted to a final concentration of 106 
PBMC /ml as detailed in Chapter 2, section 2.2. Aliquots of 5 x 105 PBMC were 
phenotyped with monoclonal antibodies recognising CD2+ T and B lymphocytes, and 
the results determined by flow cytometry according to the protocols detailed in 
Chapter 2, section 2.3. The remaining cells were stimulated with NPA (Chapter 2, 
section 2.5.1). Post -stimulation, the cells were collected by aspiration and 
centrifuged at 300g for 5 minutes. The supernatant was decanted and the cell pellet 
was re- suspended in lml PBS. The PBMC were counted (Chapter 2, section 2.2.2) 
and phenotyped following the protocol for the un- stimulated PBMC detailed above. 
The numbers of immunolabelled T and B lymphocytes /ml blood, pre -and- 
post- stimulation, were calculated for each animal (Chapter 2, section 2.9). 
4.4.2.2 The presence of JSRV alters the lymphocyte profile post -NPA 
stimulation 
The phenotypic profile of CD2 T cells and B cells from control and JSRV - 
infected lambs, pre -and post -NPA stimulation, are shown in Figure 4.7. 
CD2 T cells: The difference in the mean of the actual number of 
immunolabelled T cells /ml blood from the control group pre -stimulation (1.3x106 ± 
6.7x104), compared with post -stimulation (1.9x104 ± 1.1x104) was found to be highly 
significant (p= 0.00005). In contrast, no significant difference was detected in the 
JSRV - infected group (pre -stimulation: 8.1x105 ± 3.4x105, post -stimulation 2.3x105 ± 
5.5x104). 
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B cells: The difference in the mean of the actual numbers of immunolabelled 
B cells /ml blood from the control group pre -stimulation (1.1x106 ± 2.1x105), 
compared with post -stimulation (2.5x104 ± 9.0x103) was found to be statistically 
significant (p= 0.01). No significant difference was detected in the JSRV -infected 
group (pre -stimulation: 4.0x105 ± 1.3x105, post -stimulation 4.1x105 ± 5.7x104). 
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Figure 4.7 T and B cell phenotyping of JSRV -infected and control lambs, pre and post 
NPA stimulation. The frequency of T and B cells in the blood of 3 JSRV- infected and 3 
control lambs were compared, before and after stimulation with NPA, by immunolabelling 
with monoclonal antibodies and the results determined by flow cytometry. The results are 
shown as the mean number of immunolabelled cells /ml blood, ± SEM. In the control group, 
post -stimulation, statistically significant decreases ( *p= 0.00005 and *p =0.01) in the number 
of T and B cells were detected compared to pre -stimulation. No significant difference (pre 
and post NPA stimulation) was detected in the numbers of T and B cells from the JSRV- 
infected lambs. 
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4.5 Inhibition of NPA mitogenicity by the addition of mannose 
4.5.1 Optimisation of the mannose concentration required to induce maximum 
inhibition of NPA mitogenicity. 
4.5.1.1. Methodology 
To test the hypothesis that the mitogenicity of NPA could be inhibited by the 
addition of exogenous mannose, prior to PBMC stimulation, it was necessary to 
determine the optimum mannose concentration required. Various concentrations of 
mannose were added to 100µg NPA/ml for 24 hours at 4 °C. The PBMC were 
purified from the blood of a three- month -old lamb (Chapter 2, section 2.2.1) and 
adjusted to a final concentration of 106 PBMC /ml (Chapter 2, section 2.2.2). 
Lymphoproliferation assays were performed as described in Chapter 2, section 2.5.1 
with 100µg /ml NPA, NPA/mannose concentration series and PBMC control (no 
lectin added). The data were analysed as detailed in Chapter 2, section 2.9. 
4.5.1.2 Mannose inhibits NPA mitogenicity in a control lamb 
As shown in Figure 4.8, cpm in response to stimulation with NPA alone was 
calculated at 1545 cpm. The lymphoproliferative response was decreased when the 
PBMC were stimulated with NPA/mannose (1 mM: 181 cpm, l OmM: 300cpm, 
100mM: 17cpm, 200mM: 206cpm, 400mM: 141 cpm), after the unstimulated PBMC 
73 cpm was subtracted. Although the mitogenicity of NPA was suppressed at all the 
concentrations tested, the optimum inhibitory concentration of mannose was found to 
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Figure 4.8 Optimum mannose concentration required to inhibit NPA mitogenicity, in 
an uninfected Iamb. The PBMC purified from the blood of a 3- month -old lamb were 
stimulated with NPA alone and NPA with the addition of 1mM, 10mM, 100mM, 200mM and 
400mM mannose. The results are shown as counts per minute (cpm), determined by 3H- 
thymidine uptake. The inhibitory effect of mannose was demonstrated at all concentrations 
tested, with the optimum concentration100mM which resulted in almost complete inhibition of 
NPA mitogenicity. 
4.5.1.3 Mannose only partially inhibits NPA mitogenicity in a JSRV- infected 
lamb 
The inhibitory effect of mannose was measured in the PBMC from a JSRV 
infected lamb to determine if the optimum mannose concentration required to inhibit 
NPA in the control lamb was consistent for an experimentally JSRV -infected lamb. 
The optimisation assay detailed above was repeated with the PBMC purified from 
the blood of an age matched, experimentally JSRV -infected lamb. The results 
showed that stimulation of the PBMC with NPA alone generated 2438 cpm, after the 
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unstimulated PBMC 142 cpm was subtracted. In comparison, the addition of 1mM 
mannose did not inhibit NPA mitogenicity (2484 cpm), and the addition of 10mM 
mannose reduced the lymphoproliferative response by only 27 %. At the optimum 
concentration (100mM) identified for the control lamb, 54% lymphoproliferation 
was demonstrated with the JSRV -infected lamb. At higher concentrations (200mM 
and 400mM) mannose was not inhibitory. Therefore, it was determined from the 
resulting standard curve that the addition of 100mM mannose did result in the 
highest level of inhibition, albeit only partial, and complete inhibition was not 
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Figure 4.9 Optimum mannose concentration required to inhibit NPA mitogenicity in a 
JSRV- infected Iamb. The PBMC purified from the blood of a 3- month -old, experimentally 
JSRV- infected Iamb was stimulated with NPA alone and NPA with the addition of 1mM, 
10mM, 100mM, 200mM and 400mM mannose. The results are shown as counts per minute 
(cpm), determined by 3H- thymidine uptake. The addition of 10mM and 100mM only partially 
inhibited the mitogenicity of NPA. At all other concentrations tested, the lymphoproliferative 
response was not inhibited. The optimum inhibitory concentration of mannose was found to 
be 100mM, with only partial inhibition detected. 
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4.5.2 Mannose inhibition of NPA mitogenicity during experimental 
JSRV infection. 
4.5.2.1 Methodology 
The investigation of the inhibitory effect of mannose on NPA mitogenicity 
identified during the optimisation assays, was extended to include experimentally 
JSRV -infected and control lambs aged 1, 2, 4, 8, 10, 16 and 18 weeks. At each time 
point the PBMC were purified (Chapter 2, section 2.2) from the blood of three 
JSRV -infected lambs at 1, 2, 4 and 8 weeks and two JSRV -infected lambs at 10, 16 
and 18 weeks. The PBMC purified from the blood of two control lambs were used 
throughout. At each time point the PBMC were stimulated with NPA alone, 
NPA/mannose and PBMC controls (no lectin added). Lymphoproliferation was 
performed as described in Chapter 2, section 2.5. The data were analysed and the 
group results compiled as detailed in Chapter 2, section 2.9. 
4.5.2.2 Mannose inhibition of NPA mitogenicity is age- related in uninfected 
lambs and during JSRV infection 
Control lambs (Figure 4.10a) The addition of mannose did not inhibit the 
lymphoproliferative response to NPA stimulation in one to four week old control 
lambs Moreover the responses detected at two weeks (NPA: 3756cpm ± 216, 
NPA/mannose: 9050cpm ± 1949) and four weeks (NPA:10172cpm ± 497, 
NPA/mannose: 12248cpm ± 679) were found to be enhanced by the presence of 
mannose in comparison with those detected with NPA alone, although this increase 
was not statistically significant (p =0.1). At eight weeks a decrease in the 
lymphoproliferative response was observed in the NPA/mannose samples 
(NPA/mannose 1245cpm ± 104), compared with the response to NPA alone 
(2097cpm ± 930). From ten weeks onwards no lymphoproliferative response was 
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detected in the NPA/mannose samples, demonstrating complete inhibition of NPA 
mitogenicity. 
JSRV -infected lambs (Figure 4.10b) The responses detected to NPA 
stimulation in lambs aged one to eight weeks (1 week: 1953cpm ± 1049, 2 weeks: 
2868cpm ± 1258, 4 weeks: 5308cpm ± 640 and 8 weeks: 4341cpm ± 345) were not 
inhibited by the addition of mannose (1 week: 4031cpm ± 1881, 2 weeks: 3880cpm ± 
1034, 4 weeks: 6783cpm ± 872 and 8 weeks: 8269cpm ± 673). The enhanced 
lymphoproliferation detected in the NPA/mannose samples at two and four weeks, 
compared with the response identified to NPA stimulation, was not significant. 
However, the increased lymphoproliferation detected in the NPA/mannose sample 
compared with the response to NPA alone at *8 weeks was statistically significant 
(p= 0.007). At ten weeks the lymphoproliferative response to NPA and NPA/mannose 
stimulation was comparable (4640cpm ± 1304, 3923cpm ± 1354, respectively). At 
sixteen weeks (NPA: 4048cpm ± 666, NPA/mannose 1589cpm ± 445) and eighteen 
weeks (NPA: 6668cpm ± 2788, NPA/mannose 2744cpm ± 2000) only partial 
inhibition of NPA mitogenicity was detected. Therefore no evidence of complete 
inhibition was demonstrated at any time point, in the JSRV -infected lambs. 
4.6 NPA mitogenicity in human subjects 
To investigate the human lymphoproliferative response to NPA stimulation, 
the PBMC from the blood of adult volunteers aged 24 -56 years were compared with 
the response measured in umbilical cord blood. Unfortunately it is not possible to 
readily obtain blood samples from children, but ethical permission was granted for 
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Figure 4.10 Mannose inhibition of NPA mitogenicity during JSRV infection. The 
lymphoproliferative response to stimulation with NPA alone and NPA/mannose was tested in 
JSRV- infected and control lambs, at 1, 2, 4, 8, 10, 16 and 18 weeks old. At each time point, 
the PBMC were purified from the blood of 2 control lambs and 3 experimentally JSRV- 
infected lambs at 1, 2, 4 and 8 weeks, 2 JSRV- infected lambs at 10, 16 and 18 weeks. The 
results are shown as counts per minute (cpm) ± SEM, determined by 3H- thymidine uptake 
with the unstimulated PBMC cpm (1 week 128 : 95, 2 weeks 194 : 103, 4 weeks 388 : 161, 8 
weeks 219 : 114, 10 weeks 274 : 145, 16 weeks 330 : 227 and 18 weeks 192 : 139 cpm, 
control and JSRV- infected lambs respectively. Figure 4.10a: The lymphoproliferative 
response to NPA and NPA/mannose detected in control lambs aged 1-4 weeks revealed that 
the presence of mannose had no inhibitory effect on NPA mitogenicity. From 10 weeks 
onwards, the addition of mannose resulted in complete inhibition of NPA mitogenicity. Figure 
4.10b: The lymphoproliferative response to NPA and NPA/mannose detected in JSRV- 
infected lambs in lambs aged 1 -8 weeks, revealed that the presence of mannose did not 
inhibit NPA mitogenicity. At 8 weeks a significant increase (p= 0.007) in the response to 
NPA/mannose stimulation, compared with NPA alone was demonstrated. Only partial 
inhibition of NPA mitogenicity was detected from 10 weeks onwards. 
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4.6.1 Methodology 
4.6.1.1 Blood samples 
In total, twelve human blood samples were collected, from five volunteer adults, 
ages ranging from 24 -56 years, and seven umbilical cord bloods obtained during routine 
caesarean sections (kindly collected by Dr. Rhona Hughes, Edinburgh Royal Infirmary, 
with informed consent). All blood samples were collected into i Ounits /m1 preservative 
free heparin. The volume of umbilical cord blood ranged from 2.5 - 5m1, with 5m1 adult 
peripheral blood collected 
4.6.1.2 Mononuclear cell purification 
The umbilical cord mononuclear cells (UCMC) and the adult PBMC were 
purified within four hours of collection by layering the whole blood over 5m1 
LymphoprepTM (Nycomed Pharma AS, Oslo, Norway), followed by centrifugation at 
300g for 15 minutes. The interface cells were recovered and re- suspended in 10m1 
RPMI -1640 containing antibiotics (Chapter 2, section 2.2), 10% autologous plasma and 
1 Ounits heparin/mi. The samples were centrifuged at 240g for 10 minutes and the 
supernatant decanted. The cell pellet was then washed twice by centrifugation at 240g 
for 5 minutes and re- suspended in 5m1 RPMI -1640 medium (no added heparin). After a 
final wash the supernatant was decanted and the cells re- suspended in 5ml RPMI -1640 
with 10% autologous plasma. The cells were adjusted to a final concentration of 106 
cells /ml (Chapter 2, section 2.2.2). 
4.6.1.3 proliferation assays 
The lymphoproliferative response of the UCMC and PBMC to PHA and 
NPA stimulation was determined as described in Chapter 2, section 2.5. The data 
was analysed and group results compiled (Chapter 2, section 2.9). 
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4.6.2 Optimisation of NPA concentration for human lymphocytes 
The mononuclear cells purified from two umbilical cords and an adult blood 
were stimulated with various concentrations of NPA to determine the concentration 
of lectin required to produce maximum lymphoproliferative response. This was 
found to be 100µg /ml for UCMC and adult PBMC, (Figure 4.11). 
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Figure 4.11 NPA concentrations tested to induce maximum lymphoproliferation in 
humans. The results are shown as counts per minute (cpm), determined by 3H- thymidine 
uptake with the unstimulated PBMC (UCMC1: 204. UCMC 2: 367 and adult PBMC: 178 
cpm) subtracted. Figure 4.11a: The UCMC from two cord bloods were stimulated with 10, 
25 and 1001.1g /m1 NPA. Figure 4.11b: The PBMC from adult blood was stimulated with 10, 25 
and 100µg /ml NPA. The maximum lymphoproliferative response to NPA stimulation was 
detected *100ug /ml for UCMC and PBMC. 
4.6.3 NPA mitogenicity for human lymphocytes is age - related 
To identify if NPA mitogenicity was age -related in humans, the UCMC from 
seven cord bloods and five adult PBMC were purified as detailed in section 4.6.1.2 
and stimulated with NPA and PHA. 
As shown in Figure 4.12 PHA was strongly mitogenic for lymphocytes of 
both human age groups (UCMC mean cpm 65058 ± 12108 and adult PBMC 76161 ± 
13770) and there was no statistically significant difference in these responses. In 
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contrast, the lymphoproliferative response to NPA stimulation was significantly 
higher (p= 0.0004) with UCMC (mean cpm 11322 ± 1549) compared to adult PBMC 




















Figure 4.12 Human lymphoproliferative response to PHA and NPA stimulation. The 
mononuclear cells, purified from 7 umbilical cord bloods (UCMC) and the peripheral blood 
mononuclear cells (adult PBMC) from 5 adults (aged 24 -56 years) were stimulated with PHA 
and NPA. The results are shown as counts per minute (cpm) ± SEM, determined by 3H- 
thymidine uptake with the unstimulated PBMC (UCMC 197, Adult PBMC 157 cpm) 
subtracted. Comparison between the two groups was not statistically significant for PHA 
stimulation, but highly significant (p= 0.0004) for NPA. 
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4.7 Discussion 
The investigation into the ovine lymphoproliferative response to stimulation 
by the monocotyledonous Narcissus pseudonarcissus lectin (NPA) has identified that 
mitogenicity for sheep lymphocytes is inversely correlated to the increasing age of 
the animals. Lymphoproliferation in response to NPA stimulation was demonstrated 
in lambs as young as four days old and effective mitogenicity was still evident when 
the animals were at least four months of age. No evidence to support NPA 
mitogenicity in adult sheep was detected (section 4.1.2). 
It was established that all the lymphocyte subsets tested in the PBMC have a 
cell- surface receptor for NPA (section 4.2.1), although the percentages of double - 
labelled cells detected appeared very low in comparison with subset percentages 
detected in other studies. This was particularly true for 75 T cells, the predominant T 
cell subset in young lambs (Hein & McKay 1991). It has been established that in 
sheep, the percentage range of peripheral blood lymphocytes varies considerably 
between individual animals, for example CD4 (8 -22 %), CD8 (4 -20 %), 78 T cells 
(22 -68 %) and B cells (11 -50 %) have been demonstrated (McKay 1986, McKay et al 
1988, Hein & McKay 1991, Smith et al 1994). A study by Bachh et al (1995) 
demonstrated ovine reactivity to monoclonal antibodies in lambs aged three to four 
months and identified the percentage distribution of positively immunolabelled 
lymphocyte subsets in the peripheral blood as CD2 (30.6 %), CD4 (16.8 %), CD8 
(8.8 %), 78 T cells (15.5 %) and B cells (19.7 %), giving a CD4 : CD8 ratio 1.81:1. 
The results of the Bacch et al study corresponded closely to the previous findings of 
MacKay & Hein (1987) and Ellis et al (1991). In comparison, the smaller percentage 
of B cells identified (15 %) and the higher CD4 : CD8 ratio of 2.3:1 detected during 
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this study may have resulted because the PBMC were purified from a 2 month old 
lamb and the lymphocyte distribution would not therefore correspond exactly to the 
results obtained in the aforementioned studies. Alternatively the low response might 
be due to the presence of NPA, if binding to the cell surface receptor resulted in 
blocking attachment of the monoclonal antibody to the cells. To test this hypothesis 
the assay could be repeated, testing monoclonal antibodies recognising different 
epitopes and performing the immunolabelling prior to incubation with the FITC 
conjugated lectin. 
In this study lymphoproliferation was demonstrated for T, and possibly B 
lymphocytes also (section 4.2.2). Further characterization of the T cell population 
identified that the CD4+ subset were the most predominant responder cell to NPA, 
and 78 T cells showed a limited response, but no evidence of CD8+ T cell responses 
were detected. If binding of the lectin to the cell does adversely affect subsequent 
immunolabelling this may account for the very low proliferative response detected. 
It was revealed that the level of NPA mitogenicity was influenced by the 
presence of antigen -presenting- adherent cells (section 4.3), demonstrating that 
accessory cells are required for the mitogenicity of this lectin, a finding in sheep, 
which correlates with NPA studies performed with human lymphocytes by Kilpatrick 
et al (1990). Habu and Raff first described the influence of accessory cells on the 
mitogenicity of several lectins in 1977. Subsequent studies have demonstrated that 
the presence of antigen -presenting- adherent cells, such as monocytes, dendritic cells, 
and /or non -adherent B cells are required for the mitogenicity of several lectins. For 
some lectins the physical presence of antigen presenting cells is all that is necessary 
to enhance mitogenicity, by localising the lectin and promoting cross - linking of the 
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receptors present on the lymphocyte surface (Gallagher et al 1986). More subtle 
factors provided by antigen presenting cells control the level of mitogenicity of other 
lectins. For example, wheat germ agglutinin (WGA), (another monocotyledonous 
lectin, but not mannose specific) derived from the grass family, depends strongly on 
the soluble mediators produced by accessory cells, such as IL -1 (Kilpatrick et al 
1988). WGA mitogenicity for antigen -presenting- cell -depleted -PBMC from human 
blood has only been demonstrated with the addition of exogenous IL -2, suggesting 
therefore, that WGA, although binding to the lymphocytes directly, and consequently 
inducing IL -2R expression does not induce IL -2 production directly. It is the soluble 
mediators produced by the monocytes that are required to stimulate the production of 
this monokine, and therefore provide the essential components necessary for WGA 
mitogenicity (Kilpatrick et al 1988). Not all lectins are so dependent on accessory 
cells for mitogenicity, as demonstrated with PHA and poke weed mitogen (PWM) 
during this project (Chapter 3, section 3.4), and by several others (reviewed by 
Kilpatrick 1999). 
The lymphoproliferative response to NPA stimulation was not adversely 
affected during experimental JSRV -infection, with the level of stimulation 
comparable in JSRV -infected and control lambs (section 4.4.1). However, the T and 
B lymphocyte profiles identified post -NPA stimulation in the blood of JSRV- 
infected lambs were altered, in comparison with the control animals (section 4.4.2). 
In the PBMC from the control lambs the numbers of immunolabelled cells, post - 
stimulation, were found to be significantly reduced (T cells p= 0.00005, B cells 
p= 0.01), in comparison to the numbers detected pre - stimulation. These results were 
not as expected. It was envisaged, that as lymphoproliferation had occurred, a greater 
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number of positively immunolabelled lymphocytes (post -stimulation) would be 
detected. The reason for this observation remains unclear but could again suggest 
that the receptor for NPA in control animals blocks attachment of the monoclonal 
antibodies, decreasing the number of immunolabelled cells detected, or that 
proliferation with NPA may result in downregulating the CD2 and B cell ligands. By 
comparison, no significant difference in the numbers of T and B lymphocytes were 
detected before and after NPA stimulation, with the JSRV - infected lambs. This 
observation could indicate that during JSRV infection, proliferation with NPA results 
in the death of an inhibiting cell or that NPA utilises a receptor that does not interfere 
with monoclonal antibody binding. Perhaps therefore, NPA mitogenicity could be 
induced via different mechanisms in control and JSRV- infected lambs. 
Further evidence to support the observation that the presence of JSRV has a 
direct effect on the lymphocytes, and that NPA mitogenicity may be induced through 
a different pathway during experimental infection, was demonstrated by the altered 
cellular response in the JSRV -infected lambs to mannose inhibition of NPA 
mitogenicity (section 4.5). If lymphoproliferation occurs via the mannose pathway, it 
was hypothesised that the addition of exogenous mannose to NPA, prior to 
incubation with the PBMC, would result in inhibiting mitogenicity. The addition of 
exogenous mannose did result, as hypothesised, in complete inhibition in uninfected 
lambs aged ten to eighteen weeks. In contrast, mannose only partially inhibited NPA - 
induced proliferation in age- matched JSRV -infected lambs. It was further 
demonstrated that the addition of mannose was not inhibitory to NPA mitogenicity in 
JSRV -infected or control lambs, aged one to eight weeks old, indicating that, in 
young lambs, NPA mitogenicity was not via the mannose pathway. In the JSRV- 
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infected and control lambs, at ten weeks old, the trend towards inhibition was 
observed, culminating in the complete inhibition of NPA mitogenicity in uninfected 
lambs. Thus the inhibitory affect of mannose was age- related. In contrast, complete 
inhibition was not detected at any time point with the age- matched, JSRV -infected 
lambs. This may suggest that lymphoproliferation to NPA stimulation was not 
induced via the mannose pathway in JSRV -infected lambs. If a different mechanism 
for mitogenesis was utilised in the presence of JSRV, it could be hypothesized that 
this also may be the mechanism utilised by NPA to induce mitogenicity in very 
young lambs. The comparative data generated from the mannose inhibition study 
indicated that the immune status of JSRV -infected lambs, from the age of ten weeks, 
was more analogous to the immature immunological state identified in younger 
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Figure 4.13 Summary of results: NPA mitogenicity in sheep 
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This study has revealed for the first time that the mitogenicity of the 
monocotyledonous lectin, NPA is age -related in humans (section 4.6), (Figure 4.12). 
In contrast to previous reports (Kilpatrick et al 1990, Fenton et al 1999) this study 
has shown that NPA is mitogenic for human lymphocytes. Clear evidence 
demonstrated that the lymphoproliferative response to NPA stimulation increased 
more than sevenfold for lymphocytes from umbilical cord blood, compared with the 
blood from adults (section 4.6.3). The lymphoproliferative responses to NPA in 
sheep reflected our observations in human lymphocytes (section 4.1.2). With no age - 
dependent response to PHA stimulation evident in either humans or sheep, these 
observations indicate that age- related divergence in the mononuclear cell population 
affects the mitogenicity of NPA. 
Our findings relate only to in vitro studies and cannot predict in vivo 
responses to NPA. However, these results indicate that exposure of the human 
population to NPA could have physiological consequences. Research into the effects 
of the NPA- related Galanthus nivalis lectin (GNA) on human blood cells 
demonstrated the presence of many cell surface receptors (Fenton et al 1999). 
Consequently the lectin binding to the cell, if not culminating in lymphoproliferation 
may still have the potential to inhibit biological function. It also was proposed that 
glycosylation of white blood cells could result in increased synthesis of a 1 -3- linked 
terminal mannosyl residues, the recognised binding site for both NPA and GNA. The 
PBMC examined were purified from frozen huffy coats (Fenton, personal 
communication) recovered from blood samples obtained exclusively from people 
over 60 years of age, thus the effects of NPA on the blood cells of younger human 
subjects remained un- addressed. 
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Mononuclear cells purified 
from adult peripheral blood 
Following the discovery by Barker et al (1969) that poke weed mitogen 
(PWM) is mitogenic for human lymphocytes in vitro and in vivo, subsequent 
research has established that mitogenic plant lectins are able to withstand the 
degradative forces of the human and mouse digestive system, inducing mitogenic 
activity both within the gut and also systemically (Brady et al 1978, Kilpatrick et al 
1985, Freed et al 1987). It is essential therefore that we understand the potential 
implications of introducing foreign lectins into human and animal food sources, and 
extend our knowledge of the plant lectin - mammalian cell relationship, not only for 
species specificity but also to include all age groups. 
NPA 
mitogenicity 
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In vitro phenotyping of the OPA lung 
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Introduction 
Immunohistochemistry (IHC) is an in situ technique that allows 
characterization of different immune cells in histological sections, a distinction not 
possible with haematoxylin and eosin (H &E) staining. There are several 
immunohistochemical procedures and these have been extensively researched, 
adapted and employed for many purposes including diagnostics and in situ research 
into the pathogenesis of infections. Utilizing the specificity of monoclonal 
antibodies, the identification, distribution patterns and morphological changes in 
immune cells in infected tissues can be analysed and compared with tissues obtained 
from uninfected animals. 
The main problem to be addressed in tissue fixation for subsequent 
immunolabelling is to establish a compromise between the retention of cellular 
morphology and tissue architecture, and the preservation of sensitive cell surface 
antigens. In this study a tissue fixation procedure was developed with the use of a 
fixative based on salts from a transition metal. Protocols were optimised for the 
preservation of sheep lung and lymph node, and for subsequent IHC of those tissues. 
Several fixation protocols were compared to test the quality of the post -fixed cellular 
morphology and the retention of sensitive antigens. 
The conventional aldehyde -based fixatives (primarily formaldehyde, 
paraformaldehyde and their derivatives) undoubtedly retain the morphology of the 
fixed tissue with only minimal shrinkage. As a non -coagulating fixative, 
formaldehyde fixed tissues are not distorted by the generation of coagulum and the 
resultant production of tissue clumps. Formaldehyde, when dissolved in aqueous 
solution hydrates to form methylene glycol (Le Botlan et al 1983) so that this and 
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unhydrated formaldehyde rapidly penetrate through the tissue and form covalent 
bonds with highly reactive functional groups linking adjacent proteins, glycoproteins, 
polysaccharides or reactive sites such as primary amines (e.g. lysine) and thiols (e.g. 
cysteine). Once bound, these reactive molecules cross -link with the less reactive 
groups, such as amide or hydroxyl groups and cyclic aromatic rings, resulting in 
tissue fixation (Kunkel et al 1981). The methylene glycol/formaldehyde ratio in 
solution is maintained by dissociation of methylene glycol to formaldehyde resulting 
in a rapid penetration of the tissues paralleled by slow fixation. Therefore tissues 
fixed hi formaldehyde do not become `overfixed'. The major disadvantage of this 
fixation mechanism is directly related to the creation of the methyl bridges and cross - 
linking of the cells. This results, in many instances, in `masking' the cell surface 
antigens, impeding subsequent immunolabelling. In order to reveal the antigens for 
IHC, the cross -links require to be broken and the cell surface epitopes revealed, 
without damage to the cells or to the tissues. The main strategies employed in antigen 
retrieval are protease digestion or heat activated degradation of the cross - linked 
proteins and /or molecules surrounding the antigenic site. Enzymatic digestion as a 
method of antigen retrieval was first reported in the 1960s and since then the use of 
proteolytic enzymes such as trypsin, pronase and pepsin has been employed with 
varying degrees of success (Gown et al 1993). The use of extreme temperatures to 
expose antigens has become widely used, principally by microwave (Shi et al 1991, 
Cattoretti et al 1993, Cattoretti and Suurmeijer 1995) or pressure cooker methods 
(Norton et al 1994) The different methods of antigen retrieval have been compared 
and evaluated (Cattoretti et al 1993, Miller et al 1995, Leoncini and Falini 1997, 
Pileri et al 1997) and many adaptations have been developed; temperature variation, 
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alterations in pH (Evers and Uylings 1994), comparison of buffers (Cattoretti and 
Suurmeijer 1995, Leong 1996), holding times (Evers and Uylings 1994), 
modification of the fixative, embedding procedures and tissue processing protocols 
(Beckstead 1985, Sato et al 1986). The fundamental problem in antigen retrieval is 
that no universal method exists. The variation in antigen sensitivity, monoclonal 
antibody efficacy and the ability of different tissues to withstand such severe 
treatment mean that no single method is applicable for all IHC. 
As with the fixation method, the embedding procedure can also result in 
distortion and degradation of sensitive antigens. After the tissues have been fixed 
they are dehydrated and embedded in a matrix such as paraffin wax. This fortifies the 
tissue into a solid block, which allows thin sections to be cut and placed on glass 
slides for subsequent procedures. The use of plastic to embed tissues is employed, 
but paraffin wax is still the most universally used medium. The problem is exposure 
to high temperatures during the process. This has resulted in the development of 
paraffin waxes with melting temperatures as low as 50 -60 °C, which will not 
adversely affect heat sensitive antigens. 
Cryopreservation is a technique also widely used for the preservation of 
routine tissue sections. Tissues collected at necropsy are encased in a cryomatrix, 
which protects the fresh tissue from the extreme temperature of snap freezing in 
liquid nitrogen and allows ease of handling. The tissues can be stored at -70 °C until 
required. Relatively thin sections can then be cut on a cryostat. This method, in many 
instances, results in better preservation and reactivity of the cell surface antigens in 
comparison with aldehyde -fixed tissues. The frozen tissue blocks do not need to be 
embedded in paraffm wax, therefore any adverse effects resulting from this 
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procedure and the subsequent dewaxing process are eliminated. There is no cross - 
linking, therefore no antigen retrieval is necessary. Unfortunately this does not imply 
that freezing is the ideal method of tissue preservation. The major disadvantages of 
this procedure are that tissue may be adversely effected by freeze and thaw, with 
crystallisation within the cells disrupting the cellular morphology and the cell surface 
antigens. The actual procedure of cutting tissue sections with a cryostat is also 
extremely temperature sensitive and the temperature must be adjusted depending on 
the type of tissue to be cut. The optimum temperature must thereafter be maintained 
during the cutting process. Furthermore, cutting consistently uniform sections 
requires a great deal of skill. Some dense and compact tissues such as lymph nodes 
cut extremely well on a cryostat, whilst others such as lung are difficult to cut, with 
the tissue tearing as a result of the open network and large air spaces in the alveoli. 
Several sections are likely to be cut and discarded before a section of acceptable 
quality is produced. 
To overcome some of the problems stated above, and establish an acceptable 
compromise between cellular morphology and antigen preservation, an alternative 
method of tissue fixation has been developed. In 1994, Beckstead reviewed the 
problems encountered by different tissue fixation methods and reported that the use 
of an aldehyde -free fixative based on salts of transition metals such as zinc resulted 
in excellent cellular morphology whilst preserving sensitive antigens. It was reported 
that the morphology of tissues preserved in zinc salts fixative (ZSF) was almost 
comparable with those fixed in aldehydes, while the survival of sensitive antigens 
was analogous to cryopreservation. Although the principles of this fixation method 
have been tested, the use of ZSF is not widespread and ZSF has not been tried as a 
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primary fixation method. It was hypothesised therefore that ZSF might provide the 
solution to the dilemma of morphology versus antigen preservation in the ovine 
species. In order to test this hypothesis, an investigation into the properties of ZSF as 
a fixation agent for sheep tissue was undertaken. Adaptations of the original ZSF 
method, particularly temperature ranges and fixation times were optimised. The 
subsequent immunolabelling of tissues, which had been aldehyde fixed, 
cryopreserved and fixed in ZSF, was compared. 
It was proposed that, once established, the optimal fixation method could be 
used to preserve OPA tumour and non- neoplastic lung tissues collected at necropsy 
from confirmed OPA cases and uninfected control lambs for subsequent IHC to 
determine the identity of tumour infiltrating cells and examine the distribution and 
arrangement of immune cells. 
5.1 Comparison of tissues fixed in zinc salts fixative (ZSF), 
aldehydes and cryopreserved sections. 
5.3.1 Methodology 
To compare the quality of cellular morphology and immunolabelling in ZSF - 
fixed tissues with tissues subjected to other fixatives, samples (5 -6mm) of lung, 
bronchial, mediastinal and popliteal lymph node were collected at necropsy from 
experimentally JSRV- infected lambs and adult OPA cases (Chapter 2, sections 2.1.5 
and 2.1.1, respectively). The tissues were fixed in ZFS (Chapter 2, section 2.10.1), 
4 %, 2% and 1% formaldehyde and 4% paraformaldehyde (Chapter 2, section 2.10.2) 
and subsequently paraffin wax embedded as detailed in Chapter 2, section 2.11.1. 
Sections were cut from the preserved tissue blocks and antigen retrieval was 
attempted with each of the aldehyde -fixed sections (Chapter 2, section 2.11.3). 
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Tissue samples were also cryopreserved (Chapter 2, section 2.10.4) and sections cut 
and prepared for IHC (Chapter 2, section 2.12). Immunolabelling was preformed 
(Chapter 2, section 2.12) using the panel of monoclonal antibodies detailed in Table 
5.1, at the dilutions shown. The EnVision kit (DAKO, Ely, Cambridge, UK) 
described in Chapter 2, section 2.13.1 was the detection system used. 
Mab Antigen Reactivity Dilutions tested 
VPM5 CD1 Dendritic cells 1:50, 1:100, 1:500 
135/A CD2 T cells [aß] 1:50, 1:100. 1:500, 1:800 
17D CD4 T HELPER cells 1:50, 1:100, 1:500 
SBU -T8 CD8 T cvroTOxic cells 1:50, 1:100, 1:500 
86D y8 TCR y8 T cells 1:50, 1:100, 1:500 
VPM8 Anti -light chain B cells 1:100, 1:500, 1:800, 1:1000 
VPM65 CD14 Monocytes /macrophages 1:50, 1:100, 1:500 
Table 5. 1 Panel of monoclonal antibodies for immunohistochemical comparison of 
tissues preserved in 4 %, 2% and 1% formaldehyde, 4% paraformaldehyde, 
cryopreserved or fixed in ZSF. All monoclonal antibodies were from cell culture 
supernatants. 
5.1.2 ZSF is the preferred fixation method for immunohistochemistry of ovine 
lung and lymph nodes 
Formaldehyde fixation: In tissues fixed in formaldehydes, no positive cells 
were detected in sections labelled with any of the dilutions of monoclonal antibodies 
specific for CD1, CD2, CD4 and CD8 T cells. Immunolabelling to detect y8 T cells, 
B cells and macrophages did result in some non -specific labelling, with a reticular 
staining pattern observed throughout the tissue. Antigen retrieval by pressure cooker 
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or microwave oven methods (Chapter 2.11.3) did not improve the quality of the 
immunolabelling. Several attempts at antigen retrieval, altering the conditions by 
increasing the incubation times and trying different buffers as detailed in Chapter 2, 
section 2.11.3 did not enhance the results. 
Cryopreservation: The quality of the tissue morphology was not preserved to 
an acceptable standard in the cryopreserved lung sections. No positive 
immunolabelling was detected with any of the monoclonal antibodies tested at 1:50 
dilution. Monoclonal antibodies recognising CD1, CD4 and CD8 T cells resulted in 
positive labelling at 1:100 dilution but a large amount of non - specific background 
labelling was also evident, and at higher dilutions no positive immunolabelling was 
detected. In sections labelled for the detection of 76 T cells, macrophages and in 
particular B cells, the level of background staining was very high at 1:100 dilution, 
and no positive labelling was detected at 1:500 dilution. Attempts to decrease the 
background level by increasing the incubation time of the peroxidase block and 
removal of non -specific antigens by increasing the incubation time of the goat serum 
did not enhance the quality of the labelling. No positively immunolabelled CD2 T 
cells were detected with any dilution of the monoclonal antibody tested. 
Zinc Salts Fixative: In contrast to the other methods tested, immunolabelling 
of ZSF tissues resulted in improved detection of discrete positively labelled cells 
whilst retaining cellular morphology. Immunolabelling ZSF tissues with the 
monoclonal antibodies recognising CD1, CD4, CD8, yb T cells and macrophages 
resulted in the detection of positively labelled discrete cells, at 1:100 dilution. 
However, immunolabelling for the detection of CD2 T cells did not result in positive 
labelling, at any dilution of the monoclonal antibody tested. In the detection of B 
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cells, high levels of non -specific background labelling was evident up to 1:100 
dilution of the monoclonal antibody VPM8 and no positive labelling was detected at 
higher dilutions (results not shown). 
5.2 Optimisation of ZSF for the preservation of ovine tissues. 
5.2.1 Methodology 
To determine the optimum conditions for the preservation of ovine tissue in 
ZSF, samples (5 -6mm) of bronchial, mediastinal, popliteal and prescapular lymph 
node, lung tumour and non -neoplastic lung were collected at necropsy from 
experimentally JSRV -infected lambs and adult OPA sheep (Chapter 2, sections 2.1.5 
and 2.1.1, respectively). The tissues were fixed in ZSF (Chapter 2, section 2.10.1) at 
room temperature and at 37 °C, and in alcohol/zinc acetate (AZA) (Chapter 2, section 
2.10.2) at room temperature. After primary fixation of 4 -6 hours, the tissues were 
trimmed to 2 -3mm thick sections and post -fixed (in cassettes) in a fresh volume of 
the same fixative and temperature as detailed above, for 24 hours. The tissues were 
then dehydrated and paraffin wax embedded as detailed in Chapter 2, section 2.11.1. 
5.2.2 Cellular morphology and immunolabelling are optimal in ZSF, at room 
temperature and 37 °C 
The quality of the cellular morphology and subsequent immunolabelling 
(detailed in Chapter 2, section 2.12) for each fixation protocol was compared. 
Tissues fixed in AZA resulted in a poor standard of cell morphology. Tissues 
preserved in ZSF at room temperature and 37 °C were found to be comparable, 
resulting in acceptable cellular morphology and clear immunolabelling. This 
preliminary work was performed by Karen Neligan (MSc Project Thesis, Napier 
University, Edinburgh) under the supervision of Dr. Lorenzo Gonzalez (Veterinary 
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Laboratory Agencies, Penicuik, Midlothian. Scotland). The investigation was 
extended to adapt and further develop the fixation process with the results detailed in 
the publication at the end. 
5.3 Optimisation of monoclonal antibodies for immunolabelling 
ovine tissue 
5.3.1 Methodology 
The availability of different mouse anti -sheep monoclonal antibody clones 
was investigated for the compilation of a panel of monoclonal antibodies, which 
would result in the best quality immunolabelling of ZSF tissues. To determine the 
optimum conditions for immunohistochemistry with ZSF tissues, it was necessary to 
optimise the concentration of each monoclonal antibody selected. 
Samples (5 -6mm) of caudal, mediastinal, tracheobronchial and popliteal 
lymph nodes were collected at necropsy and fixed in ZSF (Chapter 2, section 2.10.1). 
The tissue sections were dewaxed, rehydrated and immunolabelled as detailed in 
Chapter 2, section 2.13, using the panel of monoclonal antibodies outlined in Table 
5.2. In addition, the monoclonal antibodies SBU -TcII specific for WIC class II, 
VPM30 specific for B cells and activated T cells, and VPM8 specific for B cells 
were tested also. Various dilutions, ranging from 1:25 to 1:800 for monoclonal 
antibodies from cell culture supernatants and 1:1000 to 1:256 000 for ascites fluid 
monoclonal antibodies, were tested. Incubation at room temperature for 30 minutes 
and overnight at 4 °C was compared. The EnVision detection system (secondary 
antibody, peroxidase- labelled polymer conjugated to goat anti -mouse 
immunoglobulin) was applied as detailed in Chapter 2, section 2.12. The 
immunolabelled sections were microscopically examined, and the optimum dilution 
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was determined based on the quality of discrete immunolabelled cells and low levels 
of background staining. These dilutions are shown in Table 5.2. 
5.3.2 At optimum monoclonal antibody concentrations, a high standard of 
immunolabelling and cellular morphology was demonstrated in ZSF 
lymph nodes 
The quality of cellular morphology was retained with all the sections 
examined at the optimum monoclonal antibody concentrations (Table 5.2). Precise 
definition of discrete immunolabelled cells was demonstrated within the lymph 
nodes, in accordance with the reported reactivity and cell - specificity previously 
demonstrated by the authors referenced in Table 5.2. CD1, CD4 and CD8 epitopes, 
regarded as highly sensitive to aldehyde -fixation and cryopreservation (Beckstead 
1994, and section 5.3.2) were demonstrated in ZSF tissues. In addition, 
immunolabelling of more resistant epitopes such as WC -1, MHC class II, CD14 and 
CD21 was enhanced in ZSF tissues. The monoclonal antibodies VPM8 and VPM30 
did not detect B cells in the germinal centres of the lymphoid follicle but did strongly 
label cells in the medullary cords that resembled plasmacytes (Gonzalez et al 2001, 
see publication at end of thesis). The optimisation of the monoclonal antibodies was 
performed, after discussion, by Ian Anderson (Moredun Research Institute), with the 
results analysed by Dr. Lorenzo Gonzalez (Veterinary Laboratory Agencies, 
Penicuik, Midlothian. Scotland). 
5.4 Immunohistochemistry of ZSF sheep lymph nodes, and lung 
tissues from lambs with experimentally induced OPA and 
uninfected controls. 
To determine any alteration in the distribution pattern of immune cells in the 
OPA lung, compared with uninfected lung and to characterise the subtypes and 
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Mab Antigen Reactivity Optimum 
dilution Source Reference 
17D CD4 THELPER cells 3 000 AF Basel Maddox et al (1985) 
SBU-T8* CD8 TCYTOTOXIC cells 100 SN Melbourne Maddox et al (1985) 
CC15 WC-1 yâ T cells 100 000 AF Compton Howard et al (1989) 
CC21 CD21 FDCs 30 000 AF Compton Nacssens & 
Mature B cells Howard (1991) 
CC20 CD1b Dendritic cells 10 000 AF Compton Howard et al (1993) 
VPM65 CD14 Monocytes 
macrophages 
5 000 AF Edinburgh Gupta et al (1996) 
VPM 20 IgG1 Non -specific 
control 
1:1000 AF Edinburgh 
VPM 22 IGG2 Non -specific 
control 
1:1000 AF Edinburgh 
Table 5.2 Monoclonal antibodies tested for immunolabelling sheep lymph nodes and 
lungs fixed in ZSF and paraffin wax -embedded. Basel: Basel Institute for Immunology, 
Basel Switzerland. Compton: BBSRC Institute for Animal Health, Compton Laboratory, 
Newbury, Berks, UK. Edinburgh: Veterinary pathology, University of Edinburgh, UK. 
Melbourne: University of Melbourne, School of Veterinary Science, Parkville, Victoria, 
Australia. CD, cluster designation; WC -1, workshop cluster 1; FDCs, follicular dendritic cells; 
AF, ascites fluid; SN, monoclonal antibodies from culture supernatant. * Clone 38 -65. 
location of tumour infiltrating leukocytes, samples of OPA tumour and non - 
neoplastic lung were collected at necropsy from three specific pathogen free (SPF) 
lambs with experimentally induced OPA and three SPF uninfected control lambs. 
OPA lesions were macroscopically detected in the lungs of two lambs and 
microscopic lesions were identified in the third lamb. Histopathological analysis of 
lung tissue from all three lambs confirmed that the lesions were OPA. 
5.4.1 Methodology 
Sections 5 -6mm thick of macroscopically visible areas of tumour and 
sections of lung from the lamb with microscopic nodules, together with lung tissue 
from the control lambs were collected at necropsy. The tissues were fixed in ZSF and 
paraffin wax embedded for subsequent immunolabelling. The tissue sections were 
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cut and stored at 4 °C for a maximum of seven days prior to immunolabelling. IHC 
was performed as detailed in Chapter 2, section 2.13 using the panel of monoclonal 
antibodies and controls outlined in Table 5.2, at the previously optimised dilutions 
shown. In addition to the lung sections, immunohistochemistry was performed on 
sections of sheep lymph node to confirm that the location of the immunolabelled 
cells within the lymph node was in accordance with the previous report (Gonzalez et 
al 2001). 
5.4.2 Immunohistochemistry to detect cell populations in sheep lymph nodes 
CD4 T cells: The monoclonal antibody 17D was used to detect CD4 T cells 
within the sheep lymph node. It was revealed that cells expressing this epitope were 
morphologically small and spherical, distributed as small clusters or as individual 
cells. The positively immunolabelled population was predominantly located in the 
paracortex of the lymph node, contiguous with the periphery of the follicles. In 
addition some individual immunolabelled cells were observed within the follicles 
(Figure 5.1). 
CD8 T cells: The monoclonal antibody SBU -T8, used to detect CD8 T cells 
revealed that cells expressing this epitope were small, spherical and located in 
clusters or as individual cells. They were primarily distributed in the paracortical 
region of the lymph node adjacent to the follicles, in contrast to CD4 T cells there 
was very little evidence of positively immunolabelled CD8 T cells within the 
follicles (Figure 5.2). 
yS T cells: The WC -1 epitope was detected by inununolabelling with the 
monoclonal antibody CC15 identifying yS T cells within the sheep lymph node. 
Small, spherical cells were detected throughout the paracortex, distributed as 
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scattered individual cells. Some cells were identified lining the subcapsular and 
trabecular sinuses, and the population of positively immunolabelled cells appeared to 
intensify at the capsule /cortical junction (Figure 5.3). 
Dendritic cells: The epitope CD 1 b was detected by immunolabelling with the 
monoclonal antibody CC20, identifying dendritic cells within the lymph node. The 
immunolabelling was very faint and the morphology of the individual cells was 
difficult to distinguish. All the positively immunolabelled cells detected were found 
in the paracortex, around the follicles (Figure 5.4). 
Follicular dendritic cells and mature B cells: The monoclonal antibody CC2 1 
recognises the epitope CD21, found on follicular dendritic cells and mature B cells. 
The positively immunolabelled cells within the sheep lymph node were detected 
almost exclusively within the light zone of the germinal centres within the follicles 
(Figure 5.5). The location and morphology of these cells, when seen at a higher 
magnification, were large with irregular shape and evidence of reticulated processes 
suggest that they are follicular dendritic cells. 
Macrophages: The monoclonal antibody VPM65 is specific for the CD14 
molecules found on monocytes and macrophages. Within the sheep lymph node the 
positively immunolabelled cells were identified, mainly as dispersed individual cells, 
in the medullary cords: No positively labelled cells were identified in the follicles 
and only very few cells were observed in the paracortex. Morphologically the cells 
were larger than lymphocytes and contained an extensive cytoplasm (Figure 5.6). 
Summary of results: Immunolabelling was consistent with the findings 
previously reported by Gonzalez et al (2001), although the labelling of dendritic cells 
with the monoclonal antibody CC20 was not particularly clear with very few positive 
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cells detected. The distribution of the lymphocyte subsets within the lymph nodes 
corresponded with the previous report, including the location of yS T cells, indicating 
their transient passage through the lymph node (Hein and Mackay 1991). The cells 
detected by the monoclonal antibody CC21 morphologically appeared to be follicular 
dendritic cells, in accordance with the previous study. The location and distribution 
of macrophages in the lymph node also corresponded to the previous finding. 
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Figure 5.1. CD4+ T cells immunolabelled with MAb 17D. Positively 
immunolabelled cells were detected in the paracortex of the lymph node, with 
some individual, scattered cells located in the follicle. lmmunohistochemistry 
(INC) and haematoxylin counterstain. X 100. 
Figure 5.2. CD8+ T cells immunolabelled with MAb SBU -T8. Positively 
immunolabelled cells were detected in the paracortex of the lymph node. IHC 
and haematoxylin counterstain. X 100. 
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Figure 5.3. yS T cells immunolabelled with MAb CC15. Positively 
immunolabelled cells were detected in the paracortex of the lymph node, 
mainly at the capsule /cortical junction. IHC and haematoxylin counterstain. X 
100. 
Figure 5.4. Dendritic cells immunolabelled with MAb CC20. In the 
paracortex of the lymph node only a very few positively labelled cells were 
detected. IHC and haematoxylin counterstain. X 100. 
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Figure 5.5. Mature B cells and follicular dendritic cells immunolabelled 
with MAb CC21, recognising the CD21 epitope. In the lymph node clusters 
of positively immunolabelled cells were detected in the light zone of the 
follicles. IHC and haematoxylin counterstain. X 100. 
Figure 5.6 Macrophages immunolabelled with MAb VPM65. Positively 
immunolabelled cells with large pale nuclei and extensive cytoplasm were 
detected in the medullary sinuses of the lymph node. IHC and haematoxylin 
counterstain. X 400. 
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5.4.4 Immunohistochemistry to detect alterations in cell types and distribution 
patterns in OPA tumour, non -neoplastic lung and uninfected lung of SPF 
lambs 
In situ immunolabelling was performed to compare the location and 
distribution of leukocytes in lung tissue from SPF uninfected lambs, the non - 
neoplastic area of lung and tumour from SPF lambs with confirmed OPA. 
CD4 T cells: In both the uninfected lung and non -neoplastic region of the 
OPA lung, CD4 T cells detected by the monoclonal antibody 17D were located 
mainly in the bronchial associated lymphoid tissue (BALT). The immunolabelled 
cells were small, spherical and distributed individually or as small clusters as shown 
in Figure 5.7. Some positively immunolabelled cells were detected in the alveolar 
walls, where they were distributed as individual cells (Figure 5.8). 
In the OPA tumour sections, immunolabelled CD4 T cells were detected 
infiltrating the tumour but this was not consistent for all tumour nodules. Positively 
labelled cells were found in larger nodules, which were observed macroscopically as 
shown in Figure 5.9, but no CD4 T cells were detected in microscopic nodules. The 
cells were small and spherical and no particular distribution pattern was evident. 
There was no evidence of cell migration to the tumour site (Figure 5.9). 
CD8 T cells: A considerable population of CD8 T cells, identified by the 
monoclonal antibody SBU -T8, was detected in the peripheral region of the BALT 
from the uninfected lung and in the non -neoplastic region of the OPA lung. 
Morphologically the CD8 T cells were small and spherical, and were distributed as 
small clusters or individual cells (Figure 5.10). Positively immunolabelled cells were 
also detected in the walls and lumen of the alveoli, where they were distributed 
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mainly as individual cells. This distribution pattern was found in the uninfected lung, 
and in the non -neoplastic regions of the OPA lung (Figure 5.11). 
In large tumour nodules very few immunolabelled CD8 T cells were detected, 
and these cells were observed only around the periphery of the tumour with 
practically no evidence of infiltration. In microscopic OPA tumours, positively 
immunolabelled cells were detected in the stroma and localized to the periphery of 
the tumour, with only very few positively labelled cells detected infiltrating the 
centre. The small, spherical cells were distributed as scattered individuals rather than 
as groups. A microscopic tumour is shown in Figure 5.12. 
y8 T cells: A large population of y8 T cells, identified by the monoclonal 
antibody CC 15, was detected in the sections from the uninfected lung and the non - 
neoplastic region of the OPA lung. Large numbers of positively immunolabelled 78 T 
cells were identified in the BALT and in the lamina propria of the bronchioles. 
Morphologically the y8 T cells were small and spherical, and were distributed as 
small clusters or individual cells (Figure 5.13). Positively immunolabelled cells were 
also observed in the walls and particularly the lumen of the alveoli. In addition 78 T 
cells were detected around the blood vessels. (Figure 5.14). 
y8 T cells were detected in the periphery of OPA tumour nodules, closely 
associated to the epithelium. There was no evidence of positively immunolabelled 
cells infiltrating the centre of the tumour. 78 T cells were detected around small and 
large tumour nodules, distributed mainly as individual cells (Figure 5.15). 
Dendritic cells: The monoclonal antibody CC20, specific for the CD 1 epitope 
detected only few dendritic cells in the uninfected and OPA lung. Positively 
immunolabelled dendritic cells were detected in the airways and associated with the 
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BALT. Some positively labelled cells were identified around the walls of the blood 
vessels and bronchioles. Morphologically the cells were stellate or irregular in shape 
and were mainly distributed as individual cells (Figure 5.16). Positively 
immunolabelled cells were also detected in the alveolar lumen, and to a lesser extent, 
in the alveolar walls from both the uninfected lung and non -neoplastic region of the 
OPA lung (Figure 5.17). 
Very few positively immunolabelled dendritic cells were detected in tumour 
nodules. Single cells were identified in the periphery of several tumour nodules. The 
detection of positively labelled cells was not dependent on the size of the tumour and 
no distribution pattern was evident (Figure 5.18). 
B cells: The monoclonal antibody CC21, specific for the CD21 epitope 
recognised mature B cells and follicular dendritic cells in the uninfected and OPA 
lung. Large populations of small, spherical, positively immunolabelled cells were 
detected in the BALT (Figure 5.19). The labelled cells were localized in the centre of 
the BALT aggregate, inverse to where immunolabelled CD8 T cells were detected, 
as previously shown in Figure 5.12. Positively immunolabelled cells were also 
detected in the alveolar walls of both the uninfected lung and non- neoplastic region 
of the OPA lung (Figure 5.20). 
There was no evidence of positively immunolabelled cells at the site of any 
tumour nodules examined. No positive cells were detected surrounding the periphery 
or infiltrating the tumour (Figure 5.21). 
Macrophages: The monoclonal antibody VPM65 detected macrophages in the 
uninfected and OPA lung. In the uninfected lung, no positively immunolabelled cells 
were detected in the BALT and only a few positive cells were identified in the 
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alveolar lumen (Figure 5.22). In the non -neoplastic region of the OPA lung, many 
immunolabelled cells were identified in the BALT, in the connective tissue around 
major bronchii and in the alveolar lumen. The positively labelled cells appeared to be 
larger than those detected in the uninfected lung (Figure 5.23). 
Positively immunolabelled cells were detected in the areas where tumour 
nodules were present. Macrophages were observed in the stroma around the tumours 
and in the alveolar lumen. Morphologically the cells were large and irregular in 
shape (Figure 5.24). 
Summary of results: No differences in the lymphoid cell subsets, their 
localization and distribution patterns were found between the uninfected lung and 
non -neoplastic region of the OPA lung from SPF lambs, with the exception of 
macrophages. The very few macrophages detected in the uninfected lung were 
mainly confined to the BALT, whereas in the non -neoplastic region of OPA lungs 
macrophages were detected not only in the BALT but also in the parenchyma of the 
lung. In the OPA tumour there was very little evidence of tumour infiltration, with 
the majority of lymphoid subsets found around the periphery of the nodules and the 
surrounding stroma. 
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Figure 5.7. CD4+ T cells immunolabelled with MAb 17D in the uninfected 
lung from a control lamb. Positively immunolabelled cells were detected 
mainly in the bronchial associated lymphoid tissue (BALT). IHC and 
haematoxylin counterstain. X 250. 
Figure 5.8. CD4 +T cells immunolabelled with MAb 17D in the non - 
neoplastic region of the OPA lung. Individual positively immunolabelled 




Figure 5.9. CD4+ T cells immunolabelled with MAb 17D in OPA tumour. 
Positively immunolabelled cells were detected infiltrating the tumour nodule. 














































Figure 5.10. CD8+ T cells immunolabelled with MAb SBU -T8 in the 
uninfected lung from a control lamb. Positively immunolabelled cells were 
detected in the BALT. IHC and haematoxylin counterstain. X 100. 
Figure 5.11. CD8+ T cells immunolabelled with MAb SBU -T8 in the non - 
neoplastic region of the OPA lung. Positively immunolabelled cells were 
detected in the alveolar walls and alveolar lumen. IHC and haematoxylin 




Figure 5.12. CD8+ T cells immunolabelled with MAb SBU -T8 in a 
microscopic OPA tumour. Positively immunolabelled cells were detected in 
the stroma and around the periphery of the tumour. IHC and haematoxylin 
counterstain. X 250. 
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Figure 5.13. yS T cells immunolabelled with MAb CC15 in the uninfected 
lung from a control lamb. Positively immunolabelled cells were detected in 
the BALT and alveolar walls. IHC and haematoxylin counterstain. X 250. 
Figure 5.14. yS T cells immunolabelled with MAb CC15 in the non - 
neoplastic region of the OPA lung. Positively immunolabelled cells were 
detected in the alveolar walls, lumen and lining the blood vessels. IHC and 
haematoxylin counterstain. X 200. 
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Figure 5.15. yS T cells immunolabelled with MAb CC15 in microscopic 
OPA tumour. Positively immunolabelled cells were detected in the stroma of 
the tumour and around the periphery. No positive cells were identified in the 
centre of the tumour. IHC and haematoxylin counterstain. X 250. 
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Figure 5.16. Dendritic cells immunolabelled with MAb CC20 in the 
uninfected lung from a control lamb. The few positively immunolabelled 
cells that were detected were found in the BALT. IHC and haematoxylin 
counterstain. X 400. 
Figure 5.17. Dendritic cells immunolabelled with MAb CC20 in the non - 
neoplastic region of OPA lung. Very few positively immunolabelled cells 
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Figure 5.18. Dendritic cells immunolabelled with MAb CC20 in OPA 
tumour. Very few positively immunolabelled cells were detected at the site of 
the tumour, with only a few cells found in the periphery. IHC and 
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Figure 5.19. Mature B cells immunolabelled with MAb CC21 in the 
uninfected lung from a control lamb. Positively immunolabelled cells were 
detected in the BALT. IHC and haematoxylin counterstain. X 100. 
Figure 5.20. Mature B cells immunolabelled with MAb CC21 in the non - 
neoplastic region of the OPA lung. Positively immunolabelled cells were 








Figure 5.21. Mature B cells immunolabelled with MAb CC21 in OPA 
tumour. No positively immunolabelled cells were detected in association with 
the tumour. The positively labelled cells were found only in the parenchyma 
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Figure 5.22. Macrophages immunolabelled with MAb VPM65 in the 
uninfected lung from a control lamb. Positively immunolabelled cells were 
detected in the alveolar lumen. IHC and haematoxylin counterstain. X 400. 
Figure 5.23. Macrophages immunolabelled with MAb VPM65 in the non - 
neoplastic region of the OPA lung. Macrophages were detected in the 
OPA lung and appeared larger than those identified in the uninfected lung. 
IHC and haematoxylin counterstain. X 650. 
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Figure 5.24. Macrophages immunolabelled with MAb VPM65 in the OPA 
tumour. Positively immunolabelled cells were detected in the stroma and 








































































This is the first time that ZSF, developed and adapted from the original 
method reported by Beckstead (1994), has been used to preserve ovine tissues for 
subsequent immunohistochemistry. The use of ZSF, compared with the traditional 
methods of aldehyde -fixation or cryopreservation, resulted in establishing an 
acceptable compromise between retaining cellular morphology, tissue architecture 
and the preservation of sensitive cell surface antigens, without the need for antigen 
retrieval. It has been shown that the tissue sections were morphologically almost 
comparable with aldehyde -fixed tissues and the survival of the antigens was at least 
comparable, and in some instances superior to cryopreserved. 
This study has demonstrated positive immunolabelling of extremely sensitive 
cell surface epitopes such as CD 1, CD4 and CD8, not easily attained in tissues fixed 
by conventional methods. Furthermore, ZSF resulted in enhanced immunolabelling 
of more resilient antigens. ZSF can be incorporated into routine, already established 
procedures of tissue collection, paraffin wax embedding and tissue section cutting, as 
no extra equipment is required. As the array of monoclonal antibodies continues to 
increase, and other recognized in situ procedures may benefit from this fixation 
method, the use of ZSF as a primary method of preserving ovine tissues may become 
more widespread. 
Immunolabelling within non -neoplastic regions of the lung from SPF lambs 
with experimentally induced OPA has shown that, overall, there was very little 
difference in comparison with uninfected lung tissue from identically housed control 
lambs. There was no evidence to suggest enlargement of the BALT in the OPA lung 
and furthermore, the distribution of the lymphocyte subsets throughout the 
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parenchyma was comparable. No positively immunolabelled B cells, detected by the 
CC21 monoclonal antibody, were identified either infiltrating the tumour, in the 
periphery or in the surrounding stroma, but were detected in the parenchyma and the 
BALT. Although it should be noted that the CC21 monoclonal antibody also 
recognizes follicular dentritic cells and some of the cells detected in the BALT 
appear morphology similar to as those detected in the ovine lymph node suggesting 
that they may be dendritic cells rather than B cells. Unfortunately immunolabelling 
with the monoclonal antibody VPM8, which recognizes immunoglobulin anti -light 
chain, was not successful in lung tissue on this occasion. Consequently 
immunolabelling of B cells in the lung requires to be repeated. 
Previous studies have identified lymphocytes in OPA tumour (Dualde -Perez 
1966, Hod 1977, De las Heras 1995, Garcia -Goti 2000) and also inflammatory 
infiltrates have been detected, with numerous neutrophils and enlarged macrophages 
identified within the lumen (Nobel et al 1971, Perk 1982, Sharp and Angus 1985, 
1990 and DeMartini 1997). In these studies, tissue from either conventionally housed 
lambs and adult OPA cases were examined; the use of SPF lambs in this present 
study may have contributed to the overall lack of tumour infiltration, with the 
majority of positively immunolabelled cells localised to the periphery of the tumour 
and the surrounding stroma. However in this investigation, the major difference in 
the OPA lung, in comparison with the uninfected lung was the presence of a large 
population of macrophages detected in the BALT and found in large numbers around 
the tumour nodules. Positively immunolabelled cells were identified within the 
lumen of the tumour and in close proximity to the tumour epithelium. Although the 
detection of neutrophils was not part of the present study, an influx of 
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polymorphonuclear cells, morphologically characterized as neutrophils by 
microscopic observation, was detected in the region of the tumour from one of the 
three OPA cases, with macroscopic lesions. In contrast, there was no evidence of 
neutrophils in the case with microscopic lesions, or in the tumour section from the 
lamb killed at nine weeks old. 
As part of an evaluation of phenotypic frequency alterations during naturally 
transmitted and experimentally induced OPA, Rosadio and Sharp (1992) reported 
that a 34 -fold increase in the influx of immune cells was detected in the 
bronchoalveolar lavage (BAL) from three conventionally housed, experimentally 
infected lambs, compared with two age matched uninfected controls (all lambs 5 -6 
weeks old). As with the previously mentioned studies, the increase in immune cells 
was predominantly characterized by alveolar macrophages and neutrophils. 
Furthermore in the Rosadio and Sharp study the increase detected in the BAL was 
not as a result of an alteration in the proportion of T and B lymphocytes but was 
associated with the proportion of CD4 and CD8 T cells (controls: CD4 56 %, CD8 
22 %, infected lambs: CD4: 41 %, CD8 19 %). In the present study it would appear 
that the size (maturity) of the tumour nodule might be influential as CD4 T cells were 
detected in the region of large tumours, that could be visualised macroscopically and 
not in small tumours, and CD8 T cells were identified only in the microscopic 
tumours and not in large nodules. In contrast, the presence of y6 T cells was not 
determined by the size of the tumour, as they were detected around all tumour 
nodules and surrounding stroma, connective tissue and parenchyma. As y6 T cells are 
the predominant T cell subset in young lambs and have a specific association with 
epithelial surfaces, although the localization of y6 T cells is more prevalent in the 
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upper respiratory tract than in the bronchoalveolar region of the lungs (Hein and 
Mackay 1991) the presence of a large yS T cell population was not unexpected. 
In adult field cases OPA pathology has often been accompanied by secondary 
infections, therefore the exudation of macrophages and neutrophils as a direct 
response to OPA or as a result of secondary infection remained unclear. However the 
presence of a large macrophage population and influx of neutrophils has also been 
detected in conventionally housed lambs with experimentally induced OPA (Rosadio 
and Sharp 1992, De Las Heras et al 1995). An increased population of alveolar 
macrophages in the region of the OPA tumours, and the detection of neutrophils in 
one OPA case was detected ü the present study, despite reducing the threat of 
concurrent infections b y the use of Q PF lambs. Consequently these findings are in 
with the that the exudation accordance lui previous reports that the c ( vii vi macrophages are a 
property of OPA and do not arise from secondary infection (Dualde-Perez 196 6, Hod 
1977, Be las Heras 1995, Gareia -Doti 2000). However, as tissue samples ii iiii (wily 
three QDT' f\DA i 1, ed +L,:., +,,,a the to l hers three 3I i , OPA were examined ini (IUJ study, ii results presented here are 
preliminary and farther work is required to verify these observations.  
To determine if the presence of particular lymphocyte subsets are dependent 
on tumour size, and to fully analyse any differences in the OPA lung and tumour 
nodules, compared to uninfected lung a quantitative or semi- quantitative system is 
required. There are several methods to quantify the results, for example subjective 
grading of immune cell infiltrates, a system based on tumour measurement and the 
numbers of positively labelled cells counted within a predetermined area, or utilizing 
image analysis to quantifying the overall density of imumünolabelled cells as 
A l. a uescrlucu uy J Vin sVn ea al (Lnnn). Johnson e, al have developed a sen-ii-quantitative 
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method based on the distribution pattern of immune cells within the infected lung, 
with an assessment of the degree to which the immunolabelled cells are located 
either as intratumoural (within the tumour) or peritumoural (within the tumour 
stroma). This system would not be applicable to this particular study as little 
evidence of intratumoural infiltration was detected, but may be valuable in 
quantifying differences within the local draining lymph nodes and for quantitative 
analysis of tissues from adult OPA cases and uninfected sheep. 
The further development of tissue fixation and the expansion of ovine 
immunohistochemical reagents to study OPA in situ would permit future research of 
immune responses in the microenvironment of the lung, tumour and lymph nodes. 
JSRV, as the aetiological agent OPA is unique amongst retroviruses as it transforms 
lung epithelial cells. The incidence of human bronchioloalveolar carcinoma (BAC), a 
lung cancer only weakly related to smoking and affecting both men and woman is 
increasing (Wingo et al 1998). Macroscopic, histopathological and ultrastructural 
similarities between OPA and human (BAC) have been demonstrated (Perk and Hod 
1982). Consequently an increased understanding of JSRV oncogenesis and OPA 
development may provide an experimental model for research into human BAC, 








6.1 Discussion of Results 
This investigation, following experimental JSRV infection and in the terminal 
stages of OPA, has provided evidence for an alteration in cell -mediated 
immunological response in the peripheral blood ofJSRV- infected animals. This 
alteration was identified as a significantly reduced lymphoproliferative response to 
ConA stimulation in the PBMC from the blood of conventionally housed and SPF 
lambs experimentally infected with JSRV, and also in adult sheep in the terminal 
stages of OPA. In contrast, no difference between the JSRV -infected and control 
animals was detected when the PBMC were stimulated with PHA, PWM, or NPA. 
NPA proved to be mitogenic for the PBMC from lambs and not adult sheep. 
Although no difference in the level of lymphoproliferation following NPA 
stimulation was detected between JSRV- infected and control lambs, evidence that 
the mitogenicity of this lectin was affected by the presence of the virus was 
demonstrated by an alteration in the post -stimulation T and B cell profiles identified 
between the infected and control lambs. Further evidence to substantiate an altered 
cellular response in the JSRV- infected lambs was demonstrated when only partial 
inhibition of NPA mitogenicity could be induced by the addition of exogenous 
mannose, in contrast to complete NPA inhibition detected in age -matched control 
lambs. These preliminary findings may suggest (amongst the other possibilities 
described in Chapter 4) that lymphoproliferation to NPA stimulation was induced via 
a different pathway by the presence of JSRV. 
Further investigation of the ovine response to stimulation by ConA and NPA 
revealed that for both mitogens, proliferation of CD4 T cells was detected, with only 
a limited response in y8 T cells. The results also suggested that ConA and NPA 
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stimulation induced B cell proliferation that is possibly T cell dependant. In contrast 
however, the mitogenicity of the two mitogens differed in that mitotic division of 
CD8 T cells was induced by ConA but not by NPA stimulation. Possibly the virus 
affects the surface molecules of CD8 T cells, which could explain the reduced 
response detected following ConA stimulation and not to NPA stimulation in JSRV- 
infected lambs. 
The requirement for antigen presentation in the mitogenicity of the lectins, 
determined by the depletion of adherent cells from the PBMC, demonstrated that 
accessory cells were required for NPA mitogenicity. Furthermore, it was 
demonstrated that the level of lymphoproliferation to ConA stimulation was 
influenced by the presence of antigen -presenting- adherent cells to a greater extent 
than with PHA or PWM. A study by Larsson et al (1980) demonstrated that ConA 
can bind directly to the lymphocyte membrane inducing IL-2 expression, but this 
alone was not found to be sufficient to induce lymphoproliferation and that other 
signals were required. This was elucidated when Klaus and Hawrylowicz (1984) 
identified that a second signal from accessory cells was necessary for T cell synthesis 
and expression of the IL -2 receptor. The requirement of accessory cells for the 
mitogenicity of some mitogens was first suggested by Habu and Raff (1977) and 
since then many studies have attempted to ascertain whether the whole accessory cell 
or soluble factors alone are sufficient. A series of experiments by Gallagher et al 
(1986) demonstrated that soluble factors, derived from activated accessory cells were 
not sufficient to induce lymphoproliferation to ConA stimulation. Similar studies 
performed by others are in accordance with these findings, whilst other groups 
demonstrated conflicting evidence. For example Maizel et al (1981) and Palacios 
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(1982) found that lymphoproliferation to ConA in the presence of soluble factors 
alone fully substituted for the intact cells. It was reported in the Gallagheret al 
(1986) study that the physical presence of accessory cells was required to promote 
aggregation of the cells in culture. It was demonstrated however that depletion of 
accessory cells did not result in complete loss of cross -linking. Consequently, it was 
concluded by Gallagher et al that the requirement of accessory cells in ConA 
mitogenicity was not absolute, which is in accordance with results presented in this 
present study. 
Phenotypic alterations demonstrated in the peripheral blood were confined to 
the terminal stages of OPA, and no detectable level of IFN -y, specific to infected 
animals, was detected throughout the experimental infections. Consequently during 
experimental JSRV infection, there was no evidence to suggest that an 
immunological response involving IFN -y was induced. The reason why JSRV 
appears to be undetected by the immune system is still unknown but several 
possibilities can be considered. 
6.2 Tolerance to JSRV antigens 
It has been established that the sheep genome contains copies of endogenous 
retroviral sequences highly related to the exogenous form of JSRV (detailed in 
Chapter 1, section 1.5.1). Several studies by Palmariniet al (1996a, 2000a, 2000b, 
2001) revealed that endogenous JSRV antigens, closely related to exogenous 
sequences are transcriptionally active in a wide range of tissues. It was demonstrated 
that the endogenous and exogenous forms of JSRV have different tissue activity, 
with expression controlled by the viral LTR. The exogenous JSRV has specificity for 
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the type II pneumocytes in the lung. In contrast, endogenous JSRV sequences were 
found in the gut and also in the uterus. Furthermore it was shown that the level of 
endogenous RNA expression in the uterus was related to hormonal levels, oestrous 
cycle and early pregnancy. It was suggested also that the endogenous JSRV might 
play a role in placental morphogenesis. Consequently expression of these sequences 
during foetal ontogeny could lead to the clonal deletion or clonal anergy of JSRV- 
specific T and /or B lymphocytes, thereby establishing a state of tolerance for the 
endogenous form of the virus. The immune system, subsequently encountering 
exogenous JSRV would not identify an infection as the exogenous antigens would be 
regarded as self. Consequently no immunological response would be induced. 
Studies have shown that mice carrying endogenous Moloney murine leukaemia virus 
(M -MuLV) do not develop antibodies or cytotoxic T lymphocyte (CTL) responses t 
the antigenically cross -reactive Murine sarcoma virus (MSV) (Ronchese et all 984). 
Furthermore, mice infected with M -MuLV have a lower number of CTL precursor 
cells suggesting clonal depletion of virus specific T cells. Mouse mammary tumour 
virus (MMTV), with some homology with JSRV can also exist in two forms, either 
as a transmissible virus particle or as an endogenous provirus. The life cycle of 
MMTV depends on eliciting an immune response to promote lymphocyte 
proliferation for the transportation of the virus to site of tumorigenesis as detailed in 
Chapter 1, section ? ?. It has been shown that mice carrying the endogenous MMTV 
have reduced superantigen (Sag) -specific CTL responses, and that temporally the 
Sag -specific T cells are depleted from the T cell repertoire, once the disseminated 
infection has been established (Acha- Orbeaet al 1999). Further evidence to 
substantiate a tolerance hypothesis for JSRV is the lack of JSRV- specific circulating 
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antibodies in naturally infected adult OPA cases and during experimental JSRV 
infection (Sharp and Herring 1983, Verwoerd et al 1990, Ortin et al 1998, van der 
Molen personal communication). Clonal deletion of immune cells specific for 
transcriptively active endogenous retroviral antigens encountered during foetal 
development can therefore be augmented by peripheral tolerance or clonal anergy of 
cells specific for antigens not previously encountered in utero. There is no evidence 
to suggest that cells specific for JSRV are deleted from the system but rather that 
they had been rendered immunologically nonresponsive. It has been shown that 
JSRV- specific antibodies have been detected in sheep immunised with recombinant 
JSRV capsid protein (Dr. Renate van der Molen unpublished results). Furthermore, 
in the early stages of experimental JSRV- infection and tumour development, 
phenotypically in the peripheral blood, there was no evidence supporting the deletion 
of any particular lymphocyte subset. Subsequently however, during the terminal 
stages of JSRV infection the demonstrated CD4 lymphocytopaenia could suggest 
peripheral tolerance by clonal deletion or possibly downregulation of the TcR, the 
CD4 accessory molecule or both factors. 
The preliminary in vivo phenotyping of tumours from SPF lambs with 
histopathologically confirmed OPA detected CD8 T cells only in microscopic 
tumours that were absent in large tumours, perhaps suggesting their deletion from the 
microenvironment as neoplasia progressed. However there was no evidence to 
support this hypothesis in the phenotypic profile of the peripheral blood from these 
JSRV -infected lambs, nonetheless it could be suggested that early responses elicited 
in the microenvironment of the lung are undetectable systemically. Alternatively this 
observation may suggest that cytokine imbalance, the acquisition of additional cell 
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markers or inhibitory factors may be produced during tumour development that could 
confer protection from the immune system. 
Previous studies examining the role of cytotoxic T lymphocyte (CTL) 
responses to retroviral infections have shown that, although antibody responses are 
extremely important in controlling the course of infection and evolution of the virus 
population, the cell -mediated recognition of infected cells rather than free virus is of 
equal importance in combating infection. For example, a study by Plata (1985) 
revealed that Balb /B mice, which are able to reject cells transformed with Gross 
murine leukaemia virus (GMLV) developed tumour after suppression of the CTL 
response. Cerundolo et al (1987) studying Gambian female prostitutes, who were 
repeatedly exposed to HIV and remained seronegative, suggested CTL protective 
immunity as they were found to have CTL responses (Rowland -Jones et al 1995). It 
has been shown also however, that despite high HIV- Tecific CTLs detected in 
infected individuals, the infection continues unabated (Wei et al 1995). It has also 
been shown that specific CTLs have been detected in sheep with maedi -visna virus 
(MVV), but despite this the infection was found to persist (Blacklawset al 1994). 
Cell- mediated immunity may play an important role during early JSRV infection and 
tumorigenesis, but possibly the effectiveness of the CTL response is downregulated 
as neoplasia progresses. 
6.3 Immunosuppression 
As described in the discussion in Chapter 4, there are several examples of 
retrovirally- induced immunosuppression of the lymphoproliferative response to 
mitogen stimulation. Examples include the transmembrane protein p15E of FeLV 
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(Mitani et al 1987) and murine leukaemia virus (MuLV) (Cianciolo et al 1990), and 
also Mason -Pfizer monkey virus (MPMV) (Blaise et al 2001). Furthermore 
immunosuppression can be selective for specific mitogens. Two parallel studies in 
1981 by Warner el al and Fleisher et al examined human T cell proliferation and B 
cell immunoglobulin (Ig) synthesis following ConA stimulation. It was revealed that 
a subset of cells differentiated into suppressor cells that synthesised and secreted 
soluble factors that not only inhibited cell -cell interactions, but also negatively 
modulated cellular function and humoral immune responses. The first factor, human 
soluble immune suppressor supernatant (SISS) was either produced directly by 
adherent cells or required adherent cell involvement. It was demonstrated that this 
factor inhibited mitogen and antigen -stimulated T cell proliferation (SISS -T). 
Competitive binding assays demonstrated that SISS -T binds to receptors on the 
surface ofT cells that are also recognised by inhibitory lectins such as wheat germ 
agglutinin (WGA), suggesting that SISS -T appeared to be an endogenous lectin -like 
soluble suppressor induced by ConA stimulation. Furthermore it was demonstrated 
that the inhibitory mechanism of SISS -T did not involve cell death. The second 
factor identified was SISS -B, found to inhibit B cell immunoglobulin production and 
was produced by T cells. Characteristic differences were identified between the two 
soluble suppressors, for example the ability to block SISS -T activity with N- acetyl- 
D- glucosamine, which did not affect SISS -B; whereas the addition of L- rhamnose 
did result in blocking SISS -B. Therefore the effect of ConA mitogenicity in the 
human system has been shown to synthesis two diverse soluble factors, with distinct 
cell surface receptors, which negatively modulate both the cell -mediated and 
humoral responses. Perhaps, if analogous suppressors are produced in the ovine 
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system, the presence of JSRV may modify their synthesis and secretion resulting in 
immunosuppression and the reduced lymphproliferative response to ConA 
stimulation. 
Viral modification of post -recognition events, such as transport mechanisms 
and the intracellular pathways utilized during mitogenesis, have been studied in a 
range of systems where retroviral proteins have been found to disrupt several signal 
transduction pathways. For example, the Arg -Arg amino acid residues comprising 
the N- terminal of the synthetic peptide CKS -17 and the homologous transmembrane 
peptide derived from HIV -gp41 are involved in the increased production of cAMP 
(Haraguichi et al 1995). Elevated cAMP levels, inhibition of protein kinase C (PKC) 
activity and influx of intracellular Cat+ ions suppresses activation of PKC- dependent 
lymphocytes (Ruegg et al 1991). The PKC- dependent pathway is utilised by 
activated TH1 cells for the production of IL -2, whereas the TH 2 signal transduction 
mechanism is PKC- independent for the production of cytokines such as IL -4 and cell 
proliferation (Tamura et al 1993). The glycoprotein gp120 of HIV -1 suppresses 
PHA -induced stimulation by inhibiting signal transduction through the T cell 
receptors and CD3 complex (TcR/CD3) (Cefai et al 1990). This, in conjunction with 
the larger regulatory complex involving tyrosine kinases and phosphatases, results in 
the reduced responses to PHA stimulation (Mustelin and Altman 1991, Haugan et al 
1992). Despite strong evidence of the immunosuppressive potential of HIV- gp120, 
there is little indication of such activities for SU- proteins from other retroviruses, 
thus far. Although these specific mechanisms may not relate directly to JSRV, viral 
modification of post- recognition events utilised during mitogenesis may be involved. 
Recent studies have identified that within the transmembrane subunit of the JSRV 
230 
envelope, the cytoplasmic moiety is sufficient for the transformation of NIH -3T3 
cells. Furthermore phosphorylation of protein kinase B is detected in all JSRV- 
transformed cells, indicating that expression of the JSRV envelope results in 
activation of the phosphatidylinositol 3- kinase (PI -3K) cellular signalling pathway 
(Palmarini et al 2001). This pathway, induced by the phosphorylation of protein 
kinase B by PI -3K is known to inhibit apoptotic mechanisms and is essential for the 
transition from G I -to-S-phase during the lymphoproliferative response to several 
mitogens (Roche et al 1999). Signal transduction and regulatory mechanisms may be 
influential, not only in contributing to the neoplastic process but also in determining 
the altered cellular immune response of JSRV- infected sheep. 
6.4 Evasion of the immune system 
As many viruses use survival strategies to evade immune detection, it should 
be considered that JSRV may also utilize a method to subvert exposure to the 
immune system. Many studies to identify virus survival mechanisms have examined 
the methods employed by the large DNA viruses, which carry a large complement of 
specialised genes that are not found in retroviruses. Notwithstanding, this provides an 
insight into the multitude of evasion tactics used. To be recognised by the immune 
system viral antigens must be presented, in conjunction with major 
histocompatability complex (MHC) on the cell surface, (the process of antigen 
presentation by infected cells expressing MHC class I and class II is described in 
Chapter 1, section 1.3.4). Consequently many survival strategies have evolved which 
prevent antigen presentation on the cell surface. The simplest method is failure of the 
viral protein to be degraded by the proteosomes. This is the mechanism, identified by 
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Levitskaya et al (1995), utilized by Epstein -Barr virus (EBV), where the protein 
EBNA -1 from EBV- infected B cells is not processed by the proteosomes because its 
amino acid structure contains Gly -Ala repeats, which cannot be processed by the 
proteolytic enzymes. If a protein is processed to create small peptides then 
interference with peptide uptake from the cytosol by the TAP proteins inhibits 
transportation to the MHC molecule. Herpes simplex virus (HSV) expresses an 
immediate early protein ICP47, which on binding to TAP prevents the translocation 
of the peptide to the ER (Hill et al 1995). If MHC can be prevented from reaching 
the cell surface then antigen presentation cannot occur. Accordingly there are many 
evasion techniques to retain MHC within the cell. MHC can be retained in the ER, a 
strategy adopted by certain strains of adenovirus, the viral proteins having a high 
affinity for MHC and also the ability to hold the protein -protein complex within the 
ER by the presence of an ER retention signal in the cytoplasmic tail of the 
adenovirus protein (Jackson et al 1990, Cox et al 1991). Furthermore an adenovirus 
coat protein, on entry into the cis -Golgi mediates retrograde transportation back into 
the ER (Jackson et al 1993). If an antigen -MHC class I complex should form it 
requires to travel through the ER and Golgi apparatus to reach the surface of the cell. 
The murine cytomagalovirus ( MuCMV) m152 protein retains the MHC /antigen 
trimolecular complex in the ER -Golgi intermediate compartment (Del Val et al 1989, 
Ziegler et al 1997), whereas human cytomegalovirus (HuCMV) encodes an ER 
resident glycoprotein that relocates the newly synthesised MHC class I molecule to 
the cytosol where it is subjected to proteolysis (Wiertzet al 1996a, 1996b). It has 
been demonstrated that cells devoid of, or expressing low levels of MHC class I are 
susceptible to destruction by natural killer (NK) cells (Ljunggren and Karre 1990). 
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Therefore, in order avoid NK cell detection HCMV has extra open reading frames 
m144 and UL18, which encode proteins homologous to MHC class I proteins. 
Expression of these viral proteins mimic MHC class I expression and subvert NK 
cell mediated lysis (Reyburn et al 1997). 
Other methods of evading immune detection have evolved with viral 
production of proteins, which mimic immunomodulatory molecules. For example 
HIV -type I, EBV and adenoviruses inhibit activation of the protein kinase pathway 
by producing small RNAs that bind to the protein kinase receptor (PKR) ( Imani and 
Jacobs 1988, Mathews and Shenk 1991, Levitskayaet al 1995). Vaccinia virus also 
produces a soluble protein, which is a pseudo- substrate for PKR, inhibiting 
functional activation and furthermore produces a soluble protein that binds the pro - 
inflammatory cytokine IL-1f3 (Akkaraju et al 1989). Several viruses produce soluble 
molecules homologous to cytokine receptors, which intercede and prevent them from 
reaching their target cells. Herpesvirussaimiri encodes a molecule similar to the 
human IL -8 receptor, therefore inhibiting the activity of the chemoattractant 
(Albrecht et al 1992). IL -6 can be bound by a protein from hepatitis B virus (Chisari 
and Ferrari 1995), and EBV encodes a homologue of IL -10, which inhibits IFN-y 
(Moore et al 1990). Adenovirus uses a different strategy by encoding three proteins, 
which inhibit TNF induced lysis of the infected cell (Gooding et al 1988). There is 
no evidence thus far to suggest that JSRV evades immune detection by subversion as 
no accessory proteins are encoded, however the product ofORF X remains to be 
identified. Further investigation of the relationship between JSRV and the type II 
pneumocytes, which themselves have immunomodulatory functions, may identify 
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virus induced alterations in, for example MHC class I or class II expression or a 
cytokine balance within the lung that would be beneficial to JSRV survival. 
6.5 Future Work 
The mechanisms of mitogen mitogenicity: Further research is required to determine 
the mechanism(s) of ConA and NPA mitogenicity for sheep lymphocytes. It should 
be determined if NPA mitogenicity is induced via the mannose pathway and /or 
alternative signal transduction pathways that may be utilised in the responses from 
neonatal, control and older JSRV- infected lambs. The data generated may provide an 
explanation for the altered cellular response to mannose inhibition of NPA 
mitogenicity detected in the JSRV- infected lambs. An investigation of interactions 
between the lectins and the lymphocytes, at the cell surface and intracellularly should 
be performed to elucidate the altered cellular response to ConA stimulation during 
JSRV infection. 
As IFN -y was the only cytokine measured during this study, other factors 
should be monitored in the blood and also cytokine release during ConA and NPA 
stimulation, for example IFN -y, GM -CSF, IL -2, IL -4 or IL -I0 to determine the type 
of effector response induced, and identify any cytokine alterations detected during 
JSRV infection. Studies to determine if ConA and NPA induce the synthesis of ovine 
suppressor factors, which may be altered by the presence of JSRV, should be 
included. 
The influence of antigen presentation: Due to insufficient time, and the availability 
of lambs only in the spring and autumn months, it was not possible to extend the 
findings of this study. Therefore, this work should be expanded to fully investigate 
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the requirement for antigen presentation in the mitogenicity of ConA and NPA. 
Studies of the direct physical association of antigen presenting cells on the 
lymphoproliferative response, and any involvement of soluble mediators should be 
established to analyse the role of antigen presenting cells in instigating mitogenicity. 
Furthermore, the requirement for accessory cells in correlation with the demonstrated 
age -related mitogenicity of NPA should be considered. The lymphoproliferative 
responses were only tested in uninfected control lambs during this study. Therefore 
this should be extended to compare uninfected and JSRV-infected animals. 
The development of anti -viral T cell responses is dependent on interactions 
between antigen presenting cells and naïve T cells. Although dendritic cells (DC) are 
regarded as the professional antigen presenting cells (APC), the important role of 
monocytes /macrophages as APC should be examined in JSRV infection. As the 
disseminated infection identified with JSRV, demonstrated that the highest proviral 
load was found in the monocyte /macrophages lineage (Holland et al 1999) studies 
should be undertaken to determine any association with antigen presentation in the 
altered cellular responses detected during JSRV infection. For example, it has been 
reported that HCMV infection of macrophages elicits changes in the cell, such as 
disruption of the microtubule network resulting in vacuole formation, and a 
downregulation of MHC class II molecules on the cell surface, which may support 
intracellular persistence and immune evasion. Furthermore HCMV infection 
downregulates gene expression of the lipopolysaccharide (LPS) receptor CD14, 
presumably increasing susceptibility to concurrent bacterial infections in the lung 
(Hengal et al 1998). Further investigation into the effects of JSRV on dendritic cells 
(DC) is required also to ascertain if the virus can infect the professional antigen 
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presenting cells, and if so, determine whether JSRV induces alterations in their 
effector functions that could interfere with the development of specific immune 
responses. Studies of DNA and RNA viruses have demonstrated that the DC are 
potent inducers of CTL responses and stimulate the proliferation of naïve T cells and 
the secretion of cytokines. It would be adventagous for a virus to infect and impair 
the functions of DC. It has been demonstrated that measles virus (Schneider - 
Schaulies and ter Meulen 1999, Server- Delpratet al 2000), HIV (Rubbert et al 
1998) and HSV -1 (Kruse et al 2000) infect DCs. A study by Sevilla et al (2000) 
demonstrated that the receptor on DC and the interaction with lymphocytic 
choriomeningitis virus (LCMV) virus was a crucial stage in LCMV- induced 
immunosuppression and viral persistance. 
Measurement of cellular and antibody responses At the present time adult sheep 
have been immunised with a recombinant JSRV -capsid antigen (CA) /GST construct 
and boosted with recombinant JSRV- CA/ßgal and JSRV- CA /GST. A programme to 
measure responses and detect JSRV -specific 
antibodies in the peripheral blood is currently underway (Dr. Renate van der Molen, 
personal communication). 
Immunohistochemical analysis of the OPA lung and lymph nodes: Further research 
is required to extend the preliminary findings of this study.In situ phenotyping of a 
larger number of samples should be undertaken, with serial sections of tumour and 
non -neoplastic lung phenotyped and quantitatively analysed. Comparative analysis of 
tissues from lambs and adult OPA cases would provide information regarding any 
differences in tumour infiltration arising from experimental and natural JSRV 
infection and also age -related differences in the lung. If alterations induced by JSRV 
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infection are not detectable in the peripheral blood then in situ assays to detect and 
measure intracellular cytokine expression and soluble mediators need to be 
developed. Unfortunately due to time restrictions immunochemical analysis of the 
pulmonary lymph nodes was not possible. Comparative in situphenotyping of the 
mediastinal and bronchial lymph nodes from OPA and control lambs should be 
performed, again using serial sections to identify any alterations in the profiles of 
immune cells and cellular morphology. Moreover the lymph nodes from 
experimentally infected lambs and adult OPA sheep should be compared to 
determine any age- related differences. Several factors such as viral persistence and 
age at infection are important in determining the mechanisms of virus -induced 
immunosuppression (Tishon et al 1993, Ahmed and Oldstone 1988, Evanset al 
1994). 
Investigation of a possible mechanism to transport JSRV to the lower respiratory 
tract: During experimental infection JSRV is administered intratracheally, resulting 
in direct inoculation of the lower respiratory tract by a high dose of virus. In contrast 
during naturally transmitted JSRV infection the suspected mode of transmission is 
inhalation of aerosols from infected flock mates. Therefore as JSRV dissemination 
was shown to be an early event preceding tumorigenesis (Holland et al 1 999), studies 
should be extended to examine the lymphoid tissues in the upper respiratory tract of 
naturally infected sheep. As JSRV has some homology with MMTV it would be 
interesting to determine if JSRV utilizes a viral transport mechanism similar to 
MMTV to translocate the virus from the upper respiratory tract to the 
bronchioalveolar region of the lung. Although there has been no evidence to suggest 
that JSRV encodes a superantigen, the identity of the viral product encoded by the 
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extra open reading frame ORF -Xis still unknown. A link between ORF-X and JSRV 
dissemination may be provided by the recent evidence of dissemination during 
caprine nasal adenocarcinoma virus (CNAV) infection, which possesses the extra 
open reading frame ORF -X. Contrastingly no dissemination was evident during ovine 
nasal adenocarcinoma virus (CNAV) infection, which does not have the ORF-X (C. 
Cousins, A Ortin personal communications). This is not to suggest thatORF -X 
encodes a superantigen, but possibly a product involved in viral infection of the 
lymphatic system. For example, the concept that the herpes virus EBV is transmitted 
in saliva and establishes a latent infection in circulating B cells. However viral DNA 
has been detected in epithelial cells in oral hairy leukoplakia (OHL) and also in 
nasopharyngeal carcinoma suggesting the possible transfer of virus from B cells to 
epithelial cells. There is no evidence that EBV encodes a superantigen to instigate 
translocation. However, the upper respiratory tract contains aggregates of lymphoid 
tissues, including the nasopharyngeal lymph nodes and the pharyngeal tonsils. The 
tonsils are composed of two different forms of tonsillar tissue, the surface, stratified 
squamous epithelium, invaginated into the underlying connective tissue to form 
crypts. The reticular epithelium within the crypts is loosely formed with disruptions, 
through which lymphoid cells infiltrate to form lymphoepithelium (Faulkner et al 
2000). The crypts therefore provide a first line of defence against infection of the 
respiratory tract. The mechanism postulated by Faulkner et al (2000) for EBV 
crossing the epithelial barrier is by transcytosis, an infection independent vesicular 
transport system that has also been demonstrated in vitro for HIV (Bomsel 1997). It 
has also been shown that HIV exploits M cells as a transport mechanism from the 
crypt lumen to the lymphoid tissues, for subsequent infection of macrophages and 
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CD4 T cells (Neutra et al 1996). Stahl- Henning et al (1999) demonstrated the 
presence of infected lymphoepithelium in the tonsils of macaques inoculated with 
simian immunodeficiency virus (SIV). Furthermore the spread of SIV to other 
lymphoid tissues and peripheral blood was subsequently identified. As JSRV 
dissemination is detected early during infection a possible mechanism of viral 
transportation to the lung should be investigated. 
NPA mitogenicity for human lymphocytes: This preliminary study has provided a 
foundation for further research into the mitogenicity of NPA for human subjects. The 
lymphoproliferative responses of other age groups, with increased sample numbers, 
should be analysed to determine the mitogenicity of NPA for all generations. The 
identification of human lymphocyte subsets responding to NPA, the requirement for 
antigen presentation, cytokine expression and mannose inhibition of NPA 
mitogenicity (as performed in this project, and detailed in this section, for sheep) 
should be investigated in humans. Once the mechanisms of NPA mitogenicity and 
effects on lymphocytes from healthy subjects are fully established, then any 
alterations detected during infection could be investigated. NPA therefore, as an 
agent in the fight against retrovirus infection, as detailed in the Introduction to 
Chapter 4, may have potential parallel applications for research into human and 
sheep bronchioloalveolar carcinoma. 
6.6 Concluding statement 
This study has shown overall, with the notable exception of JSRV induced 
alterations in cellular function, during experimental JSRV infection and 
tumorigenesis that there was no evidence, systemically, to distinguish infected from 
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uninfected lambs. The CD4+ lymphocytopaenia and neutrophilia detected in the 
blood of adult sheep during the terminal stages of OPA as reported by Rosadio and 
Sharp (1992) and Holland et al (1999) were also identified in this study, confirming 
that these events occur post -neoplasia and are therefore confined to the terminal 
stages of OPA. It would appear from the existing evidence and from the data 
generated during this project that JSRV is relatively immunologically silent. 
Therefore, future studies as described and investigation into possible modes of 
infection, such as vertical transmission and the detection of virus in the milk are 
crucial in elucidating the lack of immunological response Moreover the development 
of immunological assays to examine the interactions between the virus and the host 
cells, systemically, in the lymph nodes and in the microenvironment in the lung are 
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Detection of Immune System Cells in Paraffin 
Wax- embedded Ovine Tissues 
L. González *, I. Anderson, D. Deane, C. Summers and D. Buxton 
Moredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik, Midlothian EH26 OPZ,' Uh 
Summary 
This report describes a method (fixation, paraffin wax -embedding and immunolabelling) for the de- 
monstration of several immune system cell epitopes (CD1, CD2, CD4, CD8, CD14, CD21, CD45R, WC- 
1, 28 kDa surface antigen, immunoglobulins and MHC II antigens) in ovine lymph nodes collected at 
necropsy. Cell surface epitopes considered to be sensitive to processing methods were successfully 
demonstrated by a procedure that included the use of a non -aldehyde- containing, zinc salts -based fixative, 
coupled with a sensitive system of immunolabelling. This novel method had the advantage of avoiding 
antigen -retrieval steps and of providing consistently good morphological definition. 
© 2001 Harcourt Publishers Ltd 
Introduction 
Studies on the pathogenesis of animal diseases often 
require the demonstration of pathogen- specific or 
host -cell -specific antigens. While alternative 
methods such as fluorescence -activated cell sorting 
FAGS) or enzyme -linked immunosorbent assay 
ELISA) are available to detect and quantify such 
antigens in tissue samples, immunohistochemistry 
IHC) is the method of choice for their "in- situ" 
(demonstration. Unlike the other methods, IHC 
¡enables a detailed assessment to be made of the 
tissue distribution of antigens and of the spatial 
relationship between the cells that express them 
and other cells and tissue structures. A prerequisite, 
however, is good preservation of tissue morphology 
and antigenicity. 
The use of conventional aldehyde -based fixatives 
(formaldehyde and paraformaldehyde, and their 
derivatives), and to a lesser extent alcohol -based 
fixatives, results in good morphology but poor 
antigen preservation. Aldehyde -based fixatives 
establish cross -linking bridges between the cells, 
*Correspondence to: L. González, Veterinary Laboratories Agency 
('LA- Lasswade), Pentlands Science Park, Bush Loan, Penicuik, 
Midlothian EH26 OPZ, UK. 
0021- 9975/01/050041 +07 $12.00 
and these bridges often mask the cell surface an- 
tigens (Fox et al., 1985), which complicates the 
identification of lymphocytes and other cells of the 
immune system. To overcome this difficulty, several 
approaches have been adopted, including a search 
for antibodies that react with processing- resistant 
epitopes (Gerdes et al., 1992), as well as modification 
of the fixation, processing or embedding procedures 
(Beckstead, 1985; Sato et al., 1986), notably the 
addition of zinc compounds to aldehyde fixatives 
(Mugnaini and Dahl, 1983; Tome et al., 1990). The 
use of post -embedding antigen retrieval steps has 
also been explored (Cattoretti and Suurmeijer, 
1995; Miller et al., 1995), as has pre -embedding 
labelling of antigen in thick sections obtained with 
a vibrating microtome (Totterdell et al., 1992). 
Although most of these procedures have resulted 
in an improvement of antigen survival, none has 
been widely adopted, perhaps because they require 
complicated changes to normal practice or work 
only in specific instances and are therefore not 
broadly applicable. 
Beckstead (1994) reported a procedure for the 
detection of fixation -sensitive antigens in paraffin 
wax -embedded human tissues, based on the use of 
a non -aldehyde fixative containing zinc salts (zinc 
© 2001 Harcourt Publishers Ltd 
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Table 1 
Immunohistochemical demonstration of ovine cell surface antigens by Mabs after ZSF fixation and para 
wax- embedding of lymph node tissues 
AIaG Source* Dilution Antigen Reactivity Reference 
17D Basel 5000 AF CD4 T- helper cells Maddox et al. (1985) 
SBU -T8t Melbourne 100 SN CD8 T- cytotoxic cells Maddox et al. (1985) 
36F Basel 20 000 AF CD2 a -ß T cells Mackay et al. (1988) ir 
CC 15 Compton 100 000 AF WC -1 r -S T cells Howard et al. (1989) 
CC21 Compton 50 000 AF CD21 FDCs Naessens & Howard (1991) 
Mature B cells 
CC20 Compton 10 000 AF CD I b Dendritic cells Howard et al. (1993) 
SBU cII+ Melbourne 256 000 AF MHCII B cells Puri et al. (1987) 
Activated T cells 
Macrophages 
Dendritic cells 
VPM65 Edinburgh 5000 AF CD 14 Monocytes Gupta et al. (1996) 
Macrophages 
73B Basel 50 000 AF CD45RA B cells 
T -cell subset 
Mackay et al. (1990) 
w 
VPM8 Edinburgh 200 SN Ig LC B cells Yirrell et al. (1991) 
VPM30 Edinburgh 800 SN 28 kD B cells Naessens & Howard (1991) 
Activated T cells 
* Basel: Basel Institute for Immunology, Basel, Switzerland. Compton: BBSRC Institute for Animal Health. Compton Laboratory. Newbury, 
Berks, UK. Edinburgh: Dept Veterinary Pathology, University of Edinburgh, Edinburgh. UK. Melbourne: University of Melbourne, School 
of Veterinary Science, Parkville, Victoria, Australia. 
CD, cluster designation; WC -1, workshop cluster 1; FDCs, follicular dendritic cells; Ig LC. immunoglobulin light chain: MHCII, major 
histocompatibility complex class II; AF, Mabs from ascitic fluid; SN, Mabs from tissue culture supernate. 
t Clone 38 -65. 
$ Clone 49.1. 
salts fixative; ZSF). The present report describes on treated glass slides (Superfrost Plus; Menzel - 
the adaptation of this procedure for the de- Glaser, Germany) and dried overnight at 37 °C. 
monstration of lymphocyte and other immune sys- 
tem cell markers in ovine tissues. 
Materials and Methods 
Tissue Sampling and Processing 
Caudal, mediastinal, tracheobronchial and pop - 
liteal lymph nodes were obtained at necropsy from 
10 sheep. Tissue slices 5 -6 mm thick were im- 
mediately placed in a freshly prepared ZSF solution 
(0.1 M Tris base buffer with Ca acetate 0.05% 
[pH 7 -7.4], containing Zn acetate 0.5% and Zn 
chloride 0.5%). The slices were fixed for 6 -8 h 
at room temperature (RT) and then trimmed to 
2 -3 mm thickness before further fixation in ZSF 
for 24 -72 h at RT. Tissue slices were then placed 
in plastic cassettes and transferred to 70% ethanol 
30 min before processing to paraffin -wax by an 
automated procedure (80% ethanol, 45 min; 95% 
ethanol, 75 min; 99% ethanol, 3 x 75 min; iso- 
propanol, 2 x 90 min; isopropanol /xylene [1:1 v:v], 
90 min; xylene, 2 x 90 min; medium temperature 
melting [56 -58 °C] paraffin -wax, 2 x 105 min). Sec- 
tions 5 µm thick were cut on a microtome, mounted 
Fig. 
Immunohistochemistry (IHC) 
Tissue sections were dewaxed and hydrated by 
conventional methods. Immunohistochemical 
labelling was performed manually with the Se- , sou 
quenza slide rack and coverplate system (Shandon, fou 
Runcorn, UK). Antibody binding was detected by 
the EnVision Plus HRP System (Dako, Ely, UK) 
which included two initial blocking steps, namely. 
(1) quenching of endogenous peroxidase activity 
with 0.03% hydrogen peroxide (included in the 
kit), for 5 min at RT), and (2) removal of non- 
specific tissue antigens by the application of 25% 
normal goat serum for 30 min at RT. 
Monoclonal antibodies (Mabs) to several cluster 
designation (CD) or cell surface epitopes, at di- 
lutions ranging from 1 in 25 to 1 in 800 for cell 
culture supernates and 1 in 1000 to 1 in 256 000 
for ascitic fluids, were applied to sections. Two 
different incubation times (30 min and overnight) 
and temperatures (RT and 4 °C) were used. Details 
of the antigenic epitopes sought, the cell subsets 




























'C. Fig. 1. Immunolabelling of CD4 epitopes by Mab 17D re- 
vealing grouped cells in the paracortex of the node 
and scattered cells inside the follicle. IHC and haema- 
toxylin counterstain. x 164. 
d by 
mical 
se- , source are given in Table 1. Other Mabs were also 
idon, found to label the same epitopes, but to a lesser 

















The secondary antibody (peroxidase -labelled 
polymer conjugated to goat anti -mouse immuno- 
globulins, included in the EnVision system kit) was 
applied for 30 min at RT to the tissue sections. 
Conjugate binding was detected by adding the 
substrate chromogen (3,3'- diaminobenzidine; 
DAB) and colour was allowed to develop for 
7 -8 min. Finally, tissue sections were washed with 
distilled water, removed from the assembly, coun- 
ter- stained with haematoxylin, rinsed, dehydrated 
and mounted. Tris- buffered saline (TBS, 0.05 M 
Tris HC1, 0.15 M NaC1, pH 7.2 -7.6) was used to 
wash tissue sections between each stage of the 
labelling procedure and to prepare normal goat 
serum and antibody dilutions. Omission of the 
Fig. 2. Immunolabelling of CD8 epitopes with Mab SBU -T8 
showing large groups of small lymphocytes in the 
paracortex of the lymph node. IHC and haematoxylin 
counterstain. x 164. 
primary antibody was used to provide a negative 
control. 
Results 
The fixative and procedures (fixation, embedding 
and immunohistochemical) described above pro- 
vided good preservation of histological detail. They 
also facilitated precise definition of the distribution 
of the various epitopes, including some regarded 
as sensitive to fixation or wax processing, or both. 
Optimal immunolabelling was produced by in- 
cubation with the primary antibody overnight at 
4 °C. 
CD4 epitopes, detected with Mab 17D, were 
expressed by groups of small, round cells located 
in the paracortex of the lymph nodes immediately 
adjacent to the periphery of the follicles, as well as 
by some cells scattered inside the follicles (Fig. 1). 
Mab SBU -T8 labelled the CD8 epitopes on large 
44 L. González et al. 
Fig. 3. WC -1 epitope labelling by Mab CC15. yS -T cells 
appear along the subcapsular sinus and scattered in 
the paracortex. IHC and haematoxylin counterstain. 
x 164. 
populations of small round cells scattered or 
grouped in the paracortex of the nodes, whereas 
labelling was almost completely absent from the 
follicles (Fig. 2). CD2 epitopes were demonstrated 
with Mab 36F on large populations of grouped 
cells in the paracortex of the nodes and in a 
few scattered cells in the follicles. Their location 
corresponded to that of CD4+ and CD8+ cells, 
taken together. Immunolabelling of WC -1 
molecules by Mab CC15 was present on scattered, 
relatively numerous, small round cells, mainly lin- 
ing the subcapsular and trabecular sinuses but also 
scattered in the paracortex (Fig. 3). 
Strong labelling of CD21 epitopes was present 
in the light zone of the germinal centres of lymphoid 
follicles when Mab CC21 was employed. Cells 
labelled by this antibody had a characteristic re- 
ticular or dendritic shape (Fig. 4). Mab CC20 
labelled CD 1 b epitopes expressed by stellate cells, 
either scattered or in small groups, in the proximity 
Fig. 4. CD21- positive follicular dendritic cells labelled with 
Mab CC21 in the germinal centre of the follicle. Note 
reticular pattern of labelling and restriction to the light 
zone. IHC and haematoxylin counterstain. x 164. 
of the lymphoid follicles and often in the sub - 
capsular sinus area (Fig. 5). MHCII antigens, idemi 
tified with Mab SBU -cII, were demonstrated on 
large populations of small round cells within the 
cortical follicles and in the paracortex, as well as 
on scattered small cells in the medullary cords. At 
this last site, large cells with abundant cytoplasm 
lining the trabeculae were also labelled. The label- 
ling was not as obviously localized on the cell 
membrane as with other markers, and had the 
appearance of being more intercellular (Fig. 6). 
Labelling of CD 14 molecules by Mab VPM65 
defined a population of large cells, with abundant 
cytoplasm and pale ovoid nuclei, that appeared 
either as scattered individual cells or as linear 
groups of cells in the medullary cords (Fig. 7). 
There was no labelling in the lymphoid follicles. 
A restricted isoform of the common leucocyte 
antigen (CD45RA, 220 kDa) was identified with 
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ed wit Fig. S. CD I b- positive cells revealed by Mab CC20. The cells 
le. Note have a stellate or dendritic shape and are located in 
the light the subcapsular paracortex. IHC and haematoxylin 





















in the cortex of the lymph nodes, especially in the 
follicles but also in the paracortex. Mab VPM8, 
specific for the light chain of ovine immuno- 
globulins, resulted in strong cytoplasmic labelling 
of small scattered cells with abundant cytoplasm, 
located in the medullary cords and sinuses of the 
lymph node (Fig. 8), and also in light, cell -mem- 
brane labelling of some macrophage -like cells in 
the medullary cords. Labelling of a 28 kDa surface 
antigen with Mab VPM30 occurred on scattered 
cells with morphological and positional char- 
acteristics resembling those detected with Mab 
VPM8; it also occurred on small round cells 
scattered in the paracortex. With both VPM8 and 
VPM30 Mabs, there was an absence of labelled 
cells in the germinal centres of follicles. 
Discussion 
Cryo -preservation of tissue samples may provide 
optimal antigen preservation, but the preservation 
Fig. 6. Immunolabelling of MHC II antigens by Mab 49.1. 
Antigen is expressed in a slightly diffuse pattern by 
numerous cells in the paracortex of the node. IHC 
and haematoxylin counterstain. x 328. 
of morphology is often sub -optimal, making precise 
location of the antigen- expressing cells within the 
tissue difficult or impossible. Light fixation of tissue 
samples (e.g., with paraformaldehyde or caco- 
dylate- formalin) before cryo -preservation has been 
employed with good results, but in general, these 
methods have certain drawbacks, such as elaborate 
procedures for tissue handling and preliminary 
processing, and the need for ample storage space 
in appropriate freezers. It may also be difficult to 
produce cryostat sections of consistent quality and 
the handling of fresh tissues may pose biohazard 
problems. When aldehyde -fixation and paraffin 
wax -embedding are used, it is often necessary to 
apply antigen retrieval procedures before im- 
munolabelling. Unfortunately, however, there is no 
"universal" antigen -retrieval procedure, but rather 
a wide choice of methods that have to be tried and 
if necessary adapted to suit the type of tissue or 
type of antigen. These methods are often laborious 
L. González et al. 
® 1 m 
x a 
+ p g®e ANA 
Oaf 0± 
%=Af, 
Ó V ; .*° ®z- ® 0!e?6 (áa d{r 47t 
n,¢ . °s4® el 
3! q ;.®, 4 ° ,®®` VPM ,,aa :o ® ; tabs 
b 
, ® Q ts 
,®®®ay `,'`'a+' I ® p dx4.,,m0,0 iea Xo and . 
, r 1a, ®p eaffi s in ot. ® .. °` > s *` , á;, a' m w,v ,, a A a, (omn ,°`m' , 4rs ® aó Th ®t íB \:.: a e y, as caOD ® ® ®},: i9çF. S ti °ra )tore, . ® wm,® &a W® r ever, ' 
©m 
, ®, m nm ®'é o, qa',. ¿® w ® eí as pa 0,.. 
4®,,1,` ® -®i  lin ; á : ro .o o Ip g . ,,. m  e a j , t nons ®6 
®ió.a.r ' i' good 
,- K . 7 ¢1'" ® ^9 comF °,,asstd t and ( 
®"+®D"`'°Ï. ,a,perm 4 mi . . * : o,a.r®%®e .ry® . The 
6r QD 
:'.',*i, 
f.,!***6' eeF a, ., 9 . 9.1 
ag 4i , 1(f1 ! sc¢ a',r, 0 . .ó°: duo t®k 
g 
















'O. m, d 04 
s, flik 
A = ó 
Fig. 7. Immunohistochemical demonstration of macrophages 
in the medullary sinuses of the lymph node. Mab 
VPM65 labels CD14- expressing cells, which have 
abundant cytoplasm and large pale nuclei. IHC and 
haematoxylin counterstain. x 328. 
and may require specialized equipment; they may 
also damage the tissue morphology (Cattoretti and 
Suurmeijer, 1995). 
As far as the authors are aware, this is the first 
report of the use of ZSF, originally described by 
Beckstead (1994), for the preservation of ovine 
tissues. This method of fixation, followed by a 
routine paraffin wax -embedding procedure 
coupled with a highly sensitive method of im- 
munolabelling, has made possible the de- 
monstration of cell surface epitopes considered to 
be processing -sensitive, e.g., CD1, CD4 and CD8 
(Beckstead, 1994). Preliminary data (not shown) of 
the performance of ZSF and standard fixatives, 
(e.g., formaldehyde and paraformaldehyde) con- 
firmed this point and also indicated that the use of 
ZSF improved the immunolabelling of other more 
resistant epitopes, such as WC -1, MHC II, CD14 
and CD21. 
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Fig. 8. Detection of immunoglobulins with Mab VPM8. Note than] 
the strong labelling in the cytoplasm of cells resembling assist 
plasmacytes located in the medullary cords. IHC and Scho 
haematoxylin counterstain. x 328. Nelis 
raid 
help 
The results, based on immunolabelling and on 
the morphology, number and location of cells. 
accorded with previously reported reactivity or 
cell- specificity of the antigens under study (see 
references in Table 1). In this way, CD1, CD4 and 
CD8 reactivity would appear to represent dendritic 
cells, T- helper lymphocytes and T- cytotoxic lym- 
phocytes, respectively. Moreover, detection of 
CD2, WC -1 and CD2 1 reactivity would appear to 
represent ct-(3 T cells, y -8 T cells and follicular 
dendritic cells, respectively. Some B cells might 
also show CD2 1 reactivity. CD45RA- positive cells 
would represent B cells and a subset of T cells. A 
wide range of cells within the lymph node (B cells. 
T cells, dendritic cells and macrophages) would 
express MHCII antigens. CD14-positive cells 
would correspond to macrophages (in this study, 
macrophages in the medullary cords, but not ting- 
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ells would be regarded as plasma cells and oc- 
asionally macrophages, and 28 kDa- positive cells 
could be regarded as plasma cells and occasionally 
° 1 cells. The failure to label B cells in the germinal 
0icentres of lymphoid follicles with VPM8 and 
kVPIVI30 might be overcome by the use of other 
'4510 Jlabs. Thus, for example, Mabs VPM 13 (anti -IgM) 
"e/ nd 2F1 (anti -IgE) have produced good results 
in other similar studies (Stanley et al., personal 
communication). 
The ZSF is inexpensive, easy to prepare and 
store, and of low toxicity (Beckstead, 1994). How - 
ver, its major advantage is that it can be introduced 
el as part of a set of routine procedures (tissue sam- 
ling embedding in paraffin wax cutting of sec 
tles 
Ï.itg,Y 
ions and storing of blocks). In addition, ZSF gives 
good preservation of tissue morphology (almost 
comparable with that given by aldehyde fixatives) 
and does not require an antigen -retrieval step to 
permit adequate detection of cell surface epitopes. 
ÿ$,ßná The identification of such markers will aid in the 
¡1 elucidation and evaluation of disease- induced 
4 
pathological changes in animal tissues. 
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Onset and Distribution of Tissue PrP 
Accumulation in Scrapie -affected Suffolk Sheep 
as Demonstrated by Sequential Necropsies and 
Tonsillar Biopsies 
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I. Begara- McGorum* and L. González 
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Summary 
Tonsillar biopsies (single or multiple) or necropsies, or both, were performed on sheep taken from a Suffolk 
flock in which frequent cases of scrapie had occurred over a period of several years. Clinically affected 
sheep of the susceptible PrPAWAQ genotype had widespread disease -specific PrP accumulation in the central 
nervous system (CNS), lymphoreticular system and peripheral ganglia. In nine healthy PrPAQQAQ Suffolk 
sheep between 4 and 7 years of age, PrP could not be demonstrated post mortem in any of the lymphoreticular 
tissues, or in the peripheral ganglia or CNS. Tonsillar biopsies taken from animals of the resistant PrPARiAa 
and PrPAR /AQ genotypes at age 3, 8, 14, 20 or 26 months did not show PrP accumulation. Disease - 
specific PrP accumulation in tonsillar biopsies from PrP`'Q /AQ sheep was not seen in 20 animals aged 3 months, 
but was found in two of 10 animals at age 8 months and in eight of 10 animals at age 20 months. The 
numbers of PrP- positive tonsillar biopsies obtained from sheep previously biopsied on more than one occasion 
was greater than the number of positive tonsils obtained from other susceptible sheep of comparable ages. 
The earliest disease- specific PrP accumulation seen was in tingible body macrophages within germinal centres 
and only later was it detected in cells resembling follicular dendritic cells. Fourteen PrPAQ/AQ sheep examined 
post mortem at up to 17 months of age and which had not previously been biopsied or were biopsied only once 
had no CNS or tonsillar PrP accumulations. Two of these sheep subjected to necropsy at 14 months had PrP 
accumulation in lymphoreticular tissue, where it was confined to the mesenteric lymph nodes. In susceptible 
sheep, only low levels of immunohistochemically detectable PrP were present in a minority of follicles from 
tonsillar biopsies of young lambs, but by 14 months of age widespread PrP accumulation, affecting many or 
even all follicles, was present. Although clinical cases had widespread PrP accumulations in viscera, susceptible 
survivors had no such accumulations in tissues of the lymphoreticular system, peripheral nervous system or 
CNS, suggesting that some animals were not exposed to infection or were exposed to a non -infectious dose. 
Introduction 
Scrapie of sheep and goats is one of a group of 
slowly progressive neurological disorders known 
as the transmissible spongiform encephalopathies 
(TSEs), which are characterized by vacuolation of 
the central nervous system (CNS) and accumulation 
of an abnormal, partly protease- resistant form of 
0021-9975/01/050048 + 10 $35.00 
a host -coded cell surface sialoglycoprotein called 
prion protein (PrP') The detection of PrP ill 
the brains of animals with TSE is important for 
confirming clinical diagnosis. However, the re- 
cently determined linkage between variant Creutz- 
feldtJakob disease and bovine spongiform 
encephalopathy (Bruce et al., 1997) highlights the 
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Abstract 
Lectins from monocotyledonous plants such as Narcissus pseuclonarcissus (NPA) possess insecticidal properties and have the potential 
to increase pest resistance in transgenic crops. Therefore it is of interest to investigate the mitogenic properties of such lectins. 
Mononuclear cells purified from human umbilical cord and adult peripheral blood samples were stimulated with NPA and compared to 
phytohaemagglutinin as an example of a lectin from a dicotyledonous plant. Here we report that NPA is slightly mitogenic for adult 
human lymphocytes but mitogenicity is increased more than sevenfold for lymphocytes from umbilical cord blood. Similarly, NPA was 
found to be mitogenic for peripheral blood mononuclear cells (PBMC) from lambs and not adult sheep, supporting the age -related 
mitogenicity and indicating that further examination of the younger human population is warranted. © 2002 Published by Elsevier 
Science B.V. on behalf of the Federation of European Microbiological Societies. 
Keywords: Human lymphoproliferation; Mitogenicity; Narcissus pseudonarcissus lectin 
1. Introduction 
Plant lectins have been used as mitogens for several 
decades to evaluate immunocompetence. Most commer- 
cially available lectins are obtained from dicotyledonous 
plants, including phytohaemagglutin (PHA) from the red 
kidney bean, Phaseolus vulgaris. An increased interest in 
monocotyledonous lectins has developed following the dis- 
covery that some lectins of the super -family Amaryllida- 
ceae, such as snowdrop Galanthus nivalus (GNA) and daf- 
fodil Narcissus pseudonarcissus (NPA), possess insecticidal 
properties. Several prototype arable crop plants are now 
transgenic for GNA to enable preliminary assessment of 
their pest resistance [1,2]. Lectins have wide biological ac- 
tivity and concerns have been expressed about consump- 
tion of, or exposure to, crops transgenic for lectins. The 
few studies examining human subjects found GNA and 
NPA to be virtually non -mitogenic [3,4]. In one instance 
these preliminary reassuring observations were obtained 
with lymphocytes from adult donors, all over the age of 
* Corresponding author. Tel.: +44 (131) 445 5111; Fax: +44 (131) 445 
6111. E -mail address: sharm @mri.sari.ac.uk (J. Michael Sharp). 
0928- 8244/02/522.00 © 2002 Published by Elsevier Science B.V. on behalf 
PII:S0928- 8244(02)00271 -7 
60 [5]. But we now report that the mitogenicity of NPA is 
age -related, with the lymphoproliferative response of the 
peripheral blood mononuclear cells (PBMC) in umbilical 
cord blood higher than in adult blood. Similarly, NPA 
was found to be mitogenic for PBMC from lambs and 
not adult sheep, supporting the age -related mitogenicity 
and indicating that further examination of the younger 
human population is warranted. 
2. Materials and methods 
2.1. Human subjects 
In total, 12 human blood samples were collected, 7 um- 
bilical cord bloods obtained during routine caesarean sec- 
tions (kindly collected by Dr R. Hughes, Royal Infirmary 
of Edinburgh, following informed consent) and 5 volun- 
teer adults, ages ranging from 24 to 56 years. 
2.2. Sheep 
In total, PBMC from 74 blood samples were assayed 
and analysed in three groups: lambs aged 4 days -1 month 
of the Federation of European Microbiological Societies. 
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(Group A, n=37), 2-4 months (Group B, n=26), and 
adult sheep aged 1 -3 years (Group 3, n=11). All animals 
were from the Moredun Research Institute. 
2.3. Blood samples 
Human umbilical cord and adult venous blood samples 
were collected into sterile tubes containing 10 units pres- 
ervative free heparin per ml blood. The mononuclear cells 
were purified and adjusted to a final concentration of 106 
cells m1 -I in RPMI -1640 medium (Life Technologies Ltd) 
containing antibiotics and 10% autologous plasma (human 
samples) or 10% inactivated foetal calf serum (sheep sam- 
ples). 
2.4. Cell culture with lectins 













curve, of commercially purchased PHA (Sigma, Poole, 
Dorset, UK) and NPA (Vector Laboratories, Peterbor- 
ough, UK) were added to 106 PBMC ml -1. Control sam- 
ples (excluding lectin) were also prepared. All samples, at 
2 X 105 cells /well were dispensed, (human samples five rep- 
licates, sheep samples in triplicate) into 96 -well microtitre 
plates. The lymphocyte proliferation assays were per- 
formed in accordance with standard laboratory protocol 
[3] for a total of 96 h, with the addition of 0.7 .tCi ml -1 
[methyl- 3H]thymidine (specific activity 2.0 Ci/mmol, Amer - 
sham, Little Chalfont, Buckinghamshire, UK) for the final 
16 h. The cells were harvested and [3H]thymidine uptake 
measured as cpm. For each sample the mean cpm of the 
replicates was calculated and the control mean cpm sub- 
tracted: S.E.M. was determined. Two -tailed student t -test 
determined the level of significance between the human 
adult and umbilical cord mononuclear cells, and between 
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Fig. 1. In vitro lymphoproliferative response of PBMC to NPA (D) and PHA (0) stimulation. [3H]thymidine uptake, shown as cpm ±S.E.M. A; Human 
responses for umbilical cord blood (UCB) and adult blood. Comparison between the two groups was not statistically significant for PHA stimulation, 
but highly significant (P= 0.0004) for NPA. B: Ovine responses for group A lambs aged 4 days -I month, group B lambs aged 2-4 months and group 
C adult sheep aged l -3 years. Comparison between the two groups of lambs (A, B) and the adults (group C) were not statistically significant for PHA 
stimulation, but were significant for NPA, at P= 0.0005 for group A and P=0.04 for group B. 
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3. Results 
PHA was strongly mitogenic for lymphocytes of both 
human age groups (umbilical cord mononuclear cells 
mean cpm 65 058 ± 12 108 and adult PBMC 
76161 ± 13 770) and there was no statistically significant 
difference in these responses (Fig. 1A). In contrast, the 
proliferative response to NPA stimulation was signifi- 
cantly higher (P = 0.0004) with umbilical cord mononu- 
clear cells (mean cpm 11 322 ± 1549) compared to adult 
PBMC (mean cpm 1580 ±413) (Fig. 1A). 
In sheep, no statistically significant difference in the 
lymphocyte stimulation was found between the age groups 
in response to PHA (Fig. lB). Stimulation with NPA gave 
a mean cpm of 5154 ± 445 and 2203 ± 616 for groups A 
and B respectively, compared to 330 ± 128 for the adult 
group C (Fig. 1B). The statistical significance of these 
results, in comparison to the adult group C, was calculated 
at P = 0.0005 for group A and P = 0.04 for group B. 
4. Discussion 
This study has provided clear evidence, in contrast to 
previous reports [4,5] that the monocotyledonous lectin, 
NPA, is mitogenic for human lymphocytes. We have con- 
firmed that the proliferative response to NPA stimulation 
is age -related, with weak mitogenicity identified for adult 
human lymphocytes, and increasing more than sevenfold 
for lymphocytes from umbilical cord blood. Likewise, 
NPA was found to be mitogenic for PBMC from lambs 
and not adult sheep. As no age- dependent response to 
PHA stimulation was evident in either humans or sheep, 
and the lymphoproliferative responses to NPA in sheep 
reflected our observations in humans, the results presented 
3 
here suggest that age -related divergence in the mononu- 
clear cell population affects the mitogenicity of NPA. Our 
findings relate only to in vitro studies and cannot predict 
in vivo responses to NPA. However, these results indicate 
that exposure of the human population to NPA could 
have physiological consequences. Therefore, to appreciate 
fully the potential implications of introducing foreign lec- 
tins into human and animal food sources, it is essential 
that we extend our knowledge of the plant lectin- mamma- 
lian cell relationship, not only for species specificity but to 
include all age groups. 
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Jaagsiekte sheep retrovirus (JSRV) is the aetio- 
logical agent of ovine pulmonary adenocarcinoma 
(OPA). To monitor changes in cellular immune 
function during JSRV infection, lymphoproliferation 
in response to various mitogens was measured in 
the blood of conventionally housed and specific - 
pathogen -free lambs experimentally infected with 
JSRV until the development of OPA and compared 
with uninfected control lambs. In addition, blood 
samples collected from adult field cases in the 
terminal stages of OPA and control adult sheep 
were compared. No difference in the proliferative 
response to phytohaemagglutinin and pokeweed 
mitogen between the animal groups was detected. 
In contrast, reduced responses to concanavalin A 
stimulation were demonstrated in the JSRV- inocu- 
lated lambs, prior to the onset of clinical disease, 
and also in the terminally ill adult sheep. Peripheral 
blood leukocytes were monitored to identify phen- 
otypic frequency alterations. The CD4 lymphocyto- 
paenia and neutrophilia reported previously in 
adult OPA cases were demonstrated but similar 
phenotypic changes were not identified during 
experimental infection. 
The ß- retrovirus Jaagsiekte sheep retrovirus (JSRV) (Sharp 
et ai, 1983) is the confirmed aetiological agent of ovine 
pulmonary adenocarcinoma (OPA), known previously as sheep 
pulmonary adenomatosis and ovine pulmonary carcinoma 
(Palmarini et al., I996a, 1999). The immunological response to 
JSRV infection is poorly understood. No JSRV -specific humoral 
response has been detected (Sharp & Herring, 1983 ; Ortin et 
Author for correspondence: James Sharp. 
Fax +44 1 31 445 61 1 1. e -mail sharmamri.sari.ac.uk 
0001-8374 © 2002 SGM 
al., 1998). The cell -mediated response to JSRV infection is, as 
yet, unknown, although CD4 lymphocytopaenia and neutro- 
philia have been demonstrated in the peripheral blood of adult 
sheep during the terminal stages of OPA (Rosadio & Sharp, 
1992; Holland et al., 1999). A disseminated infection occurs as 
an early event, with viral RNA and proviral DNA found in 
cells of the immune system. Although very few cells are 
infected, the largest provirus load is in the monocytes /macro- 
phages, followed by B cells, then T cells. However, there is no 
evidence of virus transformation of any of these cell types 
(Palmarini et al., 1996b; Holland et al., 1999). 
The lack of appropriate antigens and JSRV -specific im- 
munological assays has impeded investigations of immune 
responses during tumourigenesis in affected flocks. However, 
OPA can be induced experimentally in neonatal lambs by 
intratracheal inoculation with virus purified from tumour 
(Martin et al., 1976), lung fluid (Sharp et al., 1983) or infectious 
JSRV molecular clones (Palmarini et al., 1999; DeMartini et al., 
2001). Thus, monitoring phenotypic and functional changes in 
the peripheral blood during experimentally induced tumouri- 
genesis is possible. 
The aim of this study was to investigate the systemic 
immune responses at all stages of JSRV infection, through 
tumourigenesis and into the terminal stages of OPA, and to 
establish if changes such as the CD4 lymphocytopaenia and 
neutrophilia reported in adult OPA cases (Rosadio & Sharp, 
1992; Holland et al., 1999) were early events during JSRV 
infection, a consequence of tumourigenesis, or were demon- 
strated only in terminally ill animals. Moreover, the investi- 
gation was extended to identify alterations in cellular immune 
function attributable to JSRV infection. 
The immune status in the terminal stages of OPA was 
determined by the lymphoproliferative responses to the 
mitogens phytohaemagglutinin (PHA), pokeweed mitogen 
(PWM) and concanavalin A (ConA) and phenotypic charac- 
teristics in a single blood sample collected from ten adult field 
cases (brought from various Scottish farms), compared with 
those of ten uninfected adult sheep (from stock at the Moredun 
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Research Institute). Systemic immune responses during the 
pre -clinical stages of disease were monitored in serial blood 
samples collected from six neonatal Dorset lambs inoculated 
intratracheally with JSRV purified from lung fluid, as described 
previously (Sharp et al., 1983), and compared with four, age - 
matched, uninfected control lambs. To exclude the effects of 
external influences and to eliminate secondary infections, the 
investigation was extended to include specific- pathogen -free 
(SPF) lambs (six JSRV -inoculated and four control Suffolk -X 
lambs). 
In all experiments, venous blood samples were collected 
into sterile, preservative -free, heparinized vacutainers (I0 units 
heparin per ml of blood). Aliquots were removed for neutrophil 
counts. To adequately remove the large neutrophil population 
present in the blood of adult OPA cases, it was necessary to 
centrifuge the whole -blood sample for 15 min at 300 g prior to 
peripheral blood mononuclear cell (PBMC) purification using a 
standard laboratory protocol (Boyum, 1968). To maintain 
consistency, this procedure was performed with all of the 
blood samples. Purified PBMCs were adjusted to a final 
concentration of IOe cells /ml in RPMI 1640 medium (Gibco 
BRL) containing antibiotics and IO % inactivated foetal calf 
serum. Plasma was collected also for the detection of JSRV 
capsid (CA)- specific antibodies. 
When symptoms of OPA were apparent, the animals were 
humanely killed by an overdose of pentobarbitone (Rhone 
Merieux) and necropsy was performed. Diagnosis of OPA, 
based on the characteristic gross and histopathological lesions 
described elsewhere (Sharp & Angus, 1990), confirmed the 
disease status of the experimentally infected lambs and adult 
sheep. For the conventionally housed lambs, OPA was 
confirmed in three lambs at 12 weeks, one lamb at 16 weeks 
and one lamb at 20 weeks of age. In the SPF experiment, OPA 
was confirmed in one lamb at 9 weeks, one lamb at 18 weeks 
and one lamb at 20 weeks of age. In each experiment, two 
control lambs were culled at 16 weeks and the remaining two 
control lambs were culled at 20 weeks; none of the lambs 
showed lesions of OPA. 
To demonstrate that phenotypic frequency alterations 
occur in adult OPA cases but not during experimental JSRV 
infection, PBMC phenotyping by indirect immunofluorescence 
was performed using standard laboratory procedures (Bachh et 
al., 1995; Lloyd et al., 1995). Cells were immunolabelled with 
a panel of mouse anti -sheep monoclonal antibodies specific for 
CD2 T cells (I35A), CD4 T cells (17D), CD& T cells (SBU -T8), 
yb T cells (86D), B cells (a -light chain VPM8) and MHC class 
II antigens (VPM54); all antibodies were supplied by Professor 
John Hopkins, University of Edinburgh, Edinburgh, UK). The 
secondary antibody was an FITC- conjugated rabbit anti -mouse 
immunoglobulin (DAKO) and the results were determined by 
flow cytometry (EPICS XL -MCL Coulter Electronics). The 
percentage of neutrophils present in the white blood cell 
population was determined by flow cytometry based on cell 
size and granularity, following red blood cell lysis with 
Erthyrolyse (Serotec). The mean percentage for each animal a 
group was determined ± SEM. Student's two -tailed t -test > 
determined the level of significance between the groups. 
In adult sheep with OPA, a significant decrease (P = 0.02) 
in the percentage of positively immunolabelled CD2 T cells 
(42+3%) was detected in the blood compared with uninfected 
controls (52 ± 3 %). The depletion in the T cell population was ' 
further characterized by a CD4 lymphocytopaenia, with a 
significantly reduced (P = 0.004) percentage of CD4 T cells 
(16 -I- 2 %) detected in the adult OPA cases compared with the 
control sheep (24 ±2 %). No significant frequency alterations 
were identified for CD8 T cells, yb T cells, B cells or MHC class 
II antigens. The percentage of neutrophils present in the blood 
showed a significant increase (P = 0.05) in the terminally ill 
adult OPA cases (52 ± 6%) compared with the control sheep 
(33 +6 %). In contrast, no statistically significant phenotypic 
frequency alterations were identified, at any time during the 20 
weeks after inoculation, in the blood of the experimentally 
JSRV- infected lambs (conventionally housed and SPF) in 
comparison with their respective controls. 
To show that ConA lymphoproliferative responses are 
reduced in experimentally JSRV- infected lambs and adult 
sheep with OPA, the optimum concentration for each mitogen, 
12 µg /ml for PHA, 15 µg /m1 for ConA and 2 µg /m1 for PWM 
(Sigma), was added to 106 PBMCs per ml RPMI 1640 medium. 
Control samples (excluding lectin) were also prepared. Lym- 
phoproliferation was performed at 2 x 10' PBMCs per well (in 
triplicate) in accordance with standard laboratory protocols 
(Kilpatrick, 1998) for a total of 96 h, with the addition of 
0.7 µCi per well [methyl- 3H]thymidine (sp. act. 2.0 Ci /mmol, 
Amersham) for the final 16 h. [3H]Thymidine uptake was 
measured as c.p.m. For each sample, the mean c.p.m. of the 
replicates was calculated and the control mean c.p.m. sub- 
traded. The resulting individual values were used to calculate 
the mean c.p.m. of each animal group ±SEM. Student's two - 
tailed t -test determined the significance of the differences 
between the mean c.p.m. of the different groups. 
No significant difference in the level of response to PHA 
stimulation was identified between the adult OPA sheep and 
the controls. In contrast, a significantly reduced response (P = 
0.03) to ConA stimulation was evident in the PBMCs of adult 
OPA cases (10955 ± 2532 c.p.m.), which was only 58% of the 
response observed in the controls (19000 ± 2426 c.p.m.). No 
difference in response to PHA (Fig. la) or PWM (Fig. Ib) 
stimulation was detected between JSRV -inoculated and con- 
ventionally housed control lambs. However, the infected 
lambs were significantly (P = 0.002- 0.008) less responsive to 
ConA stimulation than the control animals (Fig. Ic). This 
observation was detected first when the lambs were 8 weeks 
old; at that time, the response in the JSRV- infected group was 
only 33 % of that in the control lambs. Reduced responses to 
ConA stimulation in excess of 75 % were demonstrated in the 
infected lambs until the end of the experiment at 20 weeks. The 
lymphoproliferative responses of the infected SPF lambs also 
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Fig. 1. Lymphoproliferative response to PHA, PWM and ConA stimulation 
during experimental JSRV- induced OPA. PBMCs purified from blood 
samples of conventionally housed JSRV- infected and control lambs were 
stimulated with PHA, PWM and ConA. Histogram bars represent group 
means ±SEM for each mitogen. [3H]Thymidine uptake is shown as c.p.m. 
(a) Response to PHA; (b) response to PWM; (c) response to ConA. 
Statistical significance, P = 0.002 -0.008. Control lambs (open bars) were 
tested at 4, 8, 12, 16 (n = 4) and 20 (n = 2) weeks of age. JSRV- 
infected lambs (closed bars) were tested at 4, 8, 12 (n = 6), 16 (n = 3) 
and 20 (n = 1) weeks of age. 
demonstrated a reduced response to ConA stimulation (results 
not shown). 
JSRV CA- specific antibodies were not detected by indirect 
sandwich ELISA. Plasma collected from all the sheep were 
tested for the presence of JSRV CA antibodies by ELISA. A 
recombinant JSRV CA- coating antigen was prepared by 
cloning part of the JSRV gag gene (nucleotide sequence 
published by York et al., 1991) into the plasmid pBAD /His A 
(Invitrogen) and expressed in Escherichia calf LMG 194 cells. 
The plasmid without the CA insert was used as a negative 
control- coating antigen. Sheep anti -CA serum, as a positive 
control, was generated according to Palmarini et al. (1995) with 
some minor adaptations. Specific absorption values were 
calculated by subtracting the control values from the test 
values. The cut -off point to define seropositivity was set as the 
mean A45O of a negative control serum (pre -immunization 
serum) plus three times the standard deviation of the mean 
(four replicates); none of the plasma samples from the 
mmune responses in OPA 
experimental lambs or adult sheep with OPA contained any 
CA antibodies. 
The present investigation of lymphoproliferative responses 
to mitogen stimulation has revealed for the first time an 
alteration in host cellular response due to the presence of JSRV. 
A reduced response to ConA stimulation was evident in the 
PBMCs of experimentally JSRV- infected lambs as an early 
event during tumourigenesis, being apparent from 8 weeks 
of age, prior to clinical disease. Moreover, this functional 
alteration was evident in the adult OPA sheep tested. 
There are many examples of retrovirus- encoded proteins 
with immunosuppressive potential but, during JSRV infection, 
there has been no evidence of virus transformation of immune 
cells, although a disseminated infection is evident (Holland et 
al., 1999). Despite the low virus load, the results of this study 
show that the presence of JSRV does alter cellular function. 
During the early stages of human immunodeficiency virus 
(HIV) infection, when only a small percentage of CD4 
lymphocytes are infected, the cellular function of the T helper 
cell population is adversely affected prior to their depletion 
(Miedema et al., 1988). It has been established that retrovirus 
suppression can be selective for one mitogen without the 
response to other mitogens being affected. For example, HIV - 
1 inhibits PHA- induced lymphoproliferation but does not 
affect the response to ConA stimulation (Mann et al., 1987). 
The transmembrane protein pl5E from murine leukaemia virus 
(Ruegg et al., 1989; Schmidt et al., 1987) and feline leukaemia 
virus (Mathes et al., 1978, 1979) induces immunosuppression 
by preventing aggregation of ConA receptors, suggesting that 
expression of this protein interferes with the redistribution of 
the cytoskeleton (Dunlap et al., 1979). Therefore, although 
immune cells may not be transformed by JSRV, specific 
changes in glycoprotein -bound carbohydrate residues during 
JSRV infection may be involved. 
If no JSRV -specific adaptation at the cell surface occurs, 
then virus modification of post -recognition events, such as 
transport mechanisms and the intracellular pathways utilized 
during mitogenesis, may be implicated. Recent studies have 
identified that the cytoplasmic moiety of the JSRV envelope is 
sufficient to transform rat and mouse NIH 3T3 cells (Maeda et 
al., 2001; Rai et al., 2001). Phosphorylation of protein kinase B 
was detected in all JSRV- transformed cells, which would 
indicate that expression of the JSRV envelope activates the 
phosphatidylinositol 3- kinase (PI -3K) pathway (Palmarini et al., 
2001). PI -3K phosphorylation of protein kinase B is known to 
inhibit apoptotic mechanisms and is essential for the transition 
from Ga -to -S phase during the lymphoproliferative response 
to several mitogens (Roche et al., 1994). Therefore, signal 
transduction and regulatory mechanisms may be influential by 
contributing not only to the neoplastic process but also in 
determining the altered cellular response of JSRV- infected 
sheep. 
Our knowledge of the PBMC phenotypic characteristics 
already identified in OPA cases was extended during this 
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present study. No evidence of the CD4 lymphocytopaenia and 
neutrophilia, detected in the blood of adult sheep during the 
terminal stages of OPA (Rosadio & Sharp, 1992; Holland et al., 
1999) and confirmed in this study_ was revealed during 
experimental disease. This may suggest that these changes do 
not occur in direct response to JSRV infection but are a 
consequence of increased susceptibility to secondary infections 
encountered as the health of the animal declines. 
In adult OPA cases, no evidence of circulating JSRV - 
specific antibodies has been recorded either by Western 
blotting or by ELISA (Sharp & Herring, 1983; Ortin et al., 
1998). In addition, this study demonstrated a lack of specific 
antibodies for the JSRV CA during acute experimental JSRV 
infection and OPA development. 
With no circulating JSRV -specific antibodies detected and 
phenotypic alterations only demonstrated in adult OPA cases, 
the reduced response to ConA stimulation indicates an 
alteration in systemic immunity. This change is an early event 
during JSRV infection, sustained through tumourigenesis and 
into the terminal stages of OPA. 
This work was funded jointly by The Scottish Executive, Rural Affairs 
Division, and by the European Commission, Grant Number QLK2- 
CT1999 -983. 
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